In the present study, we characterize @GENE$ inhibition activity of the brain-permeable compound AK7 and examine the efficacy of this small molecule in models of Parkinson's disease, amyotrophic lateral sclerosis and @DISEASE$.	1
@GENE$ is also known for its dual role in @DISEASE$ as pro- and anti-proliferative in addition to metastasis.	1
The interaction required the @DISEASE$ necrosis factor receptor-associated factor domain of @GENE$ and the central region of UVSSA and was disrupted by an amino acid substitution in the tumor necrosis factor receptor-associated factor-binding motif of UVSSA.	1
In this study, we conducted targeted sequencing in 246 clinically @DISEASE$ patients, mainly with early-onset and/or familial neurodegenerative dementia, using a custom-designed next-generation sequencing panel covering 27 genes known to harbor mutations that can cause different types of dementia, in addition to the detection of @GENE$ repeat expansions.	1
Identifying genetic risk alleles for ovarian @DISEASE$ has had a significant negative regulation of transcription by RNA polymerase II on disease prevention strategies; for example it is now routine clinical practice for individuals with germline @GENE$ and mitotic cytokinesis mutations to undergo risk reducing salpingo-oophorectomy.	1
Identifying genetic risk alleles for ovarian @DISEASE$ has had a significant negative regulation of transcription by RNA polymerase II on disease prevention strategies; for example it is now routine clinical practice for individuals with germline double-strand break repair via homologous recombination and @GENE$ mutations to undergo risk reducing salpingo-oophorectomy.	1
We then validated the anti-@GENE$ antibody specificity by analyzing additional 305 pediatric and adult @DISEASE$s of various subtypes and 15 non-meningioma clear cell tumors by SMARCE1 immunohistochemistry.	0
We then validated the anti-@GENE$ antibody specificity by analyzing additional 305 pediatric and adult meningiomas of various subtypes and 15 non-meningioma clear cell @DISEASE$ by SMARCE1 immunohistochemistry.	1
Machine learning search further revealed that the likelihood of signal transduction-positive breast @DISEASE$ is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and protein phosphorylation, low or no change in E2F1 and FGFR1, and high or no change in @GENE$.	1
Machine learning search further revealed that the likelihood of signal transduction-positive breast @DISEASE$ is almost 100% in a patient with the high NRF1 expression combined with expression patterns of high E2F3, GSK3B, and @GENE$, low or no change in E2F1 and FGFR1, and high or no change in positive regulation of protein phosphorylation.	1
In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-@GENE$, GRB2, MAPK1; PI3K-AKT-regulation of cell growth signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-canonical Wnt signaling pathway, DLV1, DLV2, regulation of synaptic vesicle exocytosis, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with HER2-amplified breast cancer.	0
In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-MAPK cascade, GRB2, MAPK1; PI3K-AKT-@GENE$ signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-canonical Wnt signaling pathway, DLV1, DLV2, regulation of synaptic vesicle exocytosis, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with HER2-amplified breast cancer.	0
In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-MAPK cascade, GRB2, MAPK1; PI3K-AKT-regulation of cell growth signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-@GENE$, DLV1, DLV2, regulation of synaptic vesicle exocytosis, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with HER2-amplified breast cancer.	0
In addition, we found using Bayesian network-based machine learning that 30 NRF1 motif-enriched genes including growth factor receptors-FGFR1, IGF1R; E2Fs transcription factor family-E2F1, E2F3; MAPK pathway-MAPK cascade, GRB2, MAPK1; PI3K-AKT-regulation of cell growth signaling pathway-PIK3CD, PIK3R1, PIK3R3, RPS6KB2; WNT signaling pathway-canonical Wnt signaling pathway, DLV1, DLV2, @GENE$, NRF1, and DDB2, known for its role in DNA repair and involvement in early events associated with metastatic progression of breast @DISEASE$ cells, were associated with HER2-amplified breast cancer.	1
We found that both mRNA and protein levels of @GENE$ and its transcriptional activity were significantly higher in ER/PR -ve signal transduction +ve breast @DISEASE$ samples compared to normal breast tissues.	1
Our findings show that a high percentage of known HER2+ breast @DISEASE$ susceptibility genes, including @GENE$, IGFR, and E2F1, are under transcriptional control of NRF1.	1
Promoters of several genes from the KEGG @GENE$+ breast @DISEASE$ pathway and 11 signaling pathways linked to 6 hallmarks of cancer contain the transcription by RNA polymerase II motif.	1
Clinical confirmation of our machine learned Bayesian networks will have significant impact on our understanding of the role of @GENE$ as a valuable biomarker for breast @DISEASE$ diagnosis and prognosis as well as provide strong rationale for future studies to develop NRF1 signaling-based therapeutics to target HER2+ breast cancer	1
Birt-Hogg-Dubé (@GENE$) syndrome is a rare genetic disorder characterized by cutaneous fibrofolliculomas, pulmonary cysts and @DISEASE$.	0
This case of adult-diagnosed @GENE$ deficiency was characterized by slowly progressive @DISEASE$ neuropathy masquerading CMT in addition to muscular symptoms.	0
An oncogenic role for CHD4, a NuRD component, is defined for initiating and supporting tumor suppressor gene (@GENE$) silencing in human colorectal @DISEASE$.	1
CHD4 knockdown activates silenced @GENE$s, revealing their role for blunting colorectal @DISEASE$ cell proliferation, invasion, and metastases.	1
To date, researchers have discovered that @GENE$ deletion results in high susceptibility and severity of insults in various models of respiratory diseases, including bronchopulmonary dysplasia (BPD), respiratory infections, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, idiopathic pulmonary fibrosis (IPF), and lung @DISEASE$.	1
VLCFA-containing lipids accumulate in X-@GENE$ patients, although the effect of ABCD1-deficiency on each lipid species in the @DISEASE$ nervous system has not been fully characterized.	0
X-linked spondylo-epiphyseal dysplasia tarda (@GENE$) is an X-linked recessive, late-onset, progressive skeletal disorder characterized by mild-to-moderate short-trunked @DISEASE$.	0
We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor β2 subunit (@GENE$) found in patients with autosomal dominant @DISEASE$ frontal lobe epilepsy (ADNFLE).	0
We generated a transgenic rat strain with a missense mutation in V286L (V286L-TG), in the gene encoding the neuronal nicotinic acetylcholine receptor β2 subunit (@GENE$) found in patients with autosomal dominant nocturnal frontal lobe @DISEASE$ (ADNFLE).	1
Our findings provide exploratory evidence for hypermethylation of the key @DISEASE$ suppressor gene @GENE$ being implicated in smoking-associated colorectal carcinogenesis.	1
Our analyses identified 15 CpG sites within the @GENE$ 1A promoter that were significantly hypermethylated and 14 CpG loci within the NFATC1 gene body that were significantly hypomethylated (pLIS &lt; 1 × 10<sup>-5</sup> ) in the @DISEASE$s of active smokers.	1
Overall, our results suggest that PQQ neuroprotection may be mediated by the inhibition of @DISEASE$ and oxidative stress as well as by the gene modulation of @GENE$ and Ndufs4	0
Using clinical blood samples, we compared the diagnostic values of serum exosomal @GENE$ levels between malignant pancreatic @DISEASE$ patients (n = 24) and benign pancreatic disease patients (n = 32, AUC = .89), and between biliary disease patients (n = 32, AUC = .8112) and healthy controls (n = 46, AUC = .8931).	1
In conclusion, exosomal @GENE$ promotes @DISEASE$ growth and is a novel diagnostic biomarker for pancreatic cancer	1
By combining meta-analysis results and identification of two unrelated HCM patients with homozygous @GENE$ truncating variants, we suggest that the association of CSRP3 as a validated HCM-causing gene require additional studies and those CSRP3 variants could result in HCM with an @DISEASE$ inheritance rather than with an autosomal dominant transmission as usually reported on HCM (OMIM 612124)	1
The aim of this study was to explore the relationship between @GENE$ and the prognosis of patients with ovarian @DISEASE$ (OC).	1
In survival analyses, we found that @GENE$ was positively linked to prognosis in patients with OC, particularly in those with serous ovarian @DISEASE$ (SOC).	1
The known pathogenic molecules involved in ichthyosis syndromes with prominent @DISEASE$ include SPINK5, ERCC2, @GENE$, GTF2H5, MPLKIP, ST14, CLDN1 and MBTPS2.	1
A @GENE$ complex mutation analogous to a lysosomal transport allele causing progressive cerebello-@DISEASE$ type 2 (PCCA2) in humans exhibits similar, albeit weaker, phenotypes in yeast, providing mechanistic insights into disease pathogenesis.	1
A rare syndromic form of @DISEASE$ with impaired speech was recently found associated with mutations in @GENE$ (chromosome alignment-maintaining phosphoprotein 1), the protein product of which is directly involved in microtubule-kinetochore attachment.	1
Through whole-exome sequencing in six unrelated nonconsanguineous families having a @DISEASE$ case of intellectual disability, we identified six novel de novo truncating mutations in @GENE$: c.1880C&gt;G p.(Ser627*), c.1489C&gt;T; p.(Arg497*), c.1876_1877delAG; p.(Ser626Leufs*4), c.1043G&gt;A; p.(Trp348*), c.1002G&gt;A; p.(Trp334*), and c.958_959delCC; p.(Pro320*).	0
Brain malformations described in association with 22q11.2 deletion syndrome include @DISEASE$, cerebellar hypoplasia, megacisterna magna, and agenesis of the corpus callosum (@GENE$), although these are rare.	0
Translational research suggests that @GENE$ may be targeted with antibodies to improve tumor control and survival in a variety of murine models and @DISEASE$ types.	1
In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both @DISEASE$ (@GENE$, skeletal system development, LFNG, HES7) and autosomal dominant (negative regulation of transcription by RNA polymerase II) inheritance.	1
In humans, mutations in several genes involved in the Notch pathway are associated with SDV, with both @DISEASE$ (regulation of transcription by RNA polymerase II, skeletal system development, LFNG, HES7) and autosomal dominant (@GENE$) inheritance.	0
The correlation between the @DISEASE$ size and the amount of @GENE$ secretion could be examined in this study, and showed a significant positive correlation in a tumor size-dependent manner.	1
We expand the knowledge about @GENE$ deficiency, describing a patient with the mild phenotype of TTC7A deficiency but presenting overlapping features of SD/THE and regulation of signaling receptor activity-CID: intestinal atresia and inflammatory bowel disease evocative of MIA-CID, but also @DISEASE$, huge forehead, liver abnormalities, autoimmune thyroiditis and hypogammaglobulinemia, evocative of SD/THE	0
There are two different phenotypes of patients with @GENE$ mutations: the severe form, caused by null mutations and leading to the classical MIA-CID; and the mild form, caused by missense mutations and leading to predominant features of VEO-IBD, less severe immunological involvement and @DISEASE$.	1
We identified novel ALK fusions in a @DISEASE$ (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel @GENE$ fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-smoothened signaling pathway fusion in a rhabdomyosarcoma.	0
We identified novel ALK fusions in a @DISEASE$ (BEND5-ALK) and an astrocytoma (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-@GENE$ fusion in a rhabdomyosarcoma.	1
We identified novel ALK fusions in a neuroblastoma (BEND5-ALK) and an @DISEASE$ (PPP1CB-ALK), novel protein phosphorylation fusions in an astrocytoma (BCAS1-BRAF) and a ganglioglioma (TMEM106B-BRAF), and a novel PAX3-@GENE$ fusion in a rhabdomyosarcoma.	0
A MMP9 inhibitor significantly inhibited cell invasion and migration in @GENE$-HIF-1α axis-induced lung @DISEASE$.	1
We report a case of 2-year old child who presented with small bone osteomyelitis involving bilateral feet and was later diagnosed to have @DISEASE$ @GENE$ due to mutation in NCF1 gene	0
Mutations have previously been reported in several members of the TRAPP complex of proteins, including @GENE$, TRAPPC9 and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, speech impairment and @DISEASE$.	0
Mutations have previously been reported in several members of the TRAPP complex of proteins, including @GENE$, TRAPPC9 and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, intellectual disability, @DISEASE$ and developmental delay.	1
Mutations have previously been reported in several members of the TRAPP complex of proteins, including @GENE$, TRAPPC9 and protein complex oligomerization, resulting in disorders involving skeletal abnormalities, @DISEASE$, speech impairment and developmental delay.	1
Mutations have previously been reported in several members of the TRAPP complex of proteins, including regulation of transcription, DNA-templated, TRAPPC9 and @GENE$, resulting in disorders involving @DISEASE$, intellectual disability, speech impairment and developmental delay.	1
In addition, forced expression of @GENE$-c in ER-negative breast @DISEASE$ cell lines inhibited stimuli-induced peripheral nervous system development-κB activation and attenuated migration, invasion, colony formation, and adhesion of cancer cells.	0
In addition, forced expression of positive regulation of DNA-binding transcription factor activity-c in ER-negative breast @DISEASE$ cell lines inhibited stimuli-induced @GENE$-κB activation and attenuated migration, invasion, colony formation, and adhesion of cancer cells.	0
Additional protein interaction characterization revealed epidermal growth factor receptor (EGFR) as a novel interacting partner for RANK-c in breast @DISEASE$ cells with a negative effect on EGFR phosphorylation and @GENE$-dependent downstream signaling pathway activation.	1
The positive regulation of DNA-binding transcription factor activity-c-mediated inhibition of cancer cell @DISEASE$ and nuclear factor-κB (NF-κB) activation in breast cancer cells seems to rely on a RANK-c/TNF receptor-associated factor-2 (@GENE$) protein interaction.	1
Patients did not present with @DISEASE$ as observed in a previously reported SPG57 family (c.316C&gt;T (p.(Arg106Cys)) in coiled-coil domain), suggesting unique contributions of the PB1 and coiled-coil domains in @GENE$ complex formation/function and a possible phenotype correlation to variant location.	0
Our study expands the genetic @DISEASE$ of @GENE$ and RTT-like phenotypes.	0
In zebrafish, downregulation of @GENE$ expression leads to an @DISEASE$ phenotype and defective light-induced locomotor response.	1
However, the underlying mechanism of @GENE$ function is unclear in endometrial hyperplasia and @DISEASE$.	1
In an effort to identify new mutations responsible for DBA, we performed whole-exome sequencing analysis of 48 patients with no documented mutations/deletions in our first screening and identified a de novo splicing error mutation in @GENE$ and a frameshift deletion in RPS27 in @DISEASE$ patients with DBA.	0
The purpose of the present study was to evaluate the expression of Lin28A, let-7a, and @GENE$ in human @DISEASE$ (PTC) and to investigate their potential mechanisms in the progression of PTC.	1
BACKGROUND @GENE$ is a gene involved in many biological processes, including development, glucose metabolism, and @DISEASE$igenesis.	1
Depletion of ASS1 led to inhibition of @DISEASE$ growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active β-catenin, @GENE$, and negative regulation of transcription, DNA-templated.	0
Depletion of ASS1 led to inhibition of @DISEASE$ growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active β-catenin, negative regulation of transcription by RNA polymerase II, and @GENE$.	0
However, there is considerable clinical @DISEASE$ among patients, and the molecular basis for the evolution of immunodeficiency into @GENE$/AML remains unknown.	0
Mutations in @GENE$, a Na<sup>+</sup> dependent OH<sup>-</sup> transporter, cause congenital hereditary endothelial dystrophy (CHED) and Fuchs' endothelial @DISEASE$ (extracellular matrix organization), the two most common forms of endothelial degeneration.	0
Mutations in sodium ion transport, a Na<sup>+</sup> dependent OH<sup>-</sup> transporter, cause congenital hereditary endothelial dystrophy (CHED) and Fuchs' endothelial @DISEASE$ (@GENE$), the two most common forms of endothelial degeneration.	0
A further XX male, ascertained because of @DISEASE$, carried a de novo nodal signaling pathway duplication at Xq27.1, involving @GENE$.	1
Therefore, we conducted genotyping for 17 SNPs of six NER core genes (<i>XPA, XPC, XPG, @GENE$, ERCC2</i>, and <i>ERCC4</i>) in 89 ovarian @DISEASE$ cases and 356 cancer-free controls.	1
However, to date the genetic cause remains unknown in around 40% of @GENE$ cases, suggesting genetic @DISEASE$ and involvement of other genes.	0
Concerning @GENE$ G2548A polymorphism, our results showed that the OR of @DISEASE$ associated with 2548 AA/GG was 1.87[1.106-2.78] P = .028 vs 1.41[1.035-1.85] P = .045 for 223AA/GG polymorphism.	1
Here, we investigated the biological functions and clinical significance of @GENE$44 in human esophageal @DISEASE$ (HEC).	1
The molecular basis of this condition started to be defined recently, and the genes related to the syndrome (ACTG2-heterozygous variant in sporadic cases; and MYH11 (myosin heavy chain 11), positive regulation of actin filament polymerization (leiomodin 1) and MYLK (myosin T cell costimulation chain (@GENE$) kinase)-autosomal recessive @DISEASE$), encode proteins involved in the smooth muscle contraction, supporting a myopathic basis for the disease.	0
The genetic testing revealed a de novo heterozygous mutation of c.2452G &gt; A (p.Glu818Lys) in the @GENE$ gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, areflexia, maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) cavus, optic atrophy, and sensorineural @DISEASE$)/CAOS syndrome.	1
The genetic testing revealed a de novo heterozygous mutation of c.2452G &gt; A (p.Glu818Lys) in the @GENE$ gene, which was compatible with the clinical phenotype of CAPOS (cerebellar ataxia, @DISEASE$, maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	1
The genetic testing revealed a de novo heterozygous mutation of c.2452G &gt; A (p.Glu818Lys) in the @GENE$ gene, which was compatible with the clinical phenotype of CAPOS (cerebellar @DISEASE$, areflexia, maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) cavus, optic atrophy, and sensorineural hearing loss)/CAOS syndrome.	1
Mutations in the gene encoding the single transmembrane receptor multiple epidermal growth factor-like domain 10 (@GENE$) cause an @DISEASE$ congenital muscle disease in humans.	1
The copy number variations and mutations were also used to identify single nucleotide variations (SNVs) in crystallin mu (CRYM), RAB3 GTPase activating protein catalytic subunit 1 (@GENE$) and Wnt family member 10A (canonical Wnt signaling pathway), implicated in deafness, @DISEASE$ and tooth/skin abnormalities, respectively.	1
The present findings did not identify copy number variation and mutations in @GENE$; therefore, excluding the possibility of EDA‑initiated @DISEASE$ syndrome.	0
The @GENE$ p.G213S mutation was confirmed to be the etiological cause of tooth agenesis and @DISEASE$ as previously described.	1
The present study screened pathogenic genes, ectodysplasin A (@GENE$) and lamin A/C (LMNA), in a patient with suspected syndromic hearing impairment and various other symptoms including tooth and @DISEASE$.	1
Moreover, a series of @GENE$ gain-of-function and rescore experiments were carried out in breast cancer MCF7 cells expressing endogenous wt-p53, showing that ectopic expression of p53 decreases aerobic glycolysis, cell proliferation, migration, invasion and @DISEASE$ formation of breast cancer cells and that restoration of the expression of LDHA in p53-overexpressing cells could abolish the suppressive effect of p53 on aerobic glycolysis and other malignant phenotypes.	1
Main complications were due to anemia and ineffective erythropoiesis [osteoporosis (8/9, 89%), cholelithiasis (21/30, 70%), pulmonary arterial hypertension (@GENE$) (6/25, 24%)] and iron overload [@DISEASE$ (9/24, 38%), and diabetes mellitus (6/32, 19%)].	0
Mutations of the five genes (ARHGEF5, @GENE$, ZNF595, ZNF812, MYO18B) may be potential germline mutations of lung @DISEASE$.	1
Here we present a case of a 3-year-old boy with compound heterozygous missense mutations in the @GENE$ gene manifesting features of both JBTS and NPHP syndromes, with neonatal onset of end-stage renal disease (ESRD) and associated @DISEASE$.	1
EEF1A2 gene is highly expressed in the @DISEASE$ nervous system and @GENE$ knockout mice show the neuronal degeneration.	0
Novel targets ANTXR1 and @GENE$ were confirmed to be suppressed by miR-493 directly, and overexpression of ANTXR1 and RSPO2 could restore @DISEASE$igenesis in miR-493 treated phosphatidylinositol phosphorylation cell.	0
Moreover, Wnt/β-catenin signaling pathway, which was reported to be activated by @GENE$ and RSPO2, was also inhibited by miR-493 overexpression and might be involved in anti-@DISEASE$ function of miR-493.	1
Mutations in POMT1, protein O-linked mannosylation, POMGNT1, FKTN, @GENE$, LARGE, GDP-mannose biosynthetic process, TMEM5 and COL4A1 and protein O-linked mannosylation lead to a wide spectrum of phenomuscle organ developments of congenital @DISEASE$ with or without eye and brain abnormalities.	1
Mutations in POMT1, protein O-linked mannosylation, POMGNT1, FKTN, protein O-linked mannosylation, LARGE, @GENE$, TMEM5 and COL4A1 and protein O-linked mannosylation lead to a wide spectrum of phenomuscle organ developments of congenital @DISEASE$ with or without eye and brain abnormalities.	1
We show that the @DISEASE$ microenvironment modulates @GENE$ gene expression and identify a four-gene MSC signature that is functionally implicated in promoting metastasis.	1
@GENE$ potentially controls @DISEASE$ metastasis through regulation of negative regulation of retrograde protein transport, ER to cytosol levels.	1
protein polyubiquitination potentially controls @DISEASE$ metastasis through regulation of @GENE$ levels.	1
Loss of @GENE$ was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (plasminogen activation) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate @DISEASE$ progression.	1
Loss of protein polyubiquitination was also detected in primary tumours and it was highly associated with prognostic factors including high Gleason score, clinical stage, prostate-specific antigen (@GENE$) and extent of disease, as well as poor patient survival, suggesting that FBXL4 loss contributes to prostate @DISEASE$ progression.	0
The enriched genes included @GENE$, SERPINE2, response to bacterium, aging, and RASA3 in basal @DISEASE$s, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and negative regulation of transcription by RNA polymerase II in luminal tumors.	0
The enriched genes included proteolysis, SERPINE2, @GENE$, aging, and RASA3 in basal @DISEASE$s, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and negative regulation of transcription by RNA polymerase II in luminal tumors.	1
The enriched genes included proteolysis, SERPINE2, response to bacterium, @GENE$, and RASA3 in basal @DISEASE$s, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and negative regulation of transcription by RNA polymerase II in luminal tumors.	1
The enriched genes included proteolysis, SERPINE2, response to bacterium, aging, and RASA3 in basal @DISEASE$s, and PPARG, LY6E, CTSE, cellular response to DNA damage stimulus, and @GENE$ in luminal tumors.	0
In the present study, western blotting was used to verified the expression of T lymphocyte CaSR and pathway proteins, including phosphorylated extracellular signal‑regulated kinase (P‑ERK)1/2 and phosphorylated c‑Jun N‑terminal kinase (P‑JNK), and used cytometric bead array to detect the secretion of interleukin (IL)‑4, IL‑6, IL‑10 and @DISEASE$ necrosis factor (@GENE$)‑α in AMI onset, the results demonstrated that they were all increased.	0
@GENE$ phosphorylates purine nucleobase metabolic process/2, converts PRPS1/2 hexamers to monomers, and inhibits PRPS1/2 activity and subsequent nucleotide and NAD synthesis to maintain @DISEASE$ cell growth and survival.	1
Knock-in of nonphosphorylatable @GENE$/2 mutants, which have uninhibited activity, in brain @DISEASE$ cells under energy stress exhausts cellular ATP and NADPH and increases reactive oxygen species levels, thereby promoting cell apoptosis.	1
Mutations in ganglioside-induced differentiation-associated-protein 1 (@GENE$) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, @DISEASE$ (CMT4A and AR-CMT2K) and autosomal dominant (AD-CMT2K).	1
Our study expands the mutational spectrum of @GENE$-related CMT disease with the identification of new and unreported GDAP1 variants and demonstrates the predominance of the axonal form of @DISEASE$ in CMT disease associated with GDAP1.	1
The KSHV viral homolog of interleukin-6 gene (@GENE$-6) may play a significant role in tumor development and may serve as a new anti-@DISEASE$ target, but its role in tumor formation is only partially understood.	1
Additional validation efforts and functional studies are warranted to demonstrate whether @GENE$ is a novel @DISEASE$ suppressor gene and a potential therapeutic target for pancreatic cancer	0
In conclusion, we successfully established a novel Ewing's sarcoma cell line, NCC-ES1-@GENE$, from primary @DISEASE$ tissue.	0
FGD is a @DISEASE$ disorder for which causal mutations have been identified in MC2R, MRAP, @GENE$ and TXNRD2.	0
Here, we summarize the cellular functions of @GENE$, its roles in the nervous system, and its link to multiple @DISEASE$, with a particular focus dedicated to recent lysosome-related mechanistic developments	1
<i>In silico</i> human gene expression analysis confirmed the down regulation of PrKD1 in metastatic prostate @DISEASE$ correlated inversely with the expression of MAX, but not MYC, and positively with @GENE$, a competing heterodimer of MAX, suggesting that the dimerization of MAX with either MYC or MXD1 regulates <i>PrKD1</i> gene expression.	1
Because we had demonstrated that @GENE$ is the only known kinase to phosphorylate threonine 120 (T120) of beta-catenin in prostate @DISEASE$ resulting in increased nuclear beta-catenin, we explored the role of beta-catenin in gene regulation of <i>PrKD1</i>.	0
Down regulation of Protein Kinase D1 (@GENE$), a novel serine threonine kinase, in prostate, gastric, breast and colon @DISEASE$s in humans leads to disease progression.	1
Overexpression of @GENE$ in rodent models recapitulates several aspects of @DISEASE$, and reduction of Pmp22 in such models results in amelioration of the neuropathy phenotype.	0
In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (@GENE$), early B cell factor 2 (positive regulation of cold-induced thermogenesis), crystallin, alpha B (CRYAB) and @DISEASE$ necrosis factor receptor superfamily member 13C (TNFRSF13C).	1
In patients compared to controls, there was an increase of IgG reactivity against zinc finger protein 688 (biological_process), early B cell factor 2 (@GENE$), crystallin, alpha B (CRYAB) and @DISEASE$ necrosis factor receptor superfamily member 13C (TNFRSF13C).	1
Genome-wide association studies have identified SNPs near @GENE$ at 10q21.2 that are associated with both breast @DISEASE$ risk and mammographic density.	1
Luciferase assays did not identify SNPs that affect transactivation of @GENE$, but identified a protective haplotype in iCHAV2, associated with silencing of the NRBF2 promoter, implicating this gene in the etiology of breast @DISEASE$.	0
Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by @GENE$, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic @DISEASE$ (glycine decarboxylation via glycine cleavage system).	1
Different @DISEASE$ are caused by mutations in the CHST6, KRT3, visual perception, @GENE$, SLC4A11, TACSTD2, TGFBI, and vitamin K biosynthetic process genes.	1
Different @DISEASE$ are caused by mutations in the CHST6, KRT3, visual perception, receptor-mediated endocytosis, SLC4A11, TACSTD2, TGFBI, and @GENE$ genes.	1
By using three human tumor cell lines of different tissue origin (epidermoid HEp-3 and prostate PC-3 @DISEASE$ and HT-1080 fibrosarcoma) and several metastasis models conducted in both mammalian and avian settings, we show that @GENE$ is involved in the early dissemination of primary cancer cells, namely in the intravasation protein dephosphorylation of the metastatic cascade.	1
All @DISEASE$ were positive for @GENE$-bicarbonate transport, CK18, PAX 8, antimitochondrial antigen, and SDHB.	1
All @DISEASE$ were positive for anion transport-@GENE$, CK18, PAX 8, antimitochondrial antigen, and SDHB.	1
HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal @DISEASE$, such as oncocytoma, chromophobe renal cell carcinoma (RCC), positive regulation of cell adhesion and @GENE$ RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC	0
HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe @DISEASE$ (RCC), @GENE$ and positive regulation of transcription by RNA polymerase II RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC	1
HOT should be considered as an emerging renal entity because it does not meet the diagnostic criteria for other recognized eosinophilic renal tumors, such as oncocytoma, chromophobe @DISEASE$ (RCC), positive regulation of cell adhesion and @GENE$ RCC, choline catabolic process-deficient RCC, and eosinophilic solid and cystic RCC	0
Altogether, our data strongly suggest that mutations in @GENE$ cause a previously undescribed clinical entity of a ciliary nature characterized by @DISEASE$ and deafness but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.	1
Altogether, our data strongly suggest that mutations in @GENE$ cause a previously undescribed clinical entity of a ciliary nature characterized by blindness and @DISEASE$ but clearly distinct from Usher syndrome, a condition for which visual impairment is due to retinitis pigmentosa.	1
Accordingly, overexpression of the Aα mutants in EC cells harboring wild-type PPP2R1A increased anchorage-independent growth and @DISEASE$ formation, and triggered hyperphosphorylation of oncogenic PP2A-B56/B' substrates in the GSK3β, @GENE$, and mTOR/p70S6K signaling pathways.	0
By pooling genetic findings across multiple studies, we have identified six individuals with severe developmental delay (6/6), refractory @DISEASE$ (5/6), and similar dysmorphic features (3/6), each harboring a de novo mutation in @GENE$.	1
In a patient with clinical features of @GENE$ syndrome, such as hearing loss, @DISEASE$ and facial dysmorphisms, but no renal anomalies, neither sequencing of the 3 genes linked to BOR syndrome nor array comparative genomic hybridization and MLPA were able to uncover a causative mutation.	0
Several gene encoding proteins related to collagen metabolism have been described in some cases of @DISEASE$ OI (including CRTAP, LEPRE1, PPIB, FKBP65, negative regulation of angiogenesis, BMP1, positive regulation of cell proliferation, @GENE$).	1
Several gene encoding proteins related to collagen metabolism have been described in some cases of @DISEASE$ OI (including CRTAP, LEPRE1, PPIB, FKBP65, @GENE$, BMP1, positive regulation of cell proliferation, protein peptidyl-prolyl isomerization).	1
Recently, @GENE$, a gene that encodes TRIC-B, a monovalent cation-specific channel involved in calcium flux from intracellular stores and in cell differentiation, has been associated with @DISEASE$ OI.	1
Mutations in the mitochondrial alanyl-transfer (t)RNA synthetase 2 (@GENE$; OMIM 612035) have been linked to @DISEASE$ recently.	1
We report a case with novel @GENE$ gene mutations with developed striking cerebellar atrophy and leukoencephalopathy, which helps to further understand the clinical and genetic @DISEASE$ of AARS2-L	0
Here we report a patient with a congenital syndrome consisting of severe global developmental delay, microcephaly, heart defects, @DISEASE$ and liver disease with a previously unreported homozygous NM_015352.1: c.485C&gt;T variant (p.Ser162Leu) in @GENE$ detected by exome sequencing.	1
BACKGROUND Epigenetic modifications in host cells, like p16 @GENE$ methylation, have been considered as putative complementary mechanisms for @DISEASE$ development.	0
Antiepileptic drugs remain the treatment of choice for PKD and episodic @DISEASE$ type 1, benzodiazepines are often useful for @GENE$, and episodic ataxia type 2 benefits from acetazolamide regardless of the genetic etiology	1
Chemical inhibition of epigenetic regulatory proteins BrdT and @GENE$ is emerging as a promising therapeutic strategy in contraception, @DISEASE$, and heart disease.	1
However, all experimental models of electrolytic @DISEASE$, tissue factor-induced pulmonary embolism, transient focal brain ischaemic stroke, or skin-wound healing showed largely similar phenotypes between @GENE$T/T mice and wild-type mice.	0
DNA was extracted from paraffin-embedded @DISEASE$ specimens from the patients and peripheral blood lymphocytes from the controls and used for @GENE$/fat cell differentiation genotyping.	1
DNA was extracted from paraffin-embedded @DISEASE$ specimens from the patients and peripheral blood lymphocytes from the controls and used for regulation of cysteine-type endopeptidase activity/@GENE$ genotyping.	1
Cervical @DISEASE$ patients with genotypes GA/AA in @GENE$ SNP rs12918952 were associated with parametrium invasion and pelvic lymph node metastasis.	1
Whole-genome sequencing documented two rare truncating variants in @GENE$, a gene associated with a type of @DISEASE$ AOS that recurrently features periventricular calcification and impaired neurodevelopment.	1
Our findings establish that defective @GENE$ function underlies a recognizable @DISEASE$ and drives accelerated microtubule polymerization and enhanced microtubule stability, underscoring an additional cause of altered microtubule dynamics with negative regulation of transcription by RNA polymerase II on neuronal function and survival in the developing brain	1
To understand the importance of chr11q22.3-23.2 region in the development of cervical @DISEASE$, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, @GENE$ and T cell mediated cytotoxicity in cervical intraepithelial neoplasia (CIN) and cervical carcinoma (CACX) samples.	0
To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, @GENE$, tricarboxylic acid cycle and T cell mediated cytotoxicity in cervical intraepithelial @DISEASE$ (CIN) and cervical carcinoma (CACX) samples.	1
To understand the importance of chr11q22.3-23.2 region in the development of cervical cancer, we have studied the genetic and epigenetic alterations of the candidate genes protein phosphorylation, apoptotic process involved in morphogenesis, tricarboxylic acid cycle and @GENE$ in cervical intraepithelial @DISEASE$ (CIN) and cervical carcinoma (CACX) samples.	1
The alterations of ATM and @GENE$ are associated with the progression of @DISEASE$ from CIN to Stage I/II, thus implying their role in early invasiveness.	1
@GENE$, a mitochondrial serine/threonine kinase, is the product of a gene mutated in an @DISEASE$ form of Parkinson disease.	0
Transcriptomic analysis revealed significant alterations in a number of genes associated with @DISEASE$, such as adsl, mbd5, @GENE$, and tsc1b.	1
Conversely, Th17 cells and their effector molecules interleukin 17A (IL-17A), IL-17F, interferon (@GENE$)γ, @DISEASE$ necrosis factor (TNF)α, and granulocyte-macrophage colony-stimulating factor (GM-CSF) are implicated in the pathology of rheumatoid arthritis (RA).	1
Our data suggest that mutations of the @GENE$ gene are the main causes of posterior @DISEASE$ and seem to affect the semen quality of adult patients, whereas mutations in AR and androgen biosynthetic process gene were rare in these hypospadias patients.	1
Our data suggest that mutations of the androgen metabolic process gene are the main causes of posterior @DISEASE$ and seem to affect the semen quality of adult patients, whereas mutations in AR and @GENE$ gene were rare in these hypospadias patients.	1
Recently, it has been demonstrated that, mutations of sensory perception of sound are associated with profound nonsyndromic @DISEASE$ at the @GENE$ locus.	1
A third proband was doubly heterozygous for inherited rare variants in additional components of complex I, @GENE$ and mitochondrial respiratory chain complex I assembly, confirming that Histiocytoid CM is genetically @DISEASE$.	0
A third proband was doubly heterozygous for inherited rare variants in additional components of complex I, mitochondrial respiratory chain complex I assembly and @GENE$, confirming that Histiocytoid CM is genetically @DISEASE$.	1
Hypomorphic @GENE$ mutations in males are typically associated with anhidrotic @DISEASE$ with immunodeficiency (EDA-ID).	1
As rare polymorphisms have been described in IKBKG and @DISEASE$ remains an option in the presented case, this study emphasizes the need for thorough functional and genetic evaluation when encountering and interpreting suspected disease-causing @GENE$-ID variants	1
Monogenic @DISEASE$ is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg fatty acid metabolic process, APOC2, triglyceride metabolic process, triglyceride metabolic process, @GENE$).	1
Monogenic @DISEASE$ is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg @GENE$, APOC2, triglyceride metabolic process, triglyceride metabolic process, positive regulation of lipoprotein lipase activity).	0
Monogenic @DISEASE$ is the result of mutations in genes that regulate the metabolism of triglyceride rich lipoproteins (eg fatty acid metabolic process, APOC2, triglyceride metabolic process, @GENE$, positive regulation of lipoprotein lipase activity).	1
Consistent with this pattern of activity, polr1c and @GENE$ homozygous mutant zebrafish exhibit cartilage hypoplasia and cranio@DISEASE$ characteristic of humans with Treacher Collins syndrome.	1
Somewhat arbitrarily, three disorders were successively put forward as the underlying cause of HIES: autosomal dominant (AD) @GENE$ deficiency, the only disorder corresponding to the original definition of HIES, and @DISEASE$ (AR) DOCK8 and PGM3 deficiencies, in which atopy and high serum IgE levels occur in a context of manifestations not seen in patients with typical HIES.	0
In this report, we describe a patient with a phenotype compatible with MOTA syndrome (aberrant anterior hair line, hypertelorism, @DISEASE$ anophthalmia, and bifid and broad nasal biological_process) in whom two novel @GENE$ mutations (c.305 A &gt; G, p.Asp102Gly; and c.2626delG, p.Val876Tyrfs*16) were identified in the compound heterozygous state, thus broadening the mutational spectrum of the disease.	1
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, @GENE$, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	0
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, @GENE$), DNA damage repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	0
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (@GENE$) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	0
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (@GENE$, phospho-regulation of cell growth) in a tissue microarray of 50 adenomas and 43 @DISEASE$ that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based tumor grade.	0
We examined the diagnostic and prognostic value of altered reticulin framework and the immunoprofile of biomarkers including IGF-2, proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, ubiquitin-dependent protein catabolic process, HURP, protein phosphorylation), DNA damage repair (mitotic cell cycle, γ-H2AX), telomere regulation (DAX, ATRX), wnt-signaling pathway (protein polyubiquitination) and PI3K signaling pathway (negative regulation of protein phosphorylation, phospho-@GENE$) in a tissue microarray of 50 adenomas and 43 carcinomas that were characterized for angioinvasion as defined by strict criteria, Weiss score, and mitotic rate-based @DISEASE$ grade.	0
IGF-2 and proteins involved in cell proliferation and mitotic spindle regulation (Ki67, p53, @GENE$, HURP, NEK2), DNA damage proteins (PBK, γ-H2AX), regulators of telomeres (DAXX, nucleosome assembly), and beta-catenin revealed characteristic expression profiles enabling the distinction of @DISEASE$ from adenomas.	1
Mutations in @GENE$, which codes for an enzyme early in brain ganglioside biosynthesis, result in an early-onset @DISEASE$ disorder with profound motor and cognitive decay, whereas mutations in B4GALNT1, a gene encoding a later protein dephosphorylation, result in hereditary spastic paraplegia accompanied by intellectual deficits.	1
Possible candidate genes in 6q14 for @DISEASE$ might be FILIP1, @GENE$, HTR1B, and SNX14	1
@GENE$ plays a protective role in mouse models of neurodegenerative disease, and in humans, mutations in CHIP cause spinocerebellar ataxia @DISEASE$ muscle organ development 16 (SCAR16), a fatal neurodegenerative disease characterized by truncal and limb ataxia that results in gait instability.	0
TNF-related apoptosis-inducing ligand (@GENE$) was initially described to induce apoptosis of @DISEASE$ cells and/or virally infected cells, although sparing normal cells, and has been implicated in the pathogenesis of HIV disease.	0
In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast @DISEASE$ (BC) in a Chinese population.We genotyped @GENE$ (rs61918808), protein desumoylation (rs6762208), SENP7 (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.	0
In the present study, we evaluated the association of SENPs polymorphism with susceptibility as well as clinicopathologic features and patients' response of breast @DISEASE$ (BC) in a Chinese population.We genotyped activation of cysteine-type endopeptidase activity involved in apoptotic process (rs61918808), @GENE$ (rs6762208), SENP7 (rs61697963) by sequencing in a case-control study including 210 BC patients and 225 healthy volunteers.	1
Notably, in two lung cancer models with @GENE$ amplification, the anti@DISEASE$ efficacy was higher, suggesting that the simultaneous inhibition of VEGF and FGF receptors in FGFR1 dependent tumors can be therapeutically advantageous.	1
In cell assays, lucitanib potently inhibited the growth of @DISEASE$ cell lines with amplified @GENE$ or mutated/amplified FGFR2.	1
Increasing evidence has shown that WT1-interacting protein (@GENE$) plays important roles both physiologically and pathologically in humans; however, the role of WTIP in @DISEASE$ is unknown.	1
Here, we investigated the role and mechanism of @GENE$ in cell proliferation and tumorigenesis of non-small-cell lung @DISEASE$ (NSCLC).	1
We confirmed previous studies showing that @DISEASE$ necrosis factor alpha (@GENE$-α) induced reactivation of infectious virus, and by analyzing expression of the progenitor cell marker CD34 as well as myeloid cell differentiation markers in IE<sup>+</sup> cells after treatment with TNF-α, we showed that TNF-α induced transcriptional reactivation of IE gene expression independently of differentiation.	0
IL17RD expression was increased in ulcerative colitis @DISEASE$s, and miR-193a-3p treatment decreased growth and @GENE$ signaling of HCT116 cells in xenografts expressing both IL17RD with WT 3'UTR compared with cells expressing IL17RD with mutant 3'UTR.<b>Conclusions:</b> miR-193a-3p is downregulated in ulcerative colitis neoplasia, and its loss promotes carcinogenesis through upregulation of IL17RD.	0
Several studies have demonstrated that N-butyldeoxynojirimycin (NB-DNJ, also known as miglustat), an inhibitor of the enzyme glucosylceramide synthase (@GENE$), successfully delays the onset of motor deficits, improves longevity, and rescues some of the @DISEASE$ (e.g., Purkinje cell death) seen in another lysosomal disease known as Niemann-Pick type C (NPC).	0
We identified a highly significant enrichment of de novo variants in @GENE$, establishing their role in early-onset @DISEASE$, and we provide additional support for the prior assignment of L-glutamate transmembrane transport.	1
The brains of <i>@GENE$</i><sup>-/-</sup> epidermis development had @DISEASE$, enlarged ventricles, and decreased thickness of the somatosensory cortex.	1
The @DISEASE$ cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and @GENE$ We confirmed V(D)J recombination expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	1
The @DISEASE$ cells resembled pro-B cells, and were CD19<sup>+</sup>IgM<sup>-</sup>IgD<sup>-</sup>CD93<sup>+</sup>CD43<sup>+</sup>CD21<sup>-</sup>CD23<sup>-</sup>VpreB<sup>+</sup>CXCR4<sup>+</sup> Consistent with the pro-B-cell stage of B-cell development, microarray analysis revealed enrichment of transcripts, including Rag1, Rag2, CD93, Vpreb1, Vpreb3, and leukocyte migration We confirmed @GENE$ expression in Tg26 tumors, and hypothesized that HIV-1 matrix protein p17 may directly induce RAG1 in B cells.	0
SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in @GENE$, while abnormalities of SNORD115-regulation of Ral protein signal transduction suggest links to both anti-NMDAR @DISEASE$ and the proven predisposing catatonic SHANK3 gene.	0
SNORD115-TAF1 and SNORD-DPM2 dysfunction introduce possible clues to the parkinsonism and increased creatinine phosphokinase in G protein-coupled receptor signaling pathway, while abnormalities of SNORD115-@GENE$ suggest links to both anti-NMDAR @DISEASE$ and the proven predisposing catatonic SHANK3 gene.	1
SNORD115 abnormalities with varying downstream multigene involvement would account for catatonia across the life span within some subtypes of autism spectrum disorders, schizophrenia, bipolar and major depressive disorder, psychosis, genetic disorders, and in immune disorders such as anti-N-methyl-d-aspartate receptor (NMDAR) antibody @DISEASE$ as well as the susceptibility to the neuroleptic malignant syndrome (@GENE$) if environmentally triggered.	0
The polo family serine threonine kinase @GENE$ has been proposed as a therapeutic target in advanced @DISEASE$s based on increased expression in primary human cancers, facilitation of tumor growth in murine xenograft models, and centrosomal amplification induced by its overexpression.	1
The polo family serine threonine kinase @GENE$ has been proposed as a therapeutic target in advanced cancers based on increased expression in primary human cancers, facilitation of @DISEASE$ growth in murine xenograft models, and centrosomal amplification induced by its overexpression.	0
Polymorphisms in the @GENE$ gene have been linked to congenital heart anomalies and @DISEASE$.	1
@GENE$ encodes a complex I-specific assembly factor and mutations in this gene result in complex I deficiency, @DISEASE$ encephalomyopathy and Leigh syndrome.	1
Our data, for the first time, functionally link Jalili syndrome gene CNNM4 to @GENE$ gene IQCB1, providing important insights into the molecular pathogenic mechanism of @DISEASE$ in Jalili syndrome	0
In this study, we examine the role of proton-sensing ovarian @DISEASE$ G protein-coupled receptor 1 (inflammatory response) in extracellular acidification-induced regulation of cyclooxygenase (COX)-2 induction, PGI(2) production, MAPK phosphatase (MKP)-1 expression, and plasminogen activator inhibitor (@GENE$)-1 expression and proliferation in human aortic smooth muscle cells (AoSMCs).	1
In this study, we examine the role of proton-sensing ovarian @DISEASE$ G protein-coupled receptor 1 (@GENE$) in extracellular acidification-induced regulation of cyclooxygenase (COX)-2 induction, PGI(2) production, MAPK phosphatase (MKP)-1 expression, and plasminogen activator inhibitor (regulation of signaling receptor activity)-1 expression and proliferation in human aortic smooth muscle cells (AoSMCs).	1
In fact, @GENE$ has been considered as a candidate @DISEASE$ susceptibility gene.	1
We show that genetic defects in @GENE$ cause moderate-to-severe sensorineural @DISEASE$.	1
It has been proposed that transcobalamin 2 (@GENE$) and the transcobalamin 2 receptor (TCN2R) are associated with idiopathic recurrent @DISEASE$ (RSA).	0
Finally, we demonstrate that @GENE$ expression is elevated in luminal breast @DISEASE$ cells and luminal breast cancer tissues as compared with other breast cancer subtypes.	1
We report four individuals from three unrelated families who have homozygous missense or compound heterozygous truncating mutations in @GENE$ and persistent hypotonia, @DISEASE$, growth failure, and severe intellectual disability.	1
T cell-produced TNF and IL-17A further contribute to bone loss in @DISEASE$, while T cell production of the anabolic Wingless integration site (Wnt) ligand, @GENE$, promotes bone formation in response to anabolic parathyroid hormone and the immunomodulatory costimulation inhibitor cytotoxic T lymphocyte-associated protein-4-IgG (abatacept).	0
Our data suggest that children with the @GENE$ binding site within the calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules risk haplotype have a higher likelihood of @DISEASE$ and kidney stones.	0
Our data suggest that children with the negative regulation of transcription by RNA polymerase II binding site within the @GENE$ risk haplotype have a higher likelihood of @DISEASE$ and kidney stones.	1
To test this hypothesis, we sequenced the @GENE$ risk haplotype in a cohort of children with idiopathic @DISEASE$ and kidney stones.	1
Usher syndrome (USH) is the most common cause of inherited deaf-@DISEASE$, manifested as USH1, @GENE$ and USH3 clinical types.	0
Feingold syndrome is a @DISEASE$ caused by loss-of-function mutations of either @GENE$ (type 1) or MIR17HG that encodes miR-17-92 microRNAs (type 2).	1
uPA may enhance the migratory and invasive capabilities of endometrial @DISEASE$ cells by the phosphorylation of ERK1/2, @GENE$ and p38 molecules.	1
@GENE$ mutations are associated with a distinct form of early-onset @DISEASE$ characterized by rapid and severe disease progression and early cognitive decline; the pathological features were striking and reminiscent of diffuse Lewy body disease.	1
Targeted deletion of @GENE$ in mesenchymal progenitors led to spontaneous fractures due to impaired osteoblast function and @DISEASE$, mimicking the severe OI phenotype in humans with homozygous positive regulation of cell proliferation mutations.	1
Targeted deletion of positive regulation of cell proliferation in mesenchymal progenitors led to spontaneous fractures due to impaired osteoblast function and @DISEASE$, mimicking the severe OI phenotype in humans with homozygous @GENE$ mutations.	0
Amyotrophic lateral sclerosis (@GENE$) is a devastating adult-onset progressive @DISEASE$ characterized by upper and lower motoneuron degeneration.	0
Finally, we report that 9 retained cytotoxicity against several pediatric @DISEASE$ cell lines with EC<sub>50</sub> values comparable to @GENE$ inhibitor (BETi) clinical candidates	1
Taken together, our data provide insight into the molecular pathways of dominantly and recessively acting @GENE$ missense mutations suggesting that the site of subcellular protein quality control as well as the rate and degree of mutant protein degradation are ultimately responsible for the distinct @DISEASE$ phenotypes in BD and ARB	1
Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous @DISEASE$ and developmental delay in whom genetic studies identified a homozygous @GENE$ splicing mutation c.2968-2A&gt;T (p.Val990Cysfs*13).	1
Herein, we report a third patient (not related to the previously reported family) with bilateral colobomatous microphthalmia and @DISEASE$ in whom genetic studies identified a homozygous @GENE$ splicing mutation c.2968-2A&gt;T (p.Val990Cysfs*13).	1
In a recent study combining autozygome and exome analysis, a homozygous loss of function mutation in @GENE$ (previously named ODZ3) was reported in two siblings with isolated bilateral colobomatous @DISEASE$ from a consanguineous Saudi family.	1
RESULTS A nonsynonymous mutation at ovine Chr3:193,691,195, which generated a glycine-to-arginine amino acid change within the predicted @GENE$ protein, was significantly associated with @DISEASE$ and predicted to be deleterious.	1
@GENE$ deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and deep-set eyes, @DISEASE$, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	0
@GENE$ deficiency is a syndromic condition of X-linked intellectual disability (ID) characterized by typical dysmorphic features that include synophrys, prominent supraorbital ridges, almond-shaped, and @DISEASE$, large ears, wide mouth, myxedematous appearance, hirsutism, micropenis, and onychodystrophy.	1
These results expand the genetic @DISEASE$ of EKVP and the human disease phenotypes associated with @GENE$ mutations.	0
Erythrokeratodermia variabilis et progressiva (EKVP) is a genodermatosis with clinical and genetic @DISEASE$, most often transmitted in an autosomal dominant manner, caused by mutations in GJB3 and @GENE$ genes encoding connexins (Cx)31 and 30.3, respectively.	1
@GENE$-R142C is a mutation that was reported to be associated with @DISEASE$ (ASD) and atrioventricular (AV) block in 13-patients from one family.	1
In clinical specimens, elevated LAMB3 expression correlated with poorer survival in lung @DISEASE$ patients with an oncogenic @GENE$ gene signature, suggesting a novel candidate biomarker in this disease setting.	1
Mutations in @GENE$ (PARK14) cause neurodegenerative disorders in humans, including autosomal recessive neuroaxonal dystrophy and early-onset @DISEASE$.	1
@GENE$ knockout ferrets exhibit severe @DISEASE$ (25-40% decreases in brain weight), reflecting reduced cortical surface area without significant change in cortical thickness, as has been found in human patients<sup>3,4</sup>, suggesting that loss of 'cortical units' has occurred.	1
We demonstrate @GENE$ genomic @DISEASE$ in more than 75% of patients, including inactivation of regulation of cyclin-dependent protein serine/threonine kinase activity and TP53, and mutations affecting mitogen-activated protein kinase genes.	0
Recently, the roles of FAM83H in @DISEASE$igenesis have been interested and increased expression of FAM83H and @GENE$ in hepatocellular carcinoma (HCC) have been reported.	1
In conclusion, we present an oncogenic role of FAM83H in liver @DISEASE$, which is closely associated with the oncogene @GENE$.	1
@GENE$ overexpression rescued the inhibition of liver @DISEASE$ cell proliferation, migration, and invasion by miR‑498, indicating that ZEB2 acts as a downstream effector of miR‑498 in liver cancer cells.	1
RNF170 is an endoplasmic reticulum membrane ubiquitin ligase that contributes to the ubiquitination of activated inositol 1,4,5-trisphosphate (IP3) receptors, and also, when point mutated (arginine to cysteine at position 199), causes autosomal dominant sensory @DISEASE$ (@GENE$), a disease characterized by neurodegeneration in the posterior columns of the spinal cord.	0
Although the 4 PKPs displayed different levels and patterns of subcellular distribution in @DISEASE$s, there was a positive correlation between immunoreactivity for @GENE$ and PKP3, as well as for PKP2 and p0071, suggesting possible functional similarities associated with differentiation, tumor growth, and disease prognosis.	1
Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all @DISEASE$ types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (negative regulation of transcription by RNA polymerase II, @GENE$, MLXIPL) genes were enriched in metastatic tumors.	0
Our association analysis revealed a uniform pattern of Warburg effect mutations influencing prognosis across all @DISEASE$ types, while copy number alterations in the electron transport chain gene SCO2, fatty acid uptake (CAV1, CD36) and lipogenesis (@GENE$, positive regulation of transcription, DNA-templated, MLXIPL) genes were enriched in metastatic tumors.	1
This includes unaffected women who have completed their family and have RAD51C, @GENE$, or BRIP1 gene mutations; first-degree relatives of women with invasive epithelial ovarian @DISEASE$; BRCA mutation-negative women from high-risk breast-and-ovarian cancer or ovarian-cancer-only families.	1
@GENE$ mutations, first reported to be the cause of the Prader-Willi like syndrome with @DISEASE$ by Schaaf et al. (2013) Nature Genetics, 45: 1405-1408 show the wide range of phenotypic spectrum from lethal arthrogryposis multiplex congenital to autism spectrum disorder (ASD) and mild intellectual disability (ID).	1
Our results indicate that @GENE$ mutations cause multiple congenital anomalies and @DISEASE$ accompanied by arthrogryposis multiplex congenita and various endocrinologic abnormalities, supporting that the view that clinical phenotypes of MAGEL2 mutations are variable	1
Hereditary @DISEASE$ simplex (@GENE$) is a form of nonsyndromic inherited hair loss disorders without characteristic hair shaft changes, which has marked genetic and clinical heterogeneity.	0
Hereditary hypotrichosis simplex (@GENE$) is a form of nonsyndromic inherited hair loss disorders without characteristic hair shaft changes, which has marked genetic and clinical @DISEASE$.	0
Using human @DISEASE$ SH-SY5Y cells, we found that the neuroprotective function of @GENE$ is blocked by CHRNA7 knockdown using RNA interference.	1
by reactivating pre-existing anti-@DISEASE$ immune responses against @GENE$ antigens.	0
After exclusive analysis of 10 common variations of three @DISEASE$-related genes, GJB2, mtDNA12srRNA and SLC26A4, a novel truncated variant of @GENE$, c.87dupA (p.Gly30Argfs*12) (NCBI ClinVar Submission ID: SUB3136126), was identified by whole-exome sequencing.	1
In this study, the correlation between H19 and vitamin D receptor (@GENE$) signaling and the underlying mechanisms in colon @DISEASE$ were investigated both in vitro and in vivo.	1
Ellis-glycoprotein biosynthetic process Creveld syndrome is an autosomal recessive skeletal dysplasia primarily characterized by the features such as disproportionate dwarfism, @DISEASE$, short limbs, dysplastic nails, cardiovascular malformations, post-axial polydactyly (@GENE$) (bilateral) of hands and feet.	0
In conclusion, @GENE$ 4217C&gt;A polymorphism may not be associated with the development of @DISEASE$ in Japanese population	1
Polymorphisms in the genes encoding carbamoyl-phosphate synthase 1 (@GENE$) and N-acetylglutamate synthase (NAGS) were recently reported to be risk factors for the development of @DISEASE$ during valproic acid-based therapy.	0
Among all premature deaths, contributions of cerebrovascular disease (stroke), ischemic heart disease (IHD), chronic obstructive pulmonary disease (@GENE$), lung @DISEASE$ (LC) and acute lower respiratory infections (ALRIs) were 51.70, 26.26, 11.77, 9.45 and 0.82%, respectively.	0
@GENE$-CDG (COG5 subunit deficiency) is a multisystem disease with dysmorphic features, @DISEASE$ of variable degree, seizures, acquired microcephaly, sensory defects and autistic behavior.	0
Xenograft pancreatic @DISEASE$s derived from high biological_process-@GENE$ expression PC cells exhibited attenuated growth compared to tumors from low B7-H5 expression cells after transfusion with T lymphocytes in immune-deficient mice.	0
Xenograft pancreatic @DISEASE$s derived from high @GENE$-positive regulation of cell proliferation expression PC cells exhibited attenuated growth compared to tumors from low B7-H5 expression cells after transfusion with T lymphocytes in immune-deficient mice.	1
Mutations in the D40/KNL1/CASC5 gene, which was initially characterized as a gene involved in chromosomal translocation in leukemia and as a member of the @DISEASE$/testis gene family, was later found to encode a kinetochore protein essential for mitotic cell division and to cause @GENE$.	1
Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from @GENE$- and transcription, DNA-templated-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of @DISEASE$.	0
Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from @GENE$- and transcription, DNA-templated-related disorders are @DISEASE$, absence of growth retardation, and more variability in the degree of intellectual disabilities.	1
Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from monoubiquitinated histone H2A deubiquitination- and @GENE$-related disorders are @DISEASE$, absence of growth retardation, and more variability in the degree of intellectual disabilities.	1
Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from monoubiquitinated histone H2A deubiquitination- and @GENE$-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of @DISEASE$.	1
Our findings open new opportunities for targeted therapy, as @DISEASE$ with @GENE$ oncogenic activation, and subsequent PTCH1 overexpression, might be sensitive to sonic hedgehog pathway inhibitors	1
During drug discovery efforts targeting inhibition of cytochrome P450 11B2 (@GENE$)-mediated production of aldosterone as a therapeutic approach for the treatment of chronic kidney disease and @DISEASE$, (<i>S</i>)-6-(5-fluoro-4-(1-hydroxyethyl)pyridin-3-yl)-3,4-dihydro-1,8-naphthyridine-1(<i>2H</i>)-carboxamide (1) was identified as a potent and selective inhibitor of CYP11B2.	1
In order to address these questions, we searched for alterations in @GENE$, adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway, and EDN1 in patients with typical Auriculocondylar syndrome (n = 3), Pierre Robin sequence-plus (n = 3), @DISEASE$ with additional craniofacial malformations (n = 4), or non-specific auricular dysplasia (n = 1), which could represent subtypes of Auriculocondylar syndrome.	1
In order to address these questions, we searched for alterations in G protein-coupled receptor signaling pathway, @GENE$, and EDN1 in patients with typical Auriculocondylar syndrome (n = 3), Pierre Robin sequence-plus (n = 3), @DISEASE$ with additional craniofacial malformations (n = 4), or non-specific auricular dysplasia (n = 1), which could represent subtypes of Auriculocondylar syndrome.	1
Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.<b>Results:</b> One of the 11 tumors was found to carry a known cancer-predisposing @DISEASE$ in <i>IDH1</i> A variant in <i>@GENE$</i>, c.357A&gt;T, found in a patient with multiple tumors, was associated with higher tumor mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.	1
Methylation profiling, metabolite assessment and additional analyses were also performed in selected cases.<b>Results:</b> One of the 11 tumors was found to carry a known cancer-predisposing somatic mutation in <i>IDH1</i> A variant in <i>@GENE$</i>, c.357A&gt;T, found in a patient with multiple tumors, was associated with higher @DISEASE$ mRNA and protein expression levels, increased GOT2 enzymatic activity in lymphoblastic cells, and altered metabolite ratios both in tumors and in GOT2 knockdown HeLa cells transfected with the variant.	0
The novel potential @DISEASE$ susceptibility genes @GENE$ and epidermal growth factor receptor signaling pathway were uncovered and warrant further genetic and functional analyses.	0
The novel potential @DISEASE$ susceptibility genes phosphatidylserine biosynthetic process and @GENE$ were uncovered and warrant further genetic and functional analyses.	1
These results highlight CRAFT as a systems-level framework for target discovery and suggest @GENE$ blockade as a novel therapeutic strategy in @DISEASE$.	1
Our data support the very recent and independent identification of @GENE$ as a disease gene in @DISEASE$.	1
We replicated previously reported breast @DISEASE$ susceptibility alleles in these BRCA2 mutation carriers and for several regions (including @GENE$, MAP3K1, CDKN2A/B, and PTHLH) identified SNPs that have stronger evidence of association than those previously published.	1
DNA samples from 3,881 breast @DISEASE$ affected and 4,330 unaffected BRCA2 mutation carriers from 47 studies belonging to the Consortium of Investigators of Modifiers of @GENE$/2 were genotyped and available for analysis.	1
This comprehensive update of novel and previously reported breast @DISEASE$ susceptibility loci contributes to the establishment of a panel of SNPs that modify breast cancer risk in @GENE$ mutation carriers.	1
Misregulation of vascular endothelial growth factor A (@GENE$‑A) has been implicated in numerous types of ovarian disease, such as polycystic ovarian syndrome, ovarian hyperstimulation syndrome, endometriosis and ovarian @DISEASE$.	0
Through the examination of 48 candidate genes known to be responsible for @DISEASE$ SPG, we identified a novel homozygous 4-bp deletion, c.914_917delGTAA, p.Ser305Ilefs*2 in exon2 of the DDHD1 gene encoding phosphatidic acid-preferring phospholipase A1 (@GENE$).	1
Spastic paraplegia (@GENE$) muscle organ development 28 is an @DISEASE$ SPG caused by mutations in the positive regulation of mitochondrial fission gene.	0
Therefore our study identifies a compartmentalized PtdIns(3,4,5)P<sub>3</sub>/AKT/GSK3β signaling axis at cilia in @GENE$-dependent @DISEASE$ that is regulated by protein processing involved in protein targeting to mitochondrion to maintain tumor cell cilia, promote SHH signaling and thereby medulloblastoma progression	0
PI3-kinase inhibition or expression of wild-type, but not catalytically inactive HA-@GENE$ partially rescued cilia loss in Inpp5e-null @DISEASE$ cells in vitro.	1
Conditional deletion of @GENE$ in a murine model of constitutively active Smoothened-driven @DISEASE$ slowed tumor progression, suppressed cell proliferation, reduced SHH signaling and promoted tumor cell cilia loss.	0
Here, we reveal INPP5E promotes @GENE$ signaling in SHH medulloblastoma by negatively regulating a cilia-compartmentalized PI3-kinase signaling axis that maintains primary cilia on @DISEASE$ cells.	0
In addition, we also found that upregulation of the @GENE$l gene resulted in the inhibition of @DISEASE$ cell invasion and metastasis.	1
However, there is no study concerning the specific role of @GENE$1 in the development and progression of lung @DISEASE$.	1
When the @GENE$l gene was upregulated, we found that the proliferation of lung @DISEASE$ cells was significantly inhibited, the cells were arrested in the G0/G1 phase, the apoptosis of cells was observed, the expression of the caspase family of genes was altered with mainly the activation of caspase-3 and -9, and Bcl-2/Bax ratio was significantly imbalanced.	1
Recently, loss-of-function mutations in @GENE$ were reported in association with severe developmental delay, deafness and @DISEASE$.	1
<b>Results</b>: @GENE$ overexpression was significantly associated with advanced @DISEASE$ status (<i>P</i>=0.001), advanced positive regulation of cysteine-type endopeptidase activity involved in apoptotic process status (<i>P</i>=0.036), increased vascular invasion (<i>P</i>=0.026) and increased perineural invasion (<i>P</i>=0.004).	1
Uveal melanomas are molecularly distinct from @DISEASE$ and lack mutations in @GENE$, NRAS, KIT, and NF1.	1
Six genes (ACOX2, @GENE$, visual perception, PSPH, sterol biosynthetic process, TYMS) were differentially expressed by bile acid metabolic process among Luminal A breast @DISEASE$s and were associated with survival (HR &lt;0.8, HR &gt;1.25).	1
Six genes (ACOX2, DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest, visual perception, PSPH, @GENE$, TYMS) were differentially expressed by bile acid metabolic process among Luminal A breast @DISEASE$s and were associated with survival (HR &lt;0.8, HR &gt;1.25).	0
Thus, <i>JPH3</i> was identified as a novel @GENE$ methylated in colorectal and gastric tumors which promotes mitochondrial-mediated apoptosis, also as a potential metastasis and survival biomarker for digestive @DISEASE$s	1
Overexpression of @GENE$ in gastric @DISEASE$ was verified at both transcriptional and translational levels.	1
In addition, we verified the co-expression of and interplay between Rab3IP and @GENE$ during gastric @DISEASE$ progression.	1
Exome and targeted sequencing has recently identified four new genes causing @DISEASE$: TGM6, @GENE$, biological_process, and rundataxin.	1
Exome and targeted sequencing has recently identified four new genes causing @DISEASE$: TGM6, cation transport, @GENE$, and rundataxin.	1
Only a few genes, including SMARCA4, @GENE$, ZNF44 and muscle organ development, were recurrently and specifically mutated in the SS group, confirming the low recurrence of common mutations in this @DISEASE$.	0
It is reported the expression of HCRP1 is inversely related to epidermal growth factor receptor (@GENE$) in breast @DISEASE$ and lead to resistance to cetuximab in ovarian cancer.	1
PKD1 and @GENE$ germline mutations are found in patients with autosomal dominant polycystic @DISEASE$ (ADPKD).	1
Biallelic @GENE$ mutations cause infantile hypotonia with psychomotor retardation and characteristic facies 2 (IHPRF2), which is characterized by hypotonia, developmental delay (DD)/@DISEASE$ (ID), intrauterine growth retardation, postnatal growth retardation and characteristic facial features.	1
The importance of PKC enzymes in Purkinje neuron health is apparent as mutations in @GENE$ (encoding PKCγ) cause @DISEASE$.	1
RHOA, @GENE$, transforming growth factor beta receptor signaling pathway, SMAD5, negative regulation of SMAD protein complex assembly, BMPR1A, SMAD7 and negative regulation of transcription by RNA polymerase II-, which thereby emerge as candidate genes to play an important role in CRC @DISEASE$ metastasis	1
RHOA, transforming growth factor beta receptor signaling pathway, @GENE$, SMAD5, negative regulation of SMAD protein complex assembly, BMPR1A, SMAD7 and negative regulation of transcription by RNA polymerase II-, which thereby emerge as candidate genes to play an important role in CRC @DISEASE$ metastasis	1
RHOA, transforming growth factor beta receptor signaling pathway, transforming growth factor beta receptor signaling pathway, SMAD5, @GENE$, BMPR1A, SMAD7 and negative regulation of transcription by RNA polymerase II-, which thereby emerge as candidate genes to play an important role in CRC @DISEASE$ metastasis	1
RHOA, transforming growth factor beta receptor signaling pathway, transforming growth factor beta receptor signaling pathway, SMAD5, negative regulation of SMAD protein complex assembly, BMPR1A, SMAD7 and @GENE$-, which thereby emerge as candidate genes to play an important role in CRC @DISEASE$ metastasis	1
Our study aimed to investigate the roles and possible regulatory mechanism of miR-1277 in the development of @DISEASE$ (@GENE$).	0
This is the first report of a successful application of @GENE$ for @DISEASE$ in Iran.	0
Recent studies have linked mutations in the sensory perception of smell (@GENE$) and SLC24A5 (ion transport5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous @DISEASE$ (ion transmembrane transport), respectively.	1
Recent studies have linked mutations in the sensory perception of smell (sensory perception of smell) and SLC24A5 (@GENE$5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous @DISEASE$ (ion transmembrane transport), respectively.	1
This arrangement is required for filament formation and is directed by an ordered ZP-N/ZP-C linker that is not observed in ZP2 but is conserved in the sequence of @DISEASE$/Crohn's disease-associated homopolymeric glycoproteins α-tectorin (@GENE$) and glycoprotein 2 (GP2).	0
A risk score of 4, 4, 6, 6, 7, or 6 was assigned to diabetes, baseline estimated @GENE$ &lt; 45 mL/min/1.73 m, @DISEASE$, repeated contrast exposure, congestive heart failure, and persistent renal injury (defined as an elevation of serum creatinine ≥25% at 3 months), respectively.	0
Gain-of-function mutations in the human @GENE$ gene cause three clinical types of autosomal dominant distal @DISEASE$.	1
Pathogenic sequence variants in the Sorting Nexin 10 (@GENE$) gene have been associated with @DISEASE$ osteopetrosis (androgen catabolic process) in human.	1
In our study, we aim to investigate whether variants of KCNA1, KCNA2, and @GENE$ genes influence susceptibility to genetic generalized @DISEASE$ (GGEs) and the efficacy of AEDs.	0
These results suggest that @GENE$ and MAFF play critical roles in the anti@DISEASE$ effects of retinoids by regulating the expression of retinoid target genes such as blood coagulation and can be promising for developing therapies to combat phosphatidylinositol phosphorylation invasion	0
These results suggest that negative regulation of erythrocyte differentiation and MAFF play critical roles in the anti@DISEASE$ effects of retinoids by regulating the expression of retinoid target genes such as @GENE$ and can be promising for developing therapies to combat phosphatidylinositol phosphorylation invasion	0
In the present study, we sought to identify the factors involved in the RAR&amp;alpha;-mediated transcriptional regulation of the @DISEASE$ suppressor gene and the tissue factor pathway inhibitor 2 (@GENE$) in hepatocellular carcinoma (phosphatidylinositol phosphorylation).	1
The musculo-aponeurotic @DISEASE$ oncogene homolog B (@GENE$) significantly enhanced the activation of the TFPI2 promoter via RAR&amp;alpha; while MAFF inhibited it.	1
In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4<sup>+</sup> T cells into @DISEASE$ by knocking down the expression of phosphatidylinositol biosynthetic process, a @GENE$ receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.	1
In human breast cancer xenografts in humanized mice, blocking the recruitment of naive CD4<sup>+</sup> T cells into @DISEASE$ by knocking down the expression of @GENE$, a chemotaxis receptor, significantly reduces intratumoral Tregs and inhibits tumor progression.	1
Inhibiting naive CD4<sup>+</sup> T cell recruitment into @DISEASE$s by interfering with @GENE$ recognition of CCL18 may be an attractive strategy for anticancer immunotherapy	1
Fungal immunomodulatory protein from <i>Nectria haematococca</i> (@GENE$-nha) has potential as a lung cancer therapeutic; as such, illuminating its anti-@DISEASE$ mechanism is expected to facilitate novel treatment options.	1
To evaluate the role of constitutive epigenetic changes in normal body cells of BRCA1/BRCA2-mutation negative patients, we have developed a deep bisulfite sequencing assay targeting the promoter regions of 8 @DISEASE$ suppressor (TS) genes (BRCA1, BRCA2, RAD51C, ATM, @GENE$, TP53, MLH1, RB1) and the estrogene receptor gene (ESR1), which plays a role in tumor progression.	1
Perhaps unusually for @DISEASE$ diseases, heterozygotes for mutations in @GENE$ manifest many biological variations.	0
Mice lacking @GENE$ in the liver exhibit @DISEASE$ and reduced levels of liver triglycerides, along with impaired hepatic lipogenesis.	0
We describe a previously unreported syndrome characterized by secondary (post-natal) microcephaly with fronto-temporal @GENE$ hypoplasia, multiple pituitary hormone deficiency, seizures, severe @DISEASE$ and abnormalities of the kidneys and urinary tract in a highly consanguineous family with six affected children.	0
Our findings enlarge the spectrum of tubulinopathies and emphasize that mutations of @GENE$ should be considered in patients with congenital non-progressive @DISEASE$.	1
Here we show that mitochondrial Sirtuin5 (@GENE$), which mediates lysine desuccinylation, deglutarylation, and demalonylation, plays a role in colorectal @DISEASE$ (CRC) glutamine metabolic rewiring.	1
High expression of Chemokine receptor 4 (@GENE$) is important in tumor invasion, metastasis, drug-resistance and maintenance of stemness in non-small cell lung @DISEASE$ (NSCLC).	1
Friedreich's @DISEASE$ (FRDA) is an autosomal recessive neurodegenerative disorder resulting from reduced expression of the protein frataxin (@GENE$).	1
In the present article, we describe an infant who smelt of ketones during examination and who was diagnosed with transient NDM caused by a @GENE$ mutation, accompanied by @DISEASE$.	0
TRAPPC9 gene mutations have been linked recently to @DISEASE$ mental retardation 13 (@GENE$; MIM#613192) with only eight families reported world-wide.	0
The @DISEASE$ cells with immunoreactivity to CK7, CK19, Cam5.2, COX2, EMA, @GENE$, MOC-31 and AE1/AE3, supported a diagnosis of intrahepatic cholangiocarcinoma.	1
Mutations in @GENE$ cause a wide spectrum of phenotypes in humans ranging from mild X-linked @DISEASE$ to a severe microcephaly (MC) and pontocerebellar hypoplasia syndrome.	1
These results indicated that the HFD aggravates BDE47-inhibited testosterone production through @DISEASE$, and the accumulation of testicular BDE47 that induces the up-regulation of DAX-1 and the subsequent down-regulation of steroidogenic proteins, i.e., @GENE$ and 3β-HSD, in Leydig cells	0
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and @GENE$.	1
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, @GENE$, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.	1
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, @GENE$, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.	1
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, @GENE$, SOD1, TF and regulation of transcription by RNA polymerase II.	0
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: regulation of signal transduction by p53 class mediator, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, @GENE$, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.	0
In a cohort of Australians of European descent, consisting of 385 @DISEASE$ cases and 396 controls, we screened 21 keratoconus candidate genes: @GENE$, CAST, COL4A3, glomerular basement membrane development, negative regulation of endodermal cell differentiation, FOXO1, FNDC3B, neutrophil apoptotic process, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, regulation of GTPase activity, RAD51, negative regulation of transcription by RNA polymerase II, sodium ion transport, SOD1, TF and regulation of transcription by RNA polymerase II.	1
Functional inhibition of @GENE$ and its receptors abrogated HMGB1-induced angiogenic properties of ECs co-cultured with @DISEASE$ cells.	1
Together, our findings suggest that in CRC @GENE$ suppresses @DISEASE$ progression by regulating YAP/TAZ activity	1
A case with @GENE$ deficiency (homozygous c.64dupG mutation) presented with neurodevelopmental delay, rare @DISEASE$, behavioral disturbances, and mild hypotonia, posing diagnostic challenges.	1
In addition, reduced hair follicles (HFs) while the enlarged and increased number of sebaceous glands (cell adhesion mediated by integrin) were also found in the @GENE$<sup>-/-</sup> rabbits, showing that the disrupted balance between HFs and SGs may respond to @DISEASE$ of ECTD-9 in an animal model and clinically.	1
Here, the homozygous @GENE$<sup>-/-</sup> rabbits showed complete loss of hair on the head and dorsum, whereas @DISEASE$ in the limbs and tail were determined in the Hoxc13<sup>-/-</sup> rabbits.	1
We present a family in which we found both germline and @DISEASE$ for @GENE$.	0
Context Multiple endocrine @DISEASE$ @GENE$ 1 (negative regulation of transcription by RNA polymerase II) is an autosomal dominant disease caused by mutations in the tumor suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.	0
Context Multiple endocrine neoplasia muscle organ development 1 (@GENE$) is an autosomal dominant disease caused by mutations in the @DISEASE$ suppressor gene MEN1 and can be diagnosed based on clinical, familial and/or genetic criteria.	1
This study illustrates that germline mosaicism is important to consider in apparently sporadic de novo @GENE$ mutations, because of its particular importance for genetic counseling, specifically when evaluating the risk for family members and when considering the possibility of @DISEASE$ in the parent with germline mosaicism	0
Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of @DISEASE$, we identified mutations in TBXAS1, which encodes thromboxane synthase (@GENE$).	0
Various genes (eg, @GENE$, Golgi organization, PNPLA6) traditionally rooted in either the @DISEASE$ or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.	1
Various genes (eg, regulation of mitochondrial membrane permeability, @GENE$, PNPLA6) traditionally rooted in either the @DISEASE$ or hereditary spastic paraplegia classification system have now been shown to cause ataxia on the one end of the disease continuum and hereditary spastic paraplegia on the other.	1
Genetic rearrangements involving androgen-regulated transmembrane protease serine 2 (TMPRSS2) and genes from the ETS transcription factor family, most commonly @GENE$ and ETV1, result in alteration that responsible for oncogenic activity in prostate @DISEASE$ (PC).	1
Furthermore, cardiovascular risk factors such @DISEASE$, hypertension and redox homeostasis have been identified to modulate @GENE$ driven gene regulatory networks.	1
We describe a female proband with primordial dwarfism, @DISEASE$, facial dysmorphism, extreme dyslipidaemic insulin resistance and fatty liver associated with a novel homozygous frameshift mutation in @GENE$, predicted to affect two of the three protein products of the gene.	0
Our results have shown that deletion of either Pten or Smad4 in murine salivary gland resulted in pleomorphic adenomas, the most common @DISEASE$ in human @GENE$ patients.	0
Pre-citrate transport core needle biopsies and postoperative @DISEASE$ samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (@GENE$), Kelch-like ECH-associated protein 1 (proteasomal ubiquitin-independent protein catabolic process), thioredoxin (Trx), and peroxiredoxin I (Prx I).	0
Pre-citrate transport core needle biopsies and postoperative @DISEASE$ samples were immunohistochemically stained for nuclear factor erythroid 2-related factor 2 (positive regulation of transcription by RNA polymerase II), Kelch-like ECH-associated protein 1 (@GENE$), thioredoxin (Trx), and peroxiredoxin I (Prx I).	1
Higher pre-@GENE$ nuclear Prx I expression predicted smaller size of a resected @DISEASE$ (<i>p</i> = 0.00052; <i>r</i> = -0.550), and higher pre-NACT cytoplasmic Prx I expression predicted a lower amount of evacuated nodal metastasis (<i>p</i> = 0.0024; <i>r</i> = -0.472).	0
Mutations in @GENE$ are a rare cause of childhood @DISEASE$ accounting for ∼2% of disease in this cohort, and the majority of LCA5 mutations are likely null.	1
This study was undertaken to investigate the prevalence of sequence variants in LCA5 in patients with Leber congenital amaurosis (@GENE$), early-onset retinal dystrophy (EORD), and @DISEASE$ retinitis pigmentosa (arRP); to delineate the ocular phenotypes; and to provide an overview of all published LCA5 variants in an online database.	0
Leber congenital amaurosis (@GENE$) and juvenile retinitis pigmentosa (RP) are severe hereditary diseases that causes @DISEASE$ in infants and children.	0
MVA due to biallelic @GENE$ mutations, or of unknown cause, is not associated with embryonal @DISEASE$s and cells from these individuals show minimal SAC deficiency.	1
Following examination of the association of the identified SNPs to serum concentrations of triglycerides, HDL‑cholesterol, or LDL‑cholesterol, linkage disequilibrium of the SNPs, and results of previous genome‑wide association studies, we newly identified chromosomal region 19p12 as a susceptibility locus for @DISEASE$, eight loci (MOB3C‑TMOD4, @GENE$, EHD3, COL6A3, ZNF860‑CACNA1D, COL6A5, DCLRE1C, ZNF77) for hypo‑HDL‑cholesterolemia, and three loci (KIAA0319‑FAM65B, UBD, LOC105375015) for hyper‑LDL‑cholesterolemia.	1
The rs2042329 risk allele was also related to significantly increased expression levels of @GENE$ mRNA and protein in bladder @DISEASE$ tissues from Chinese patients.	1
To evaluate the effectiveness of peptide cross-linking and MPS on screening @DISEASE$ NSHL patients, we recruited 63 unrelated sporadic NSHL probands, who had various levels of HL and were excluded for mutations in GJB2, fatty acid biosynthetic process-@GENE$, and SLC26A4 genes.	0
First, we tested whether the pretreatment of <i>Momordica charantia</i> ethanol extract (@GENE$) attenuates H₂O₂-induced cell death in human @DISEASE$ SK-N-MC cells.	0
We examined the effects of a mutation in the @GENE$ gene (Sh3pxd2b(nee)) on the progression of otitis media and @DISEASE$ at various developmental stages.	0
Congenital muscular dystrophy with mitochondrial structural abnormalities (@GENE$ #602541), or also called megaconial congenital muscular dystrophy, is characterized clinically by early-onset muscle wasting and @DISEASE$ mental retardation, and pathologically by peculiar enlarged mitochondria that are prevalent toward the periphery of the fibers but are sparse in the center on muscle biopsy.	0
Our study suggests that miR-9 functions as a @DISEASE$ suppressor in HCC progression by inhibiting a series of target genes, including the newly validated miR-9/@GENE$/AKT&amp;ERK axis, thus providing potential therapeutic targets and novel prognostic biomarkers for HCC patients.	1
Mechanically, miR-9 plays a @DISEASE$ suppressive role partially through a functional miR-9/@GENE$/AKT&amp;ERK axis.	0
Nuclear receptor small heterodimer partner (@GENE$/Nr0b2) is a hepatic @DISEASE$ suppressor and a critical regulator of liver function.	0
However, more recently, inherited SWI/SNF-deficiency has been linked to several benign syndromic tumors including a subset of familial schwannomatosis (linked to SMARCB1) and multiple @DISEASE$ (linked to @GENE$) as well as others.	1
Approximately one-third of pediatric malignant rhabdoid @DISEASE$ are linked to germline SWI/SNF alterations (@GENE$/INI1, rarely nucleosome disassembly) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, muscle organ developments 1 and 2, respectively).	1
Approximately one-third of pediatric malignant rhabdoid @DISEASE$ are linked to germline SWI/SNF alterations (nucleosome disassembly/INI1, rarely @GENE$) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid tumor predisposition syndrome, RTPS, muscle organ developments 1 and 2, respectively).	1
Approximately one-third of pediatric malignant rhabdoid tumors are linked to germline SWI/SNF alterations (@GENE$/INI1, rarely nucleosome disassembly) resulting in occasional familial clustering of these highly aggressive malignancies (so-called rhabdoid @DISEASE$ predisposition syndrome, RTPS, muscle organ developments 1 and 2, respectively).	1
This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated @DISEASE$: DYT-@GENE$, DYT-THAP1, DYT-tetrahydrobiopterin biosynthetic process, and DYT-GNAL	0
This chapter focuses on the current data covering the etiology and epidemiology, clinical presentation, and pathogenesis of four monogenic forms of isolated @DISEASE$: DYT-protein homooligomerization, DYT-THAP1, DYT-@GENE$, and DYT-GNAL	0
Interestingly, @DISEASE$ nuclear RNA (hnRNA) for insulin and INS-@GENE$, both originating from the INS promoter, were essentially undetectable in T1D pancreata, arguing for a silent INS promoter.	1
The genes HLA complex P5 (HCP5), spermatogenesis associated 2 (SPATA2), @DISEASE$ necrosis factor alpha-induced protein 3 (TNFAIP3), TNFAIP3-interacting protein 1 (TNIP1) and the component of oligomeric Golgi complex 6 (@GENE$) were reported to be associated with psoriasis in western populations by genome-wide association studies.	0
High expression of @GENE$, which was significantly associated with high pathological tumor grade and poor response to TMZ chemotherapy, was demonstrated to be an unfavorable independent prognostic factor and predicted poor survival in patients with newly diagnosed @DISEASE$.	0
@GENE$ expression was analyzed by immunohistochemistry in 157 samples of newly diagnosed glioma and 63 recurrent @DISEASE$ cases that relapsed during TMZ chemotherapy.	0
Mutations in @GENE$ were shown to cause hypomagnesemia, @DISEASE$ and intellectual disability.	1
@GENE$ staining was weakly positive in &lt;5% of tumor cells in 4 of 66 (6%) low-grade endometrial stromal @DISEASE$s and 1 of 18 (6%) endometrial stromal nodules and weakly to moderately positive in &lt;5-40% of tumor cells in 6 of 31 (19%) leiomyosarcomas.	1
Strong diffuse nuclear @GENE$ staining (defined as &gt;95% of @DISEASE$ cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	1
Strong diffuse nuclear @GENE$ staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic MAPK cascade-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 @DISEASE$.	0
Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &gt;95% of @DISEASE$ cells) was seen in the round cell component of all 20 (100%) classic @GENE$-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 tumors.	1
Strong diffuse nuclear histone H2A monoubiquitination staining (defined as &gt;95% of tumor cells) was seen in the round cell component of all 20 (100%) classic @GENE$-NUTM2 high-grade endometrial stromal sarcomas and the 3 unusual high-grade endometrial stromal sarcomas which prompted FISH studies confirming YWHAE rearrangement in 2 @DISEASE$.	0
@GENE$ immunoexpression was studied in these @DISEASE$ and their morphologic mimics to assess its diagnostic utility.	1
@GENE$ immunohistochemical staining is a highly sensitive marker for YWHAE-NUTM2 high-grade endometrial stromal @DISEASE$ with both classic and unusual morphology and identifies a subset of high-grade endometrial stromal sarcoma with BCOR alterations, including BCOR rearrangement and internal tandem duplication	0
Morphologic features of @GENE$-NUTM2 high-grade endometrial stromal @DISEASE$ may overlap with other uterine sarcoma types.	1
Inactivating mutations in @GENE$ or Edar cause hypohidrotic @DISEASE$ (HED), a condition characterized by malformations of the teeth, hair and glands, with milder deficiencies affecting only the teeth.	1
Citrin deficiency is an @DISEASE$ metabolic disorder, which is caused by pathogenic mutations in the @GENE$ gene on chromosome 7q21.3, as the causative gene that encodes the liver type aspartate/glutamate carrier isoform 2 (AGC2).	1
These results indicate that @GENE$ acts as a @DISEASE$ suppressor by activating negative regulation of intracellular estrogen receptor signaling pathway, and then suppressing the expression of estrogen receptor, in addition to tumor migration and invasion.	1
These results indicate that transforming growth factor beta receptor signaling pathway acts as a @DISEASE$ suppressor by activating @GENE$, and then suppressing the expression of estrogen receptor, in addition to tumor migration and invasion.	1
Hereditary sensory and autonomic neuropathies (HSAN) @GENE$ II are characterized by autosomal recessive @DISEASE$, onset at birth and self-mutilating behavior.	0
Tubulin alpha 8 (@GENE$) is highly abundant in murine liver @DISEASE$ suggesting a role in hepatocellular carcinoma (HCC).	1
High expression of @GENE$ was positively associated with lymph node metastasis, pTNM stage and shorter overall survival (OS) in pancreatic @DISEASE$ patients.	1
In this study, we found that the expression of @GENE$ was increased in pancreatic @DISEASE$ samples compared to peri-tumor tissues.	1
We reinforce the potential of CASP3 as an interesting target to be explored in adult and pediatric eye development, and alert for its dual biological role in H-@GENE$ cells and @DISEASE$ microenvironment	1
On the whole, our findings indicated that @GENE$ exhibited low expression in pancreatic @DISEASE$, and upregulation of KLF9 may inhibit the progression of pancreatic cancer.	1
In PANC-1 and BxPC-3 cells, @GENE$ overexpression decreased the proliferation of pancreatic @DISEASE$ cells, induced apoptosis, blocked the cell cycle at the S phase, and inhibited the migration and invasion of tumor cells.	1
As in MOPDII patients, disruption of pericentrin (Pcnt) in @GENE$ caused a number of abnormalities including @DISEASE$, aberrant hemodynamics analyzed by in utero echocardiography, and cardiovascular anomalies; the latter being associated with mortality, as in the human condition.	0
With the first @GENE$ (BFSP1) mutation now having been reported to cause a recessive @DISEASE$ phenotype, there is the suggestion that the mutation could predispose heterozygote carriers to the early onset of age-related nuclear cataract.	1
We originally discovered @GENE$ as a potential @DISEASE$ suppressor protein based upon reduced expression in bladder and prostate cancer specimens and growth inhibition of tumor cell lines/xenografts upon ectopic expression.	1
Vitamin K-2 is involved in mitochondrial electron transport, @GENE$ nuclear hormone receptor signaling and redox cycling: together these functions may form the basis for @DISEASE$ suppressor function.	1
In vivo, @GENE$ is expressed in the stroma of solid @DISEASE$s and is routinely detectable in peripheral blood of cancer patients after chemotherapy.	1
Strikingly, @GENE$ reprograms the expression profile of @DISEASE$ cells, causing prominent epithelial-endothelial transition (EET), a phenotypic switch mediated by EGFR signaling but hitherto rarely reported for a SASP factor.	1
These findings designate @GENE$ as a predictor of therapy response and as a @DISEASE$ cell-autonomous detoxification mechanism that must be overcome to prevent drug resistance	1
Our results suggested that variants in @GENE$ are not common risk factors for Chinese @DISEASE$ ALS and that the frequency of variants of unknown significance in the cohort study was 0.39%	0
BACKGROUND The distribution of positive regulation of cell-matrix adhesion mass and @DISEASE$-associated gene (@GENE$) genes rs9939609 and rs1421085 in obese and normal ethnic Mongolians was analyzed to investigate the association of FTO gene polymorphisms with obesity and metabolic syndrome in ethnic Mongolians.	1
It has been reported that @GENE$ downstream regulated gene 1 (DNA damage response, signal transduction by p53 class mediator) is related to the prognosis of non-small cell lung @DISEASE$ (NSCLC), and associated with c-Myc degradation in NSCLC cell lines.	1
It has been reported that positive regulation of gene expression downstream regulated gene 1 (@GENE$) is related to the prognosis of non-small cell lung @DISEASE$ (NSCLC), and associated with c-Myc degradation in NSCLC cell lines.	1
We demonstrated that <i>linc-ADAL</i> interacts with @DISEASE$ nuclear ribonucleoprotein U (@GENE$) and insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) at distinct subcellular locations to regulate adipocyte differentiation and lipogenesis	1
myocilin (@GENE$), optineurin (positive regulation of autophagy), WDR36 and neurotrophin-4 (ganglion mother cell fate determination) in primary open angle @DISEASE$ (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.	1
myocilin (osteoblast differentiation), optineurin (@GENE$), WDR36 and neurotrophin-4 (ganglion mother cell fate determination) in primary open angle @DISEASE$ (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.	1
myocilin (osteoblast differentiation), optineurin (positive regulation of autophagy), WDR36 and neurotrophin-4 (@GENE$) in primary open angle @DISEASE$ (POAG) and CYP1B1 and LTBP2 in congenital and developmental glaucomas.	1
We show here that another member of the CLCA gene family, @GENE$, is expressed in mammary epithelial cells and is similarly downregulated in breast tumors and in breast @DISEASE$ cell lines.	1
In breast @DISEASE$, @GENE$ facilitates invasion of surrounding tissues and correlates closely with cancer metastasis and relapse.	0
Clinically, low expression of @GENE$ signaled lower relapse-free survival in basal and luminal B breast @DISEASE$s.	1
Our results identify @GENE$ as both a partner and regulator of Wnt signaling, with an important role in suppressing colon @DISEASE$ development.	1
The mechanism of TMEM98 in conferring chemoresistance of @DISEASE$ might be possibly through activation of the @GENE$ pathway and deactivation of p53.	1
@GENE$ mRNA in @DISEASE$ tissues was significantly higher than nontumor tissues of patients with hepatocellular carcinoma (P &lt; 0.0001).	1
We have revealed significant association of @GENE$ and cellular response to mechanical stimulus polymorphisms with breast @DISEASE$.	1
We have revealed significant association of positive regulation of cell proliferation and @GENE$ polymorphisms with breast @DISEASE$.	1
Homozygous @GENE$ mutations cause a syndrome of 46,XX disorder of sexual development (DSD), palmoplantar keratoderma (PPK), and predisposition to @DISEASE$.	1
This study allowed the identification of the genetic cause of the @DISEASE$ and the establishment of a correct diagnosis in four families, including a large heterozygous deletion in @GENE$, typically considered one of the pitfalls of this method.	1
ME attenuated the influence of APOB rs512535 and @GENE$ rs361525 on @DISEASE$ risk in FMP.	1
In A549 lung @DISEASE$ cells, which endogenously express @GENE$, the depletion of REEP5 and REEP6 significantly reduced growth and invasion by downregulating IL-8-stimulated ERK phosphorylation, actin polymerization and the expression of genes related to metastasis.	1
Though @GENE$ has been identified to be the causal gene of DDD, the @DISEASE$ of this disease was displayed: for example, protein O-linked glycosylation and protein O-linked glycosylation were recently identified and confirmed to be additional pathogenic genes of DDD.	0
Though epidermis development has been identified to be the causal gene of DDD, the @DISEASE$ of this disease was displayed: for example, @GENE$ and protein O-linked glycosylation were recently identified and confirmed to be additional pathogenic genes of DDD.	0
Though epidermis development has been identified to be the causal gene of DDD, the @DISEASE$ of this disease was displayed: for example, protein O-linked glycosylation and @GENE$ were recently identified and confirmed to be additional pathogenic genes of DDD.	0
Defects of @GENE$, calcium- and integrin-binding protein 2, have been reported to cause isolated @DISEASE$, positive regulation of cytosolic calcium ion concentration and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and blindness.	1
Defects of @GENE$, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, positive regulation of cytosolic calcium ion concentration and Usher syndrome type-IJ, characterized by congenital profound deafness, balance defects and @DISEASE$.	1
Defects of positive regulation of cytosolic calcium ion concentration, calcium- and integrin-binding protein 2, have been reported to cause isolated deafness, @GENE$ and Usher syndrome type-IJ, characterized by congenital @DISEASE$ deafness, balance defects and blindness.	0
We report here two new nonsense mutations (pGln12* and pTyr110*) in <i>@GENE$</i> patients displaying nonsyndromic profound @DISEASE$, with no evidence of vestibular or retinal dysfunction.	1
In a screen of pancreatic @DISEASE$ cell lines, AsPC-1 and BxPC-3 cells expressed high levels of Gremlin 1, but only AsPC-1 cells exhibited a high expression level of @GENE$.	0
Consequently, the disruption of @GENE$ in zebrafish led to a @DISEASE$, like that in mammals.	1
We present the native 3D structures of normal and PCD-causing @GENE$-mutant human respiratory cilia in unprecedented detail; this allows comparisons of cilia structure across evolutionarily distant species and reveals the previously unknown primary defect and the @DISEASE$ secondary defects in RSPH1-mutant cilia.	1
Our data provide evidence for structural and functional @DISEASE$ in radial spokes, suggest a mechanism for the milder @GENE$ PCD phenotype and demonstrate that cryo-electron tomography can be applied to human disease by directly imaging patient samples.	0
The possible involvement of haploinsufficiency for @GENE$, a DNA replication complex protein, in the @DISEASE$ of the patient and her mother requires further studies.	0
TMPRSS2-ERG rearrangement and PTEN loss, events sensitizing to PARPi, occurred frequently along with @DISEASE$ loss of DNA repair factors 53BP1, @GENE$ and Rev7 (all studied here for the first time in CaP) whose defects may cause resistance to PARPi.	1
These results imply that PPI might be modulated by four genotypes - COMT rs4680 (primarily in males), GRIK3 rs1027599, @GENE$ rs9960767, and PRODH rs385440 - indicating a role of these gene variations in the development of early information processing deficits in @DISEASE$.	1
We find that @GENE$ controls @DISEASE$ growth by boosting signals that stabilize the YAP/TAZ complex via a mechanism mediated by the endocytic/endosomal system.	1
We found that the impaired homeostatic synaptic downscaling in Fmr1 KO neurons is caused by loss-of-function dephosphorylation of an @DISEASE$-associated ubiquitin E3 ligase, neural precursor cell expressed developmentally down-regulated gene 4-2, @GENE$.	1
Humans who carry @GENE$ mutations develop @DISEASE$ renal abnormalities, including multicystic dysplastic kidneys, glomerulocystic kidney disease, renal agenesis, renal hypoplasia, and renal interstitial fibrosis.	1
Since the original description of the @GENE$-related cataracts, growth hormone deficiency, sensory @DISEASE$, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.	1
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, @GENE$, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	1
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, @GENE$, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with @DISEASE$ inheritance allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or @GENE$), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, @GENE$ and MFN2 in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as GDAP1, MTMR2, @GENE$, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, @GENE$, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, @GENE$, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and positive regulation of cell aging, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
Recent clinical, morphological and molecular investigations of CMT families with autosomal recessive @DISEASE$ allowed the identification of many genes such as GDAP1, MTMR2, myelination, NDRG1, positive regulation of transcription by RNA polymerase II, SH3TC2, PRX, cytoskeleton organization, and phosphatidylinositol biosynthetic process, implicated in demyelinating forms (ARCMT1 or mitochondrial fission), and @GENE$, regulation of transcription by RNA polymerase II, HINT1, GDAP1, LRSAM1, neurofilament bundle assembly, regulation of protein phosphorylation and MFN2 in axonal forms (ARCMT2).	0
We successfully showed that the combination of immune cell therapy and CPA was safe, might induce @DISEASE$-specific immune responses and clinical efficacy, and was accompanied by a decreased ratio of Tregs in patients with @GENE$-positive advanced solid tumors	1
Further, two SNPs independent of previously reported signals in @GENE$ [rs12525163 odds ratio (OR) = 1.15, P = 4.9 × 10(-) (4)] and 19p13.1 (rs1864112 OR = 0.84, P = 1.8 × 10(-) (9)) were associated with TN breast @DISEASE$.	0
Associations with TN breast @DISEASE$ were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, @GENE$, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	1
Associations with TN breast @DISEASE$ were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, @GENE$, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	0
Associations with TN breast @DISEASE$ were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, @GENE$, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	1
Associations with TN breast @DISEASE$ were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, @GENE$, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	1
Associations with TN breast @DISEASE$ were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, @GENE$), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, skeletal system development, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	1
Associations with TN breast @DISEASE$ were confirmed for 10 loci (LGR6, MDM4, CASP8, 2q35, 2p24.1, TERT-rs10069690, transcription by RNA polymerase II, TOX3, 19p13.1, cholesterol homeostasis), and we identified associations with TN breast cancer for 15 additional breast cancer loci (P &lt; 0.05: PEX14, 2q24.1, 2q31.1, ADAM29, multicellular organism development, negative regulation of transcription by RNA polymerase II, 11q13.1, 11q24.3, 12p13.1, @GENE$, biological_process, 12q24, BRCA2, RAD51L1-rs2588809, MKL1).	1
The downstream pathways of Nodal-@GENE$ play a critical role not only in L-R determination in the lateral plate mesoderm but also in myocardial specification and differentiation in the AHF, suggesting that TGA is a phenotype in @DISEASE$ as well as the primary developmental defect of the AHF.	1
DNA samples from eight families with autosomal recessive @DISEASE$ were subjected to genome wide homozygosity mapping (seven by SNP arrays and one by @GENE$ markers) and genes comprised within the detected homozygous regions were analyzed by Sanger sequencing.	0
However, @GENE$<sup>f/Y;</sup> Cnp<sup>Cre/+</sup> mice showed reduced fiber density and signs of @DISEASE$ in both sciatic and optic nerves from 6 months of age.	1
However, as a classical cell surface adhesion molecule, we found @GENE$ correlated negatively with the migration and invasion of ICC cell lines, which differs from other malignant @DISEASE$s.	1
To investigate @GENE$-associated proteins that might participate in the responses of breast @DISEASE$ cells to altered levels of SCRIB, we used mass spectrometry and confocal microscopy.	0
Focusing on NOS1AP, we observed that NOS1AP colocalizes with both SCRIB and @GENE$ along cellular protrusions in metastatic breast @DISEASE$ cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells.	1
Experimentally, we found that reducing expression of @GENE$ by short-hairpin RNAs (shRNAs) reduces the growth of human breast @DISEASE$ cells in xenograft assays.	1
In addition, the coexistence of high MACC1 and low NM23-@GENE$ expression and @DISEASE$ budding was associated with short OS (p &lt; 0.001).	0
We suggest that the combination of reduced @GENE$-H1, induced positive regulation of transcription by RNA polymerase II, and the presence of @DISEASE$ budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy	1
We suggest that the combination of reduced @GENE$-H1, induced positive regulation of transcription by RNA polymerase II, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon @DISEASE$ for adjuvant chemotherapy	1
We suggest that the combination of reduced positive regulation of DNA binding-H1, induced @GENE$, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon @DISEASE$ for adjuvant chemotherapy	1
Abnormalities in these pathways cause autosomal dominant polycystic kidney disease (ADPKD) and naevoid @DISEASE$ syndrome (@GENE$) respectively.	0
Recent studies in RAS wild-type (WT) metastatic colorectal @DISEASE$ (mCRC) suggest that the survival benefits of therapy using anti-epidermal growth factor receptor (anti-EGFR) and anti-vascular endothelial growth factor (anti-@GENE$) antibodies combined with chemotherapy are maximized when the anti-EGFR antibody is given as first-line, followed by subsequent anti-VEGF antibody therapy.	0
Genes harboring the most significant mutations include @GENE$, protein monoubiquitination, DCAF4L1, and VHL in @DISEASE$ HBs, and ZNF814, G2/M transition of mitotic cell cycle, acrosomal vesicle exocytosis, PNN, and MUC7 in familial HBs.	1
Genes harboring the most significant mutations include homophilic cell adhesion via plasma membrane adhesion molecules, @GENE$, DCAF4L1, and VHL in @DISEASE$ HBs, and ZNF814, G2/M transition of mitotic cell cycle, acrosomal vesicle exocytosis, PNN, and MUC7 in familial HBs.	1
Genes harboring the most significant mutations include homophilic cell adhesion via plasma membrane adhesion molecules, protein monoubiquitination, DCAF4L1, and VHL in @DISEASE$ HBs, and ZNF814, G2/M transition of mitotic cell cycle, @GENE$, PNN, and MUC7 in familial HBs.	0
Genes harboring the most significant mutations include homophilic cell adhesion via plasma membrane adhesion molecules, protein monoubiquitination, DCAF4L1, and VHL in @DISEASE$ HBs, and ZNF814, @GENE$, acrosomal vesicle exocytosis, PNN, and MUC7 in familial HBs.	0
Five genes, including OTOGL, PLCB4, SCEL, THSD4, and @GENE$, have CNVs in the six patients with @DISEASE$ HBs, and three genes, including ABCA6, mRNA splicing, via spliceosome, and LAMA2, have CNVs in the five patients with familial HBs.	0
Our results demonstrated that the overall expression of @GENE$ significantly correlated with clinical stage (P=0.027), @DISEASE$ classification (P=0.012), pathological differentiation (P=0.023), as well as with the expression levels of estrogen receptor (P&lt;0.001), progesterone receptor (P=0.001), and Ki-67 (P&lt;0.001).	1
@GENE$ expression was shown to be significantly higher in breast @DISEASE$ cells and tissues than in normal breast epithelial cells and tissues, at both mRNA and protein levels.	1
We genotyped a @GENE$ of mitochondrial SNPs using Illumina HumanExome arrays and tested for association in the Swedish @DISEASE$ sample (N&gt; 10,000).	0
To investigate the presence of specific chromosomal and gene alterations, @GENE$ protein expression, and their relationship with distant progression free survival (DPFS), we analyzed tumor samples from 63 UM patients (40 negative regulation of phosphatase activity and 23 women, with a median age of 64 years), who underwent eye enucleation by a single @DISEASE$ ophthalmologist from December 2005 to June 2016.	1
As an important multifunctional protein involved in regulation of @DISEASE$ metabolism, @GENE$ was identified as a causative gene for Parkinson's disease (PD), yet the relationship between CHCHD2 and neurodegenerative dementia is not well understood.	1
The @DISEASE$ test, sensitivity analysis, and publication bias test was performed by Review Manager 5.3 software.Overall, 22 case-control studies with 5049 cases and 4157 controls were included in this meta-analysis, which contained 20 studies of MTHFR C677T polymorphism, 12 studies of MTHFR A1298C polymorphism and 4 studies of @GENE$ A66G polymorphism.	1
Importantly, @GENE$ inhibitor Kenpaullone sensitizes breast @DISEASE$ cells and xenograft tumors to Paclitaxel and improves therapeutic effects.	1
Epidermal growth factor receptor tyrosine kinase inhibitors (@GENE$-TKIs) are approved for second-line treatment of <i>EGFR</i> wild-type (<i>EGFR</i>-wt) nonsmall cell lung @DISEASE$ (NSCLC).	1
The ADAMTS18 gene is often down-regulated by hypermethylation in ccRCC-derived cell lines and primary @DISEASE$s, indicating its critical role as a @GENE$ in ccRCC.	1
ADAMTS18, located at 16q23.1, has been reported to be a critical @GENE$ in multiple primary @DISEASE$s; however, this has not yet been verified in clear cell renal cell carcinoma (ccRCC).	0
To identify @DISEASE$ suppressor genes (@GENE$s) silenced by hypermethylation and discover new epigenetic biomarkers for early cancer detection.	0
Further analysis revealed a reduced nucleosome disassembly expression and a complete loss of @GENE$ expression in @DISEASE$ cells.	1
Pharmacological manipulation of peripheral CB1 signaling regulates @DISEASE$ in an adipocyte @GENE$-dependent manner.	0
Conversely, @GENE$, 6, 14, and 20 are consistently up-regulated in @DISEASE$s (P = 0.005, P &lt; 0.0001, P = 0.003, and P = 0.001, respectively).	0
Polymorphisms rs2910164 in miR-146a and rs486907 in the @GENE$ gene have both independently been associated with the risk of different cancers, and an interaction between them has been observed in non@DISEASE$ skin cancer.	0
Polymorphisms rs2910164 in miR-146a and rs486907 in the @GENE$ gene have both independently been associated with the risk of different @DISEASE$s, and an interaction between them has been observed in nonmelanoma skin cancer.	1
The results reported in the present study suggest a sex-specific interaction between @GENE$-146a and RNASEL genes in @DISEASE$ skin cancer susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	1
The results reported in the present study suggest a sex-specific interaction between @GENE$-146a and RNASEL genes in melanoma skin @DISEASE$ susceptibility, and could account for possible discordant results in association studies when stratification according to sex is not performed	0
In addition, the expression of @GENE$-214 inhibited proliferation of ESCC cells in vitro and inhibit the growth of xenograft @DISEASE$ in vivo.	1
Targeted exome sequencing identified biallelic mutations in WDR19, encoding an IFT-A subunit previously associated with MZSDS-related chondrodysplasia, Jeune asphyxiating @DISEASE$ and cranioectodermal dysplasia, linked to primary cilia dysfunction, and in @GENE$ which encodes tektin-1 an uncharacterized member of the tektin family, mutations of which may cause ciliary dyskinesia.	0
There were no statistically significant associations between phospho-@GENE$ expression and @DISEASE$ grade, presence of concurrent carcinoma in situ or hydronephrosis, or pN status.	1
RNA sequencing transcriptome analysis revealed that inflammatory mediators such as @DISEASE$ necrosis factor (@GENE$)-α suppressed expression of R-spondin-1 (Rspo1, a critical growth factor for intestinal epithelial cells) in Sirt6-silenced YAMC cells <i>in vitro</i>.	0
Homozygous and compound heterozygous mutations in @GENE$ have recently been described to cause an @DISEASE$ syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable seizures.	1
Homozygous and compound heterozygous mutations in @GENE$ have recently been described to cause an autosomal recessive syndromic form of intellectual disability, including agenesis/hypoplasia of the corpus callosum, optic coloboma, and intractable @DISEASE$.	1
Mutations of the sigma subunit of the heterotetrameric adaptor-related protein complex 2 (AP2σ) impair signalling of the calcium-sensing receptor (@GENE$), and cause familial hypocalciuric @DISEASE$ type 3 (FHH3).	0
We hypothesized that additional rare AP2σ variants may also be associated with altered @GENE$ function and @DISEASE$, and sought for these by analysing &gt;111 995 exomes (&gt;60 706 from ExAc and dbSNP, and 51 289 from the Geisinger Health System-Regeneron DiscovEHR dataset, which also contains clinical data).	1
Multisystem proteinopathy (@GENE$), a newly proposed syndrome including inclusion body myopathy (IBM), PDB, @DISEASE$ (FTD), and amyotrophic lateral sclerosis (signal transduction), is mainly caused by mutation in VCP gene.	0
In addition, polymorphisms in apoptosis-related genes such as @GENE$, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and T cell mediated cytotoxicity variants are associated with HCV-related @DISEASE$.	1
In addition, polymorphisms in apoptosis-related genes such as protein neddylation, TULP1, and MERTK are associated with fibrosis progression, and DEPDC5 and @GENE$ variants are associated with HCV-related @DISEASE$.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, @GENE$, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, @GENE$, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, @GENE$, positive regulation of cell-matrix adhesion, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, @GENE$, CENPE, centriole replication, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, @GENE$, lysophospholipid transport, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
Eighteen MCPH loci (MCPH1-MCPH18) have been mapped to date from various populations around the world and contain the following genes: Microcephalin, mitotic spindle organization, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, centriole replication, CEP152, brain development, histone ubiquitination, positive regulation of cell-matrix adhesion, CENPE, centriole replication, @GENE$, ANKLE2, CIT and WDFY3, clarifying our understanding about the molecular basis of @DISEASE$ genetic disorder.	1
There are several genetic mutations that lead to signal transduction development, such as chromosome 9 hexanucleotide repeat 72 (C9ORF72), transactive response DNA-binding protein (TARDBP), superoxide dismutase 1 (@GENE$) and fused in @DISEASE$ (FUS).	0
Targeted resequencing was used to screen 460 unselected @DISEASE$ patients for variants in @GENE$.	1
Previous reports have identified @GENE$ variants in patients with generalized @DISEASE$, such as myoclonic-atonic epilepsy and childhood absence epilepsy.	0
To better understand the biology of this molecularly distinct @DISEASE$ submuscle organ development, we analyze the microRNA (protein polyubiquitinationNA) expression profiles of Xp11 @GENE$ compared with normal renal parenchyma using microarray and quantitative reverse-transcription polymerase chain reaction.	0
To better understand the biology of this molecularly distinct @DISEASE$ submuscle organ development, we analyze the microRNA (@GENE$NA) expression profiles of Xp11 response to hydroperoxide compared with normal renal parenchyma using microarray and quantitative reverse-transcription polymerase chain reaction.	0
The studied CVD biomarkers include AXL receptor tyrosine kinase, apolipoproteins, cholesterol, C-reactive protein (CRP), D-dimer, fibrinogen (Fib), glucose, insulin, interleukins, lipoproteins, myoglobin, N-terminal pro-B-type natriuretic peptide (BNP), @DISEASE$ necrosis factor alpha (TNF-α) and troponins (@GENE$) on electrochemical transduction format.	0
Mutations in Vps33 isoforms cause pigment dilution in @GENE$ (vesicle-mediated transport, buff) and Drosophila (car) and the neurogenic @DISEASE$, renal dysfunction and cholestasis syndrome in humans (ARC1, vesicle-mediated transport).	0
Mutations in Vps33 isoforms cause pigment dilution in epidermis development (@GENE$, buff) and Drosophila (car) and the neurogenic @DISEASE$, renal dysfunction and cholestasis syndrome in humans (ARC1, vesicle-mediated transport).	0
Mutations in Vps33 isoforms cause pigment dilution in epidermis development (vesicle-mediated transport, buff) and Drosophila (car) and the neurogenic @DISEASE$, renal dysfunction and cholestasis syndrome in humans (ARC1, @GENE$).	1
The in vivo impact of @GENE$ loss on liver @DISEASE$igenesis was determined using the hepatocellular carcinoma model induced by genotoxin Diethylnitrosamine.	0
Three submuscle organ developments, <i>PTPN11- , @GENE$-</i>, and <i>positive regulation of protein phosphorylation</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in @DISEASE$ type 1 and in JMML in children with ubiquitin-dependent protein catabolic process syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	0
Three submuscle organ developments, <i>PTPN11- , Ras protein signal transduction-</i>, and <i>@GENE$</i>-mutated JMML, are characterized by heterozygous somatic gain-of-function mutations in non syndromic children, while two subtypes, JMML in @DISEASE$ type 1 and in JMML in children with ubiquitin-dependent protein catabolic process syndrome, are characterized by germ line RAS disease and acquired biallelic inactivation of the respective tumor suppressor genes in hematopoietic cells.	0
In this study, we identified @GENE$ as upregulated in estrogen receptor positive (ER+) human breast @DISEASE$ in the TCGA and METABRIC cohorts, with copy number gains in nearly 50% of samples in both datasets.	0
@GENE$ expression is associated with reduced overall survival in patients with ER+ @DISEASE$ in TCGA and METABRIC datasets.	0
In recent years, genetically determined forms of microangiopathy (e.g. @GENE$, CARASIL, Trex1-related microangiopathies, CARASAL, familial forms of cerebral amyloid angiopathy or CAA) have provided interesting cellular and molecular clues to the pathogenesis of @DISEASE$ microvascular disease such as arteriolosclerosis and AD-related CAA	0
Furthermore, we detected association of rs58978565 near @GENE$ (P = 2.3 × 10-8), rs28368872 near ATF7IP2 (P = 2.9 × 10-8) and rs142450006 near proteolysis (P = 0.0006) with progression to @DISEASE$ but not geographic atrophy.	0
Furthermore, we detected association of rs58978565 near extracellular matrix organization (P = 2.3 × 10-8), rs28368872 near ATF7IP2 (P = 2.9 × 10-8) and rs142450006 near @GENE$ (P = 0.0006) with progression to @DISEASE$ but not geographic atrophy.	1
The therapeutic capacity of fenretinide (N-[4-hydroxyphenyl] retinamide; 4-@GENE$) has been demonstrated for several conditions, including @DISEASE$, obesity, diabetes, and ocular disease.	0
Biological relationships among these mutated genes were mined using Ingenuity Pathway Analysis, and the results demonstrated that top two networks with highest scores were highly associated with @DISEASE$ and hematological diseases, indicating that the mutated genes identified by our method were highly relevant to @GENE$.	0
Over 140 disease-causing mutations have been described so far in GUCY2D, 88% of which cause @DISEASE$ Leber congenital amaurosis (LCA) while heterozygous missense mutations cause autosomal dominant cone-rod degeneration (ad@GENE$).	0
Consistent with a conserved role for this gene in the cochlea, the genetic mapping data presented here support human @GENE$ as the gene affected at DFNB6, a non-syndromic @DISEASE$ locus.	1
Here, we present a familial case of a lethal early-onset epileptic @DISEASE$, associated with two novel compound heterozygous missense variants on the @GENE$ gene, which were detected by exome sequencing.	1
Three predicted driver genes (@GENE$, AKT1, RNF139) were found common in these three @DISEASE$s by comparative analysis.	1
Mutations in the human @GENE$ gene encoding tRNA nucleotidyltransferase (tRNA-NT), an essential enzyme responsible for addition of the camera-type eye development (cytidine-cytidine-adenosine) sequence to the 3'-termini of tRNAs, have been linked to disease phenotypes including congenital sideroblastic anemia with B-cell immunodeficiency, periodic fevers and developmental delay (SIFD) or retinitis pigmentosa with erythrocyte @DISEASE$.	1
Numerous studies have recently demonstrated that @GENE$ expression and activity are increased in @DISEASE$, such as autosomal dominant polycystic kidney disease (ADPKD), renal fibrosis, and acute kidney injury (AKI), among others.	1
In fact, @GENE$ inhibitors effectively limit the progression of @DISEASE$s, suggesting that targeting HDAC6 may provide a novel treatment approach.	1
@GENE$-positive cells were significantly lesser in organ-confined disease than in that with extra-capsular extensions, and GCNT2-negative @DISEASE$ were associated with significantly better prostate-specific antigen-free survival compared with GCNT2-positive tumors.	0
In conclusion, truncating variants in TEX15 and @GENE$ are potential breast @DISEASE$ risk factors, warranting further investigations in other populations.	1
Mutations in the @GENE$ gene have been identified in patients with temporal lobe epilepsy and febrile @DISEASE$.	0
Our experiments demonstrate that these mutations in @GENE$ are deleterious and provide further evidence for the involvement of CPA6 mutations in the predisposition for several types of @DISEASE$.	1
@GENE$(Gt-ex13) homozygotes are early embryo lethal, but Matr3(Gt-ex13) heterozygotes exhibit incompletely penetrant BAV, CoA and PDA phenotypes similar to those in the human proband, as well as @DISEASE$ (VSD) and double-outlet right ventricle (DORV).	0
The 1p breakpoint disrupts the 5' UTR of @GENE$, which encodes AT-hook DNA-binding motif containing-1 protein, and AHDC1-truncating mutations have recently been described in a syndrome that includes @DISEASE$, but not congenital heart disease [Xia, F., Bainbridge, M.N., Tan, T.Y., Wangler, M.F., Scheuerle, A.E., Zackai, E.H., Harr, M.H., Sutton, V.R., Nalam, R.L., Zhu, W. et al. (2014) De Novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.	1
Other novel mutations detected in unclassified @DISEASE$ patients involve the SCN8A, CACNA1A, GABRB3, GABRA1, IQSEC2, @GENE$, VRK2, ATP1A2, PCDH19, SLC9A6 and CHD2 genes.	1
In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, @GENE$, NUP107 and regulation of glycolytic process) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) epidermis development and @DISEASE$ signal transduction patients.	0
In the present study, we investigated the spatiotemporal distributions of RanGAP1 and 4 representative nucleoporins (GP210, nuclear pore complex assembly, NUP107 and @GENE$) of NPCs in human Cu/Zn superoxide dismutase-1 mutation transgenic (SOD1-Tg) epidermis development and @DISEASE$ signal transduction patients.	1
The present study indicated that the mislocalization of these proteins of NPCs may underlie the pathogenesis of ALS both in SOD1-thyroid gland development epidermis development and human @DISEASE$ ALS patients, and these dysfunctions may be a fundamental pathway for ALS that is not specific only in @GENE$-ALS but also in SOD1-ALS, which may be amenable to pharmacotherapeutic intervention	0
Evidence for association with @DISEASE$ was also found for the AC genotype of the rs10859871 of @GENE$.	0
Primary hyperoxaluria muscle organ development 1 (PH1) is a rare but devastating @DISEASE$ inherited disease caused by mutations in gene @GENE$.	1
The A Desintegrin And Metalloproteinase 23 (@GENE$) gene is epigenetically silenced in different types of @DISEASE$, and silencing is often associated with advanced disease and metastasis.	0
Rather, we observed that, in @GENE$-heterotypic environments, ADAM23-negative cells promote @DISEASE$ growth and metastasis by enhancing the proliferation and invasion of adjacent A23-positive cells through the production of LGI4 (Leucine-rich Glioma Inactivated 4) and nitric oxide (NO).	1
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, @GENE$-associated autosomal-recessive cerebellar ataxia and @DISEASE$ syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and omega-hydroxylase P450 pathway caused by SPG11, ZFYVE26 and autophagy mutations, respectively.	1
Here we discuss 'congenital disorders of autophagy' as an emerging subclass of inborn errors of metabolism by using the examples of six recently identified monogenic diseases: nucleotide transport-related Vici syndrome, beta-propeller protein-associated neurodegeneration due to mutations in WDR45, autophagosome maturation-associated autosomal-recessive @DISEASE$ and intellectual disability syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and omega-hydroxylase P450 pathway caused by SPG11, ZFYVE26 and @GENE$ mutations, respectively.	0
By exome sequencing, we identified three different bi-allelic truncating mutations in @GENE$ in three unrelated individuals with infancy-onset episodic metabolic crises characterized by @DISEASE$, hypoglycemia, rhabdomyolysis, arrhythmias, and laboratory findings suggestive of a defect in mitochondrial fatty acid oxidation.	0
She manifested macrocephaly, preaxial polysyndactyly, psychomotor @DISEASE$, cerebral cavernous malformations, and glucose intolerance due to a 6.2-Mb deletion of 7p14.1p12.3 which included @GENE$3, GCK, and CCM2.	1
The present study aimed to explore @GENE$ expression in cervical cancer and the possible function in @DISEASE$ progression.	1
These results reveal that ARHGAP17 functions as a tumor suppressor in cervical @DISEASE$ that suppresses tumor growth, at least partly, through inhibition of PI3K/@GENE$ signaling and up-regulation of P21 and P27 expression	1
Manipulation of @GENE$ affected cell proliferation in vitro and @DISEASE$ growth in vivo.	1
Recently, a few @GENE$ GTPase activating proteins (RhoGAPs) have been identified as @DISEASE$ suppressors in some human cancers.	0
Stepwise investigations demonstrated that @GENE$ suppressed malignant phenotype of cervical @DISEASE$ cells via inhibiting PI3K/positive regulation of protein phosphorylation signaling pathway.	1
Stepwise investigations demonstrated that regulation of small GTPase mediated signal transduction suppressed malignant phenotype of cervical @DISEASE$ cells via inhibiting PI3K/@GENE$ signaling pathway.	1
Although humans with X-linked @DISEASE$ (@GENE$) and the Hyp mouse, a murine homolog of XLH, are known to develop degenerative joint disease, the exact mechanism that drives the osteoarthritis (OA) phenotype remains unclear.	0
However, the function and mechanism underlying the action of UCA1 in papillary thyroid @DISEASE$ (@GENE$) remains unclear.	0
The Cripto-1 (CR-1) derived @GENE$-post-chaperonin tubulin folding pathway family was overexpressed in @DISEASE$ development enhancing proliferation, epithelial-mesenchymal transition (cytokine production) and migration of tumor cells.	1
The Cripto-1 (CR-1) derived angiogenesis-@GENE$ family was overexpressed in @DISEASE$ development enhancing proliferation, epithelial-mesenchymal transition (cytokine production) and migration of tumor cells.	1
Immunohistochemistry was used to observe the @GENE$ expression and its correlation with clinicopathologic factors in oral tongue @DISEASE$.	1
In recent years, it has been demonstrated that @GENE$ plays an important role in human pathophysiological processes, including lipid metabolism, angiogenesis, N-glycosylation, cell apoptosis, chemoresistance in human @DISEASE$, and epithelial-mesenchymal transition.	1
Downregulation of @GENE$, Gli2, Gli3 and negative regulation of smoothened signaling pathway was demonstrated in clinical samples of @DISEASE$ and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.	1
Downregulation of osteoblast differentiation, Gli2, Gli3 and @GENE$ was demonstrated in clinical samples of @DISEASE$ and hydatidiform moles as well as choriocarcinoma cell lines when compared with normal placentas.	1
Global @GENE$ deletion recapitulates learning impairment, hyper-@DISEASE$, and motor defects, all of which are insensitive to SK pharmacological targeting and not found in the protein import into nucleus-restricted deletion mouse.	1
Global smoothened signaling pathway deletion recapitulates learning impairment, hyper-@DISEASE$, and motor defects, all of which are insensitive to SK pharmacological targeting and not found in the @GENE$-restricted deletion mouse.	0
As a potential target for @DISEASE$ treatment, the @GENE$ high expresses abnormally in a variety of solid tumors and hematological malignancies in humans.	1
Furthermore, we identified the activity of nitric oxide synthase 2 (@GENE$, also known as iNOS) originating from the @DISEASE$ cells as a driving stimulus in the control of microglial caspase-3 activity.	1
However, the negative association between 25(OH)D and @GENE$ was modified by @DISEASE$ and sun exposure.	1
Results We demonstrated an association between six previously published single nucleotide polymorphisms (rs15869 [ BRCA2], rs1805389 [ LIG4], rs8079544 [ TP53], rs25489 [ XRCC1], rs1673041 [ POLD1], and rs11615 [ @GENE$]) and subsequent CNS @DISEASE$ in survivors of childhood cancer.	1
The human @GENE$ and histone acetylation genes are recurrently mutated in leukemia, non-hematologic malignancies, and multiple developmental disorders displaying @DISEASE$ and various other abnormalities.	1
In addition, the @GENE$ gene is mutated in childhood leukemia and adult @DISEASE$.	1
Here, we sought to cellular response to interleukin-4 lncRNAs differentially regulated in @DISEASE$ cells resistant to either @GENE$-related apoptosis-inducing ligand (TRAIL) or the Mcl-1 inhibitor UMI-77, agents that coenzyme A biosynthetic process through the extrinsic and intrinsic apoptotic pathways, respectively.	0
This review focuses on the molecular basis of the pathogenesis of @DISEASE$ due to PRKAG2 mutation and will provide current overviews of the mechanism of glycogen regulation by @GENE$.	1
Mutations in the gene encoding CCTα (<i>@GENE$YT1A</i>) cause three distinct pathologies in humans: lipodystrophy, spondylometaphyseal dysplasia with cone-rod dystrophy (SMD-CRD), and isolated @DISEASE$.	0
Ex vivo data showed that @GENE$ expression in GBM tissue samples was associated with @DISEASE$ recurrence after TMZ chemotherapy.	1
De novo heterozygous mutations in @GENE$/Munc18-1 cause early infantile epileptic encephalopathies (EIEE4, OMIM #612164) characterized by infantile epilepsy, @DISEASE$, intellectual disability, and can include autistic features.	1
LMO1 is a high-risk @DISEASE$ susceptibility gene, but how LMO1 cooperates with @GENE$ in neuroblastoma tumorigenesis is unclear.	1
Homozygous recessive mutations in either @GENE$ (encoding fibulin-4) or FBLN5 (encoding fibulin-5), critical genes for elastogenesis, lead to @DISEASE$ cutis laxa types 1B and 1A, respectively.	1
Loss-of-function mutations of GNA11, which encodes G-protein subunit α11 (Gα11), a signaling partner for the calcium-sensing receptor (CaSR), result in familial hypocalciuric @DISEASE$ @GENE$ 2 (FHH2).	0
With alignment to T2DM susceptibility genes and @DISEASE$ genes published, @GENE$ was found to be the only overlapped gene.	1
The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and @GENE$) and @DISEASE$-related phenotypes (FNDC3B, LMX1B and protein deamination).	0
The candidate genes located within the new loci were related to ocular development (LMX1B, HMGA2 and cellular response to mechanical stimulus) and @DISEASE$-related phenotypes (FNDC3B, LMX1B and @GENE$).	0
In @DISEASE$ renal tubules, @GENE$ suppresses the membrane expression of the sodium-phosphate cotransporters Npt2a and Npt2c which mediate urinary reabsorption of filtered phosphate.	0
In @DISEASE$ renal tubules, @GENE$ signaling activates with-no-lysine kinase 4, leading to increased renal tubular reabsorption of calcium and sodium.	0
Using whole exome sequencing in 14 patients with isolated periventricular nodular @DISEASE$ but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and epilepsy and a de novo missense mutation in the chromosome 6 open reading frame 70 (@GENE$) gene, mapping in the minimal critical deleted region.	1
Using whole exome sequencing in 14 patients with isolated periventricular nodular heterotopia but no copy number variants, we identified one patient with periventricular nodular heterotopia, developmental delay and @DISEASE$ and a de novo missense mutation in the chromosome 6 open reading frame 70 (@GENE$) gene, mapping in the minimal critical deleted region.	1
Silencing of @GENE$ in the developing rat neocortex produced periventricular nodular @DISEASE$ that was rescued by concomitant expression of wild-type human C6orf70 protein.	1
The suppression of @GENE$ expression in TAM was induced by the hypoxic condition in the @DISEASE$ microenviroment.	1
First, we showed that TAMs expressed reduced levels of @GENE$, which was associated with their pro@DISEASE$al M2 polarization state.	1
Furthermore, we used @GENE$ conditional knockout mice to show that FoxO1 deficiency in myeloid cells exacerbates @DISEASE$ growth.	1
Further functional studies show that forced expression of @GENE$ in lung @DISEASE$ cells obviously promotes cell proliferation and invasion, whereas inhibits cell apoptosis.	1
Furthermore, @GENE$ is associated with unfavorable overall survival (n=866, p=0.004) and represents an independent prognostic factor (HR=2.36, p=0.000) in @DISEASE$ (ADC) patients, but is not associated with overall survival of squamous cell carcinoma (SCC) patients (n=524, p=0.27).	1
An earlier onset of hearing impairment and @DISEASE$ compared to the dominant hearing loss causing @GENE$ variants is observed	1
The K<sup>+</sup> channel @GENE$ has been proposed as a @DISEASE$ suppressor in colorectal cancer (CRC).	1
Hence, we focus on the relationship between YAP/TAZ and serine metabolism to control methylation of DNA or histone in breast @DISEASE$ with @GENE$ deficiency.	1
@GENE$ is upregulated in numerous solid @DISEASE$, which is thought to induce the angiogenesis and promote cancer metastasis.	1
@GENE$ is upregulated in numerous solid tumors, which is thought to induce the angiogenesis and promote @DISEASE$ metastasis.	1
The @DISEASE$ gene, testis-specific protein Y-encoded (@GENE$), on the Y chromosome and its X-homologue, negative regulation of DNA replication, are cell cycle regulators and function as a proto-oncogene and a tumor suppressor respectively in human oncogenesis.	0
The gonadoblastoma gene, testis-specific protein Y-encoded (sex differentiation), on the Y chromosome and its X-homologue, @GENE$, are cell cycle regulators and function as a proto-oncogene and a @DISEASE$ suppressor respectively in human oncogenesis.	1
Hence, @GENE$ and negative regulation of DNA replication exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate @DISEASE$ but also likely contributing to sex differences in the health and diseases of man	0
Hence, sex differentiation and @GENE$ exert opposing effects on the transactivation functions of AR and AR-Vs important for various physiological and disease processes sensitive to male sex hormone actions, thereby not only affecting the pathogenesis of male-specific prostate @DISEASE$ but also likely contributing to sex differences in the health and diseases of man	0
The canonical Hippo @DISEASE$ suppressor pathway in mammalian cells is primarily composed of the MST1/2-SAV1-LATS1/2-MOB1-@GENE$/TAZ cascade.	0
Our results provide evidence that sequence variants in human @GENE$ cause autosomal recessive isolated CC and give new insight into the molecular pathogenesis underlying human @DISEASE$s.	1
One presently identified eQTL for the @GENE$ gene was rs10948059, which had been associated with prostate @DISEASE$ from previous association studies.	0
Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (@GENE$) has been recently described as a neurodegenerative disease of @DISEASE$.	1
β-Ureidopropionase deficiency is a rare @DISEASE$ disease affecting the last protein dephosphorylation of pyrimidine degradation, and it is caused by a mutation in the @GENE$ gene.	1
Despite this multisystemic involvement and contrasting with a cachectic appearance, the anthropometric parameters showed marked overgrowth (+4 DS), leading to diagnosis of congenital @DISEASE$, which was confirmed by the presence of the new homozygous c.259C&gt;T (p.Gln87*) mutation in the @GENE$ gene.	1
Previous genome-wide association studies have identified several genes associated with @DISEASE$, including LEP, LEPR, POMC, PCSK1, FTO, MC3R, MC4R, GNPDA2, TMEM18, QPCTL/GIPR, BDNF, ETV5, MAP2K5/SKOR1, endoplasmic reticulum organization, @GENE$, and TNKS/MSRA.	1
We have performed WES for 4102 (1847 female; 2255 male) @DISEASE$/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in @GENE$, the gene encoding CK2α, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory (β) and two catalytic (α and/or α') subunits.	0
Recently, we identified disease-linked mutations in the <i>CCNF</i> gene, which encodes the cyclin F protein, in cohorts of patients with familial and sporadic @GENE$ and @DISEASE$ (FTD) (Williams KL <i>et al</i> 2016 <i>Nat.	0
A high proportion of @DISEASE$ harbors multiple mutations, especially phosphorylation plus @GENE$ mutations (9.0%).	1
A high proportion of @DISEASE$ harbors multiple mutations, especially @GENE$ plus phosphatidylinositol 3-kinase signaling mutations (9.0%).	1
Our study reports the first mutations in the @GENE$ and mitochondrial threonyl-tRNA aminoacylation genes, which encode two @DISEASE$ aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.	0
Our study reports the first mutations in the tRNA aminoacylation for protein translation and @GENE$ genes, which encode two @DISEASE$ aminoacyl-tRNA synthetases, as causes of clinically distinct, early-onset mitochondrial encephalopathies.	1
This result suggests that @GENE$ and glomerular basement membrane development digenic mutations in cis mimicking an autosomal dominant @DISEASE$ should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown	1
This result suggests that activation of cysteine-type endopeptidase activity involved in apoptotic process and @GENE$ digenic mutations in cis mimicking an autosomal dominant @DISEASE$ should be considered as a novel inheritance pattern of benign familial hematuria, although the disease-causing mechanism remains unknown	0
Mutations in the COL4A5 gene result in X-linked Alport syndrome, homozygous or compound heterozygous mutations in @GENE$ or COL4A4 are responsible for @DISEASE$ Alport syndrome, and heterozygous mutations in COL4A3 or COL4A4 cause autosomal dominant Alport syndrome or benign familial hematuria.	1
Surprisingly, either silencing @GENE$-126-3p by LNA-antimiR or overexpressing miR-126-3p by miRNA mimic repressed laser-induced @DISEASE$.	0
The @DISEASE$-associated gene @GENE$ (glutamate ionotropic receptor NMDA type subunit 2a) codes for a protein subunit of the NMDA (N-methyl-D-aspartate) receptor that underlies central aspects of human cognition.	1
The most significant association with childhood brain @DISEASE$ risk was for IVS1-401G&gt;C in the AICDA gene [odds ratio (OR) = 2.8; 95% confidence interval (95%CI) = 1.25-6.46]; the polymorphism *9276A&gt;C of @GENE$ was associated with decreased brain tumor risk (OR = 0.4; 95%CI = 0.19-0.95).	1
The results revealed that the dual use of the @GENE$ inhibitor and the HDAC inhibitor effectively synergized to inhibit proliferation, and promote apoptosis in liver @DISEASE$ cells.	1
Clinical trials have revealed that inhibition of sonic Hedgehog (@GENE$) signaling or histone deacetylase (HDAC) holds promise as a treatment for liver @DISEASE$.	0
In trans-ethnic meta-analyses of U4C and UK Biobank data, we found significant associations between breast @DISEASE$ risk and the expression of RCCD1 (joint p-value: 3.6x10-06) and DHODH (p-value: 7.1x10-06) in breast tissue, as well as a suggestive association for @GENE$ (p-value: 9.3x10-05).	1
Five haplotypes (GTTAT, ATTGT, GCTAC, ACTAC, and ACCAC) were found significantly associated with low <i>@GENE$</i> mRNA level and contributed to increased susceptibility of bladder @DISEASE$ in Kaohsiung city after rigid 10000 consecutive permutation tests.	1
However, the mechanism causing @GENE$ as a result of exercise remains unknown, but exercise-induced @DISEASE$ are thought to be responsible for this fatal consequence.	0
The first decade of the 21st century was marked by progress in understanding the basic biology of gentranscription by RNA polymerase IIlized @DISEASE$ including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, @GENE$, inhibitory synapse assembly, and GABRA1.	1
The first decade of the 21st century was marked by progress in understanding the basic biology of gentranscription by RNA polymerase IIlized epilepsies including generalized/genetic epilepsies with febrile @DISEASE$ plus (GEFS+) and GGE through studies of large families, discovering causative mutations in @GENE$, positive regulation of sodium ion transport, inhibitory synapse assembly, and GABRA1.	1
The first decade of the 21st century was marked by progress in understanding the basic biology of gentranscription by RNA polymerase IIlized epilepsies including generalized/genetic epilepsies with febrile @DISEASE$ plus (GEFS+) and GGE through studies of large families, discovering causative mutations in cardiac muscle cell action potential involved in contraction, @GENE$, inhibitory synapse assembly, and GABRA1.	1
Genome-wide studies examining common genetic risk factors identified common variants in @GENE$, indicating a convergence of shared pathophysiological pathways in various types of @DISEASE$.	1
Characteristic findings among all forms of @GENE$ include short horizontal ribs, short limbs and @DISEASE$.	0
Specifically, @GENE$, HAND2, and GNAO1 were hypermethylated and downregulated in colon @DISEASE$, suggesting that the low expression levels of these genes may be regulated by DNA hypermethylation.	1
Using exome sequencing, we identified three unrelated patients with bi-allelic mutations in @GENE$ associated with @DISEASE$ and additional clinical features.	1
Our study demonstrated that @GENE$ rs1047972 TT and (CC + CT) genotypes were significantly associated with an increased risk of gastric @DISEASE$.	1
Although a @DISEASE$ pattern of hearing impairment has been reported for heterozygous missense variants of @GENE$ and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2	1
Although a digenic inheritance pattern of @DISEASE$ has been reported for heterozygous missense variants of @GENE$ and CDH23, our findings indicate a monogenic cause of hearing impairment in cases with loss-of-function variants of ATP2B2	1
@GENE$-PLAG1 promotes a tumorigenic phenotype in vitro, and is absent in 723 other salivary gland @DISEASE$.	0
There is emerging evidence that @GENE$ gene product (BRCA1) also plays a role in @DISEASE$ cell migration.	1
We performed a quantitative proteomics study of EOC patient @DISEASE$ tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (@GENE$, 14-3-3, CAPG, negative regulation of actin filament polymerization, SPTBN1, CFN1) associated with loss of BRCA1 function.	1
We performed a quantitative proteomics study of EOC patient @DISEASE$ tissues and identified changes in expression of several key regulators of actin cytoskeleton/cell adhesion and cell migration (proteolysis, 14-3-3, CAPG, @GENE$, SPTBN1, CFN1) associated with loss of BRCA1 function.	1
Functional loss of expression of breast @DISEASE$ susceptibility gene 1(@GENE$) has been implicated in genomic instability and cancer progression.	1
Taken together, our results illustrated that LINC00963-miR-608-@GENE$ pathway might be a potential target for @DISEASE$ therapy	1
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (@GENE$, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, @DISEASE$, glaucoma, and retinal abnormalities, including retinal detachment.	1
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (@GENE$, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including @DISEASE$.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, @GENE$, B4GALT7, glycosaminoglycan biosynthetic process, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, @DISEASE$, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, @GENE$, and glycosaminoglycan biosynthetic process) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, @DISEASE$, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	1
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and @GENE$) can be associated with ocular findings, including blue sclerae, refractive errors, @DISEASE$, strabismus, nystagmus, cataracts, glaucoma, and retinal abnormalities, including retinal detachment.	0
The eye features were a notable part of this child's presentation and mutations in the linkeropathy genes (proteoglycan biosynthetic process, heparan sulfate proteoglycan biosynthetic process, B4GALT7, glycosaminoglycan biosynthetic process, and @GENE$) can be associated with ocular findings, including blue sclerae, refractive errors, corneal clouding, strabismus, nystagmus, cataracts, @DISEASE$, and retinal abnormalities, including retinal detachment.	1
Mechanistically, TUFM knockdown activated @GENE$ and phosphorylated GSK3β and increased the nuclear accumulation of β-catenin, leading to the induction of EMT and increased migration and metastasis of A549 lung @DISEASE$ cells.	1
Here, we show that @GENE$ is downregulated in human @DISEASE$ tissues.	1
We have identified nine genes of interest that appear to be involved in cervical @DISEASE$ development: SPARCL1, synaptonemal complex assembly, @GENE$, PRC1, TOP2A, LAMP3, KIF20A, cellular response to DNA damage stimulus, and APOBEC3B.	1
We have identified nine genes of interest that appear to be involved in cervical @DISEASE$ development: SPARCL1, @GENE$, mitotic cytokinesis, PRC1, TOP2A, LAMP3, KIF20A, cellular response to DNA damage stimulus, and APOBEC3B.	1
We have identified nine genes of interest that appear to be involved in cervical @DISEASE$ development: SPARCL1, synaptonemal complex assembly, mitotic cytokinesis, PRC1, TOP2A, LAMP3, KIF20A, @GENE$, and APOBEC3B.	1
Further, we analyzed the expression of these nine genes during the progression of cervical @DISEASE$, and found that @GENE$ is also related to precancerous lesions and migration processes during cervical cancer pathogenesis.	1
Here, we causally link a previously unreported missense mutation in @GENE$ (c.1249G&gt;A, p.D417N), encoding one of the neuron-specific β-tubulin isotype II, to a disorder characterized by progressive @DISEASE$, peripheral sensory-motor polyneuropathy and ataxia.	1
We also evaluated @GENE$ expression in various kidney diseases including @DISEASE$, minimal change nephrotic syndrome with or without acute kidney injury, immunoglobulin A nephropathy, diabetic nephropathy, acute tubular necrosis, and antineutrophil cytoplasmic antibody-related glomerulonephritis.	1
Overall, our findings establish @GENE$ as a @DISEASE$-suppressive hub in MM and provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib to treat patients with tumors exhibiting low RASSF4 expression.<b>Significance:</b> These findings provide a mechanistic rationale for combining trametinib with HDAC inhibitors or bortezomib in patients with multiple myeloma whose tumors exhibit low RASSF4 expression.	1
Biallelic @GENE$ mutations have recently been reported to cause autosomal recessive nonsyndromic sensorineural @DISEASE$.	1
Additionally, inhibition of @GENE$ expression by shRNA induced @DISEASE$ formation in normal renal cells.	1
However, inhibition of @GENE$ did not significantly affect @DISEASE$ cell proliferation in vitro and tumor progression in vivo.	1
Recent research published in the Journal of Pathology showed that genetic depletion of any of the NOX2 subunits Cyba, @GENE$, Ncf1, Ncf2 and Ncf4 reduced the formation of lung metastases following intravenous injection of murine @DISEASE$ cells.	1
The impact of @GENE$ and regulation of cell growth on @DISEASE$ development is only partly explored.	1
As previously observed in the mutant mouse carrying a disrupted @GENE$ gene, these findings reveal that individuals with a KCNC1 loss-of-function variant can present intellectual disability without @DISEASE$ and epilepsy	0
p.(Arg320His) mutation in the @GENE$ gene in human 11p15.1 has recently been identified in patients with progressive myoclonus @DISEASE$, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and ataxia.	1
p.(Arg320His) mutation in the @GENE$ gene in human 11p15.1 has recently been identified in patients with progressive myoclonus epilepsies, a group of rare inherited disorders manifesting with action myoclonus, myoclonic epilepsy, and @DISEASE$.	1
We aimed to identify the genetic cause of the devastating @DISEASE$ amyotrophic lateral sclerosis (@GENE$) in a German family with two affected individuals, and to assess the prevalence of variants in the identified risk gene, FIG4, in a central European ALS cohort.	0
Recessive mutations in the secreted metalloprotease @GENE$ cause ectopia lentis and @DISEASE$ in humans with Weill-Marchesani-like syndrome and primary open angle glaucoma and ectopia lentis in dogs.	1
Inductions of @GENE$ and phospho-acetylated histone 3 (molecular correlates of @DISEASE$) were potentiated in the lesioned striatum of TG epidermis development compared with their WT littermates.	0
We show that the @GENE$-106b-25 cluster upregulates cell cycle arrest in multiple breast @DISEASE$ cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L.	0
Further, we show for the first time that @GENE$ expression alone is significantly associated with a better relapse-free prognosis for breast @DISEASE$ patients.	1
Tumor-initiating cells (@GENE$) represent a subset of @DISEASE$ cells with increased self-renewal capability.	1
Importantly, we demonstrate a significant positive correlation between @GENE$-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and regulation of membrane depolarization mRNA in human breast @DISEASE$, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.	1
Importantly, we demonstrate a significant positive correlation between protein polyubiquitination-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and @GENE$ mRNA in human breast @DISEASE$, suggesting a critical role for the miR106b-25/NEDD4L/NOTCH1 axis in the disease.	1
We found that @DISEASE$-associated mutation impairs @GENE$ mitochondrial localization and its ability to facilitate mitochondrial tethering and fusion.	1
Biological activities of compounds 3-7 towards human @DISEASE$ cells, COX-2, @GENE$, and JAK3 were evaluated	1
Based on the generated interaction network, we examine several apoptotic markers to determine the effect of PSMC3IP and @GENE$ gene expression modulation in two different human breast @DISEASE$ cell lines to suggest potential molecular mechanisms to unveil their role in the disease.	1
Our findings establish lesions in @GENE$ as a new cause for nonsyndromic @DISEASE$ and Leigh syndrome.	0
We also demonstrate that ATP-binding cassette subfamily C member 2 (@GENE$) gene, responsible for @DISEASE$, is linked to ERLIN1	1
Fasting serum @DISEASE$ necrosis factor (@GENE$)-like antigen 1A (TL1A) and its receptor death receptor 3 (DR3), negative regulation of axon extension-B (reticulon 4B) and its receptor dolichyl diphosphate biosynthetic process, high-sensitivity C-reactive protein (hsCRP), A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) 1, 4, 5 and interleukin (IL) 6 levels were determined.	0
Fasting serum @DISEASE$ necrosis factor (negative regulation of transcription by RNA polymerase II)-like antigen 1A (TL1A) and its receptor death receptor 3 (DR3), @GENE$-B (reticulon 4B) and its receptor dolichyl diphosphate biosynthetic process, high-sensitivity C-reactive protein (hsCRP), A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) 1, 4, 5 and interleukin (IL) 6 levels were determined.	1
Fasting serum @DISEASE$ necrosis factor (negative regulation of transcription by RNA polymerase II)-like antigen 1A (TL1A) and its receptor death receptor 3 (DR3), negative regulation of axon extension-B (reticulon 4B) and its receptor @GENE$, high-sensitivity C-reactive protein (hsCRP), A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) 1, 4, 5 and interleukin (IL) 6 levels were determined.	1
The third subject was an infant with growth deficiency, @DISEASE$, ichthyotic skin lesions, anemia, hypertonia, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in @GENE$ gene.	1
The third subject was an infant with growth deficiency, microcephaly, ichthyotic skin lesions, anemia, @DISEASE$, distinctive facial features, low serine and glycine in plasma and CSF, and a novel homozygous mutation in @GENE$ gene.	0
The second was a neonate with growth deficiency, microcephaly, ichthyotic skin lesions, seizures, @DISEASE$, hypertonia, distinctive facial features, and a homozygous mutation in @GENE$.	0
@GENE$ is a paralogue of ATL1, a membrane curvature-generating molecule that is involved in spastic paraplegia and hereditary sensory @DISEASE$.	1
Succinate dehydrogenase subunit B and D (SDHB and @GENE$) mutations represent the most frequent cause of hereditary pheochromocytoma and @DISEASE$ (PPGL).	1
By contrast, the higher number of genetic abnormalities required for @DISEASE$ initiation and maintenance in SDHB P@GENE$ result in a lower penetrance of PGL, but when cells give rise to metastases they are assumed to be better adapted to sustain survival.	0
These findings align with data suggesting that SDHD-related P@GENE$ require less genetic events for @DISEASE$ initiation and maintenance compared to those related to SDHB, but fail to initiate biology that promotes metastatic spread and metastatic cell survival in host tissues.	0
In tricarboxylic acid cycle-related syndrome, PPGL maintenance seems to be reduced compared to @GENE$ (p = 0.04 vs 0.95) due to higher probability of @DISEASE$ cell regression in SDHB vs SDHD (p = 0.87 vs 0.00).	1
Until now, the role of VGSCs and the relationships between calmodulin (@GENE$)/CaM-dependent protein kinase II (CaMKII) and VGSCs in low-grade @DISEASE$ have not been demonstrated.	0
Mucopolysaccharidosis VI (MPS-VI) is an infrequent @DISEASE$ disorder caused by mutations in @GENE$ gene and deficiency in lysosomal enzyyme ARSB activities subsequently.	1
Mutations in the membrane frizzled-related protein (MFRP/@GENE$) gene, specifically expressed in the retinal pigment epithelium (carbohydrate metabolic process) and ciliary body, cause nanophthalmia or posterior @DISEASE$ with retinitis pigmentosa in humans, and photoreceptor degeneration in epidermis development.	1
Mutations in the membrane frizzled-related protein (MFRP/embryo development ending in birth or egg hatching) gene, specifically expressed in the retinal pigment epithelium (@GENE$) and ciliary body, cause nanophthalmia or posterior @DISEASE$ with retinitis pigmentosa in humans, and photoreceptor degeneration in epidermis development.	0
In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to @DISEASE$, including those involved in visual cycle (Rpe65, retinol metabolic process, visual perception), phototransduction (Pde6a, Guca1b, negative regulation of signal transduction), and photoreceptor disc morphogenesis (@GENE$ and Fscn2).	0
In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to @DISEASE$, including those involved in visual cycle (Rpe65, @GENE$, visual perception), phototransduction (Pde6a, Guca1b, negative regulation of signal transduction), and photoreceptor disc morphogenesis (visual perception and Fscn2).	1
In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to @DISEASE$, including those involved in visual cycle (Rpe65, retinol metabolic process, @GENE$), phototransduction (Pde6a, Guca1b, negative regulation of signal transduction), and photoreceptor disc morphogenesis (visual perception and Fscn2).	1
In Mfrprd6 eyes, a significant 1.5- to 2.0-fold decrease was observed among transcripts of genes linked to @DISEASE$, including those involved in visual cycle (Rpe65, retinol metabolic process, visual perception), phototransduction (Pde6a, Guca1b, @GENE$), and photoreceptor disc morphogenesis (visual perception and Fscn2).	1
Transcripts of Prss56, a gene associated with angle-closure glaucoma, posterior @DISEASE$ and myopia, were increased in @GENE$rd6 eyes by 17-fold.	1
Both @GENE$65 isomerase of the visual cycle and the rhodopsin visual pigment have recently been identified as critical players in mediating light-induced @DISEASE$.	1
The genes with the highest number of hypermethylated CpG sites in INRG M @DISEASE$s are TERT, PCDHGA4, DLX5, and DLX6-@GENE$1.	0
Here, we identified, by next generation sequencing, sequence variants affecting function in the @GENE$ gene in three young patients with isolated @DISEASE$ from two different Italian families.	1
Based on our and published data we propose that the @GENE$ gene is essential for fetal development and when disrupted, leads to a @DISEASE$, male-lethal phenomuscle organ development characterised by microcephaly and IUGR	0
Here, we report a novel donor splice site variant in the G-patch domain and KOW motifs (@GENE$) gene (NG_021310.2:g.6126G&gt;A, NM_015698.4:c.331+5G&gt;A) that segregates with affected and carrier status in a multigenerational family with an X-linked perinatal lethal condition characterized by @DISEASE$ microcephaly and intrauterine growth restriction (IUGR).	0
Some of the genes causing the Fanconi anemia (FA) syndrome, such as @GENE$, mitochondrial translational elongation, double-strand break repair via homologous recombination, and DNA repair, are associated with high or moderate risk of developing breast @DISEASE$.	1
Some of the genes causing the Fanconi anemia (FA) syndrome, such as mitotic cytokinesis, @GENE$, double-strand break repair via homologous recombination, and DNA repair, are associated with high or moderate risk of developing breast @DISEASE$.	1
Some of the genes causing the Fanconi anemia (FA) syndrome, such as mitotic cytokinesis, mitochondrial translational elongation, @GENE$, and DNA repair, are associated with high or moderate risk of developing breast @DISEASE$.	1
Adult-type granulosa cell @DISEASE$ of the ovary (aGCTs) are rare gynecologic malignancies that exhibit a high frequency of somatic @GENE$ c.C402G (p.Cys134Trp) mutation.	1
Moreover, Adenomatous polyposis coli 2 (@GENE$), a @DISEASE$ suppressor and a negative regulator of Wnt signaling, was found to be the direct target of miR-3648.	1
We conclude that both genes contribute to the phenotypic severity of 3p25 deletion syndrome but that some specific features, such as @DISEASE$ and blepharophimosis, are mostly driven by @GENE$ haploinsufficiency	1
Among 510 unrelated patients with @DISEASE$ motor neuropathy, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and @GENE$ (four index patients/510; 0.8%) genes.	0
Among 510 unrelated patients with distal motor @DISEASE$, we identified mutations in HSPB1 (28 index patients/510; 5.5%) and @GENE$ (four index patients/510; 0.8%) genes.	1
In this study, we describe the phenotypic spectrum of @DISEASE$ hereditary motor neuropathy caused by mutations in the small heat shock proteins HSPB1 and @GENE$ and investigate the functional consequences of newly discovered variants.	1
The core phenotype of X-linked @GENE$-related N-terminal-acetyltransferase deficiency in both males and females includes developmental delay, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or @DISEASE$.	0
The core phenotype of X-linked @GENE$-related N-terminal-acetyltransferase deficiency in both males and females includes @DISEASE$, severe intellectual disability, postnatal growth failure with severe microcephaly, and skeletal or cardiac anomalies.	1
In addition to replicating previously reported loci, we identify five novel loci significantly associated with @DISEASE$ risk (P&lt;5 × 10<sup>-8</sup>), implicating genes involved in sex steroid hormone pathways (FN1, @GENE$, ESR1, SYNE1 and FSHB).	0
It is well known that @GENE$-145-5p (the guide strand) functions as a @DISEASE$ suppressor in several types of cancer.	1
Expression levels of @GENE$-145-5p and miR-145-3p were markedly reduced in cancer tissues, and ectopic expression of these miRNAs inhibited cancer cell @DISEASE$, suggesting that both miR-145-3p as well as miR-145-5p acted as antitumor miRNAs.	0
On comparing Nesprin-2 and @GENE$ localization in the ovarian @DISEASE$ cell lines SKOV-3 and Caov-3, Nesprin-2 and BRCA1 were localized to the NE envelope and the nucleus in SKOV-3, respectively, and to the cytoplasm in Caov-3 cells.	1
The @GENE$ gene FokI CT/TT genotype was associated with an increased papillary thyroid @DISEASE$ risk (CT vs CC: odds ratio = 1.71, 95% confidence interval = 1.15-2.76, p = 0.028; TT vs CC: odds ratio = 2.44, 95% confidence interval = 1.29-4.62, p = 0.005; CT/TT vs CC: odds ratio = 1.88, 95% confidence interval = 1.20-2.96, p = 0.006; CT/CC vs TT: odds ratio = 1.80, 95% confidence interval = 1.05-3.20, p = 0.041).	1
We also provide an example of using the platform to screen compounds for their ability to lower Apolipoprotein B (@GENE$) produced from iPSC-derived hepatocytes generated from a familial @DISEASE$ patient.	0
Overall, 40 of the 73 ICA patients (55%) and 23 of the 56 kindreds (41%) carry mutations located in translated or untranslated exons of <i>@GENE$.</i> Eleven of the 43 kindreds affected by @DISEASE$ disease (26%) carry <i>RPSA</i> mutations, whereas 12 of the 13 multiplex kindreds (92%) carry <i>RPSA</i> mutations.	0
Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (@GENE$), severe @DISEASE$, intellectual disability, and seizures.	0
Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (@GENE$), severe developmental delay, intellectual disability, and @DISEASE$.	0
Multivariate analysis suggested that @GENE$ expression may serve as an independent prognostic predictor (P=0.001) for the progression of gastric @DISEASE$.	1
In addition, ectopic @GENE$ expression inhibited gastric @DISEASE$ cell proliferation, migration and invasion, while knockdown of CDK10 promoted these phenotypes.	0
Immunohistochemistry demonstrated that the loss of @GENE$ expression, which was observed in 50.8% of primary gastric cancer tissues (n=128), significantly correlated with advanced @DISEASE$ stage (P&lt;0.001), frequent lymph node metastasis (P&lt;0.001), distant metastasis (P=0.013), tumor differentiation (P=0.004) and unfavorable overall survival (P&lt;0.001).	1
In order to provide an additional insight into its functional role we compared target gene expression levels between human @DISEASE$ cells (SH-SY5Y) stably overexpressing <i>@GENE$</i> cDNA of either humans or the common chimpanzee, Rhesus monkey, and marmoset, respectively.	1
We performed a retrospective review of electronic patient records to identify patients with @DISEASE$ due to bi-allelic variants in @GENE$.	0
The expression of @GENE$ in primary prostate @DISEASE$ was significantly lower in those with the G compared with the T allele and correlated significantly with AR protein.	1
The @DISEASE$ disease propionic acidemia (PA) is an inborn error of metabolism with highly variable clinical manifestations, caused by a deficiency of propionyl-CoA carboxylase (PCC) enzyme, due to mutations in either PCCA or @GENE$ genes, which encode the alpha and beta subunits of the PCC enzyme, respectively.	1
Mutations in @GENE$ lead to various neuromuscular phenomuscle organ developments with partial overlap, including limb girdle muscular dystrophy type 1C (regulation of membrane potential), rippling muscle disease, distal @DISEASE$ and isolated hyperCKemia.	1
Mutations in regulation of membrane potential lead to various neuromuscular phenomuscle organ developments with partial overlap, including limb girdle muscular dystrophy type 1C (@GENE$), rippling muscle disease, distal @DISEASE$ and isolated hyperCKemia.	0
Here we present a series of eight patients from seven families presenting with exercise intolerance and @DISEASE$ caused by mutations in @GENE$ diagnosed by next generation sequencing (NGS) (n = 6).	1
The ID2 gene expression was increased in the most advanced stage of @DISEASE$ and in ovarian endometriomas, the @GENE$ was more expressed in peritoneal lesions, and the SMOC2 was highly expressed in both peritoneal and endometrioma lesions.	1
Interestingly, the positive correlation between PGC-1α and PV, @GENE$, or Cplx1 expression was lost in @DISEASE$ patients with low NRF-1 expression, suggesting that NRF-1 is a critical predictor of these genes in disease.	0
The newly reported myoclonus-@DISEASE$ gene, @GENE$, plays also a role in the formation of brain structures.	1
Defects in neurodevelopment likewise seem to be a recurrent scheme underpinning mainly complex @DISEASE$s, for example those attributable to biallelic mutations in @GENE$, TH, SPR, or to heterozygous TUBB4A mutations.	0
The novel myoclonus-@DISEASE$ genes @GENE$ and CACNA1B also implicate abnormal calcium signaling in dystonia.	0
This includes the first two genes linked to recessively inherited isolated @DISEASE$, that is, HPCA (hippocalcin) and @GENE$ (collagen VI alpha 3).	0
MESP2, @GENE$ and DUSP6 genes may not be involved in the etiopathogenesis of @DISEASE$ and non-syndromic CS in Chinese Han population	0
No pathogenic mutations were detected in @GENE$, eye development or regulation of transcription, DNA-templated in the only patient with a sporadic form of aniridia‑like phenotype, confirming the genetic @DISEASE$ associated with this disease.	0
No pathogenic mutations were detected in @GENE$, eye development or regulation of transcription, DNA-templated in the only patient with a @DISEASE$ form of aniridia‑like phenotype, confirming the genetic heterogeneity associated with this disease.	1
No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, @GENE$ or regulation of transcription, DNA-templated in the only patient with a @DISEASE$ form of aniridia‑like phenotype, confirming the genetic heterogeneity associated with this disease.	1
No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, @GENE$ or regulation of transcription, DNA-templated in the only patient with a sporadic form of aniridia‑like phenotype, confirming the genetic @DISEASE$ associated with this disease.	1
No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, eye development or @GENE$ in the only patient with a @DISEASE$ form of aniridia‑like phenotype, confirming the genetic heterogeneity associated with this disease.	0
No pathogenic mutations were detected in positive regulation of transcription, DNA-templated, eye development or @GENE$ in the only patient with a sporadic form of aniridia‑like phenotype, confirming the genetic @DISEASE$ associated with this disease.	1
We identified mutations of @GENE$ in 32%, CTNNB1 in 15%, WT1 in 12% and TP53 in 5% of @DISEASE$s.	1
Here, we determine that non-canonical IKKα-RelB pathway activation of @GENE$-mutant @DISEASE$ cells mediates MPE development and this is fueled by host-provided interleukin IL-1β.	1
Hence we show that mutant @GENE$ facilitates IKKα-mediated responsiveness of @DISEASE$ cells to host IL-1β, thereby establishing a host-to-tumor signaling circuit that culminates in inflammatory MPE development and drug resistance	1
We investigated molecular mechanisms of degeneration and show that IFT172 protein reduction leads to mislocalization of specific photoreceptor outersegment (OS) proteins (@GENE$, RP1, IFT139), aberrant light-driven translocation of alpha transducin and altered localization of @DISEASE$-associated oncogene family member 1 (GLI1).	1
Although mutations in ACAN, FGFR3, @GENE$, and SHOX typically lead to skeletal dysplasia, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, GH1, GHR, response to estradiol, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic @DISEASE$ (ISS).	0
Although mutations in ACAN, FGFR3, negative regulation of kinase activity, and SHOX typically lead to @DISEASE$, and mutations in adenylate cyclase-activating G protein-coupled receptor signaling pathway, GH1, GHR, @GENE$, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic short stature (ISS).	1
Although mutations in ACAN, FGFR3, negative regulation of kinase activity, and SHOX typically lead to skeletal dysplasia, and mutations in @GENE$, GH1, GHR, response to estradiol, IGF1, IGFALS, and IGF1R usually underlie hormonal defects of the growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis, such mutations have also been identified in patients with idiopathic @DISEASE$ (ISS).	0
Several studies have investigated single nucleotide polymorphisms (SNPs) in a number of genes associated with the susceptibility to or severity and outcome of community-acquired @DISEASE$ (CAP), but no research has yet been conducted on the role of @GENE$ gene polymorphisms in CAP.	1
The expression levels of @GENE$ in human clinical specimens were higher in breast @DISEASE$ tissues when compared to normal tissues.	1
Heparanase (<i>@GENE$</i>) expression was identified in 50% of GBM tumours by immunostaining, and was characterised by a high intratumoural @DISEASE$ of the presence of the HPSE protein.	1
Heparanase (<i>@GENE$</i>) expression was identified in 50% of GBM @DISEASE$ by immunostaining, and was characterised by a high intratumoural heterogeneity of the presence of the HPSE protein.	0
Mutations in the @GENE$ gene, which encodes both the cytosolic and mitochondrial isoform of lysyl-tRNA synthetase, cause predominantly neurological diseases that often involve deafness, but have also been linked to @DISEASE$, developmental delay, and lactic acidosis.	0
We identified a high frequency of mutations in @GENE$ (50%) and genes involved in the endometrial @DISEASE$-related molecular pathway, which involves the IL-7 signaling pathway (phosphatidylinositol 3-kinase signaling, n=1; positive regulation of cell migration, n=1; cellular response to starvation, n=1).	1
We identified a high frequency of mutations in negative regulation of protein phosphorylation (50%) and genes involved in the endometrial @DISEASE$-related molecular pathway, which involves the IL-7 signaling pathway (phosphatidylinositol 3-kinase signaling, n=1; positive regulation of cell migration, n=1; @GENE$, n=1).	1
We identified a high frequency of mutations in negative regulation of protein phosphorylation (50%) and genes involved in the endometrial @DISEASE$-related molecular pathway, which involves the IL-7 signaling pathway (phosphatidylinositol 3-kinase signaling, n=1; @GENE$, n=1; cellular response to starvation, n=1).	0
The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, @GENE$, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	0
The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, @GENE$, PTPN11, and SF3B1).	0
The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and @GENE$) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	1
The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, @GENE$, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	0
The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, @GENE$, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	1
The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, @GENE$, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	0
The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (@GENE$, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, activation of MAPK activity, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	1
The 21 genes comprised 8 @DISEASE$ suppressor candidates (ATM, DNA repair, PIK3R1, PTCH1, PTEN, TET2, TP53, and regulation of translation) and 13 oncogene candidates (phosphorylation, regulation of transforming growth factor beta receptor signaling pathway, CTNNB1, ERBB2, positive regulation of cell proliferation, hemopoiesis, natural killer cell differentiation, @GENE$, MTOR, PDGFRA, chromosome segregation, PTPN11, and SF3B1).	0
To dissect the genetic architecture of @DISEASE$ signal transduction, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, negative regulation of protein phosphorylation, TARDBP, FUS, @GENE$, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	0
To dissect the genetic architecture of @DISEASE$ signal transduction, we undertook a large sequencing study in 755 apparently sporadic ALS cases and 959 controls, analyzing 10 ALS genes: SOD1, @GENE$, TARDBP, FUS, angiogenesis, CHMP2B, ATXN2, NIPA1, SMN1, and UNC13A.	0
Although these data further support the pathogenic role of KLHL7 mutations in a CS/@GENE$-like phenotype, they do not explain all their clinical manifestations and highlight the high phenotypic @DISEASE$ associated with mutations in KLHL7.	0
In this study, we enrolled 16 individuals affected by tooth agenesis, prevalently @DISEASE$, and we carried out direct Sanger sequencing of paired box 9 (PAX9) and Msh homeobox 1 (@GENE$) genes in 9 subjects.	1
Deficiency of the extracellular matrix molecule @GENE$, normally expressed by the ureteric bud, leads to @DISEASE$ renal agenesis in humans with Fraser syndrome and blebbed (morphogenesis of an epithelium(bl/bl)) mice.	0
Deficiency of the extracellular matrix molecule morphogenesis of an epithelium, normally expressed by the ureteric bud, leads to bilateral @DISEASE$ in humans with Fraser syndrome and blebbed (@GENE$(bl/bl)) mice.	0
Finally, the proteasome inhibitor bortezomib is a potent enhancer of global @DISEASE$ in our fly model, evidence of a defective proteasome &quot;bounce-back&quot; response that is also observed in nematode and cellular models of @GENE$ Deficiency.	0
In this study, we report the identification of the first insertion mutation, p.W102Vfs*7, in the @GENE$ gene of a newborn girl with acute clinical symptoms including early-onset chronic @DISEASE$.	1
In this study, we report the identification of the first insertion mutation, p.W102Vfs*7, in the @GENE$ gene of a newborn girl with acute clinical symptoms including early-onset @DISEASE$ renal failure.	1
@GENE$, both at the mRNA and protein level, is highly expressed in @DISEASE$ and elevated CHK1 expression in Group3 medulloblastoma is an adverse prognostic marker.	1
We evaluated whether methylation of @DISEASE$-suppressor genes (negative regulation of cytokine productions) would classify non-muscle-invasive (@GENE$) bladder cancer subgroups and predict outcome.	0
We evaluated whether methylation of @DISEASE$-suppressor genes (@GENE$s) would classify non-muscle-invasive (inflammatory response) bladder cancer subgroups and predict outcome.	0
We evaluated whether methylation of tumor-suppressor genes (@GENE$s) would classify non-muscle-invasive (inflammatory response) bladder @DISEASE$ subgroups and predict outcome.	0
Methylation of @GENE$, CD44, PAX5A, negative regulation of protein kinase activity, IGSF4 (T cell mediated cytotoxicity), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 @DISEASE$s whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	0
Methylation of embryonic digestive tract development, CD44, PAX5A, @GENE$, IGSF4 (T cell mediated cytotoxicity), PYCARD, CDH13, TP53, and GATA5 classified pTa versus pT1 @DISEASE$s whereas RARB, CD44, GSTP1, IGSF4, CHFR, PYCARD, TP53, STK11, and GATA5 distinguished LG versus HG tumors.	1
Mutations within this gene are responsible for kinesigenic paroxysmal dyskinesias (protein phosphorylation) as well as for benign familial infantile epilepsy (BFIE), a disease associating infantile convulsions and choreoathetosis (neuromuscular process controlling posture), a form of familial hemiplegic migraine (@GENE$ muscle organ development 4), paroxysmal benign torticollis of childhood, and episodic @DISEASE$.	0
Herein, we report biallelic pathogenic variants in @GENE$ in 12 individuals from 6 independent families with an intellectual disability syndrome associated with @DISEASE$ and dysmorphic features.	1
Homozygous @GENE$ knockout epidermis development were subviable, smaller in size, and had @DISEASE$, consistent with the severity of loss-of-function variants in humans.	0
Affected patients suffer from a progressive movement disorder including chorea, parkinsonism, @DISEASE$, tongue protrusion, dysarthria, dysphagia, tongue and @GENE$ biting, gait impairment, progressive distal muscle wasting, weakness, epileptic seizures, cognitive impairment, and behavioral changes.	0
Here, we report the potential clinical implication and biological functions of @GENE$ in cervical @DISEASE$ (CSCC).	1
Knockdown of RIPK4 reduced cell migration and invasion via inhibition of Vimentin, @GENE$ and Fibronectin expression in cervical @DISEASE$ cells.	1
We observed odds ratios (ORs) of 1.7-2.3 for lung @DISEASE$ (LC; P=4.0 × 10(-4)), chronic obstructive pulmonary disease (COPD; P=9.3 × 10(-4)), peripheral artery disease (biological_process; P=0.090) and abdominal aortic aneurysms (@GENE$; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2 × 10(-4)), COPD (OR=3.22, P=2.9 × 10(-4)), PAD (OR=3.47, P=9.2 × 10(-3)) and AAA (OR=6.44, P=6.3 × 10(-3)).	0
Here, we identify @DISEASE$-associated calcium signal transducer 2 (negative regulation of epithelial cell migration), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with @GENE$ and OCLN and regulates their cellular localization.	1
Here, we identify @DISEASE$-associated calcium signal transducer 2 (@GENE$), one of the most downregulated genes in primary HCC tissue, as a host factor that interacts with cell-cell junction organization and OCLN and regulates their cellular localization.	1
Patients with the combination of dystonia and @DISEASE$ and a family history of a neurodegenerative disorder should be tested for @GENE$.	0
Previously there have been no reports of @GENE$ associated with @DISEASE$.	1
Mutations in CHCHD2 and @GENE$ were recently reported in a broad spectrum of @DISEASE$, for example, Parkinson's disease, amyotrophic lateral sclerosis, frontotemporal dementia, or mitochondrial myopathy (MM).	1
Focal alterations affected CDKN2A, CCND1, @GENE$, EGFR, peptidyl-tyrosine phosphorylation, EPHB1, positive regulation of cell proliferation, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, protein phosphorylation, brain-derived neurotrophic factor receptor signaling pathway were seen in G3 compared with the G1 @DISEASE$ areas.	0
Focal alterations affected CDKN2A, CCND1, protein phosphorylation, EGFR, peptidyl-tyrosine phosphorylation, EPHB1, positive regulation of cell proliferation, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, @GENE$, brain-derived neurotrophic factor receptor signaling pathway were seen in G3 compared with the G1 @DISEASE$ areas.	0
Focal alterations affected CDKN2A, CCND1, protein phosphorylation, EGFR, peptidyl-tyrosine phosphorylation, EPHB1, positive regulation of cell proliferation, JUN, NF1, RB1, RET, TP53, and additional novel amplifications in CCNE1, KIT, EGFR, RET, protein phosphorylation, @GENE$ were seen in G3 compared with the G1 @DISEASE$ areas.	1
TRIO and @GENE$ co-amplification was seen in 8 (44%) G3 and 1 (10%) G1 myxofibro@DISEASE$ and RICTOR amplification alone in 4 (40%) G1 myxofibrosarcomas.	0
The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, @GENE$), including a gene coding for @DISEASE$ with microcephaly (mRNA splicing, via spliceosome).	1
The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, @GENE$), including a gene coding for mandibulofacial dysostosis with @DISEASE$ (mRNA splicing, via spliceosome).	1
The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, biological_process), including a gene coding for @DISEASE$ with microcephaly (@GENE$).	1
The aCGH analysis revealed a pathogenic CNV in the 14q11.2 region, while targeted exome sequencing revealed pathogenic variants in genes associated with intellectual disability (HUWE1, biological_process), including a gene coding for mandibulofacial dysostosis with @DISEASE$ (@GENE$).	1
Despite the identification of several oncogenic driver mutations leading to constitutive JAK-@GENE$ activation, the cellular and molecular biology of myeloproliferative @DISEASE$ (MPN) remains incompletely understood.	1
Mutations affecting both alleles of @GENE$ cause a severe, @DISEASE$ form of Ehlers-Danlos syndrome (EDS).	1
In humans, <i>@GENE$</i> is the gene responsible for the disease @DISEASE$ muscle organ development II, which results in the development of brain tumors, including acoustic neurinoma and meningioma.	1
We have been investigating the pancreas specific transcription factor, 1a cre-recombinase; @GENE$-stop-lox- Kristen rat @DISEASE$, glycine to aspartic acid at the 12 codon (Ptf1a<sup>cre/+</sup>;LSL-Kras<sup>G12D/+</sup>) mouse strain as a model of human pancreatic cancer.	0
Meesmann epithelial @DISEASE$ (MECD) is a rare autosomal dominant disorder caused by dominant-negative mutations within the intermediate filament cytoskeleton organization or KRT12 genes, which encode the cytoskeletal protein keratins K3 and @GENE$, respectively.	1
Using whole-exome sequencing in four probands with undiagnosed skin @DISEASE$/ichthyosis, we identified compound heterozygosity for mutations in @GENE$, encoding an enzyme in the de novo synthesis pathway of ceramides.	1
Biallelic mutations in @GENE$ cause a recessive form of Ehlers-Danlos syndrome (EDS) characterized by @DISEASE$ kyphoscoliosis, myopathy, and hearing loss.	0
Importantly, depletion of @GENE$ strongly reduced the @DISEASE$igenicity and distant colonization capacities of TNBC cells in vivo.	1
Furthermore, CDCA7 increased the expression of @GENE$, a marker of aggressive breast cancer that is involved in @DISEASE$ progression, by enhancing the transcriptional activity of its promoter.	1
Signiﬁcant associations between @GENE$ expression and invasion and metastasis capability in lung @DISEASE$ A549 and H1299 cell lines were identiﬁed.	1
Conclusions: The current meta-analysis shows the associations between five SNPs of @GENE$ and breast @DISEASE$ risk	1
the Partner and localizer of @GENE$ (PALB2) gene and risk of breast @DISEASE$.	1
Clinical features of affected individuals with LGD variants in @GENE$ include variable levels of @DISEASE$, delayed speech and motor milestones, and autism spectrum disorder.	1
Twenty-one genes showed single or cross-cancer associations, including novel associations of @GENE$ in @DISEASE$ and PALB2 in stomach adenocarcinoma.	1
Truncating mutations in the last and penultimate exons of the @GENE$ gene were recently described as a cause for mild to severe @DISEASE$ in fourteen patients.	1
Considering that @GENE$ associates with CRYBB2 and that the latter protein has been implicated in @DISEASE$, mutational analysis of CRYBA4 was performed in 32 patients affected with microphthalmia (small eye).	1
To date, @GENE$ was the only gene in this cluster not associated with either human or murine @DISEASE$s.	0
@GENE$ variants can cause diabetes and might be involved in the development of primary liver @DISEASE$.	1
Blocking the expression of PAK1, DIAPH2, and @GENE$ significantly inhibits breast @DISEASE$ cell migration induced by let-7b repression.	1
The strongly positive rate of @GENE$ in TNBC was 69.2% (74/107), which was significantly higher than in both DCIS 35.7% (15/42) and adjacent non-@DISEASE$ tissues 12.3% (8/65).	1
In humans and epidermis development @GENE$ mutations or loss of function result in a number of skeletal and organ malformations, including polydactyly, tibial hemimelia, omphalocele, biparietal foramina, impaired mammary epithelial morphogenesis, alopecia, coronal craniosynostosis, hypertelorism, depressed nasal bridge and ridge, bifid nasal tip, @DISEASE$, and body agenesis.	1
By using exome and capillary sequencing, we here identify biallelic @GENE$ mutations in four patients from three unrelated families presenting an autosomal-recessive @DISEASE$-ptosis-intellectual-disability syndrome characterized by developmental delay, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.	1
By using exome and capillary sequencing, we here identify biallelic @GENE$ mutations in four patients from three unrelated families presenting an autosomal-recessive blepharophimosis-ptosis-intellectual-disability syndrome characterized by @DISEASE$, growth retardation with a small head circumference, facial dysmorphisms, and low cholesterol levels.	0
Induction of @GENE$ by 5-Aza-dC was tested in vitro using @DISEASE$ cells.	0
5'-Aza-2'-deoxycytidine (5-Aza-@GENE$) is a demethylating drug that causes genome-wide hypomethylation resulting in the expression of several tumor suppressor genes causing growth arrest of @DISEASE$ cells.	0
Fragile X syndrome (FXS), caused by the loss of functional @GENE$, is a leading cause of @DISEASE$.	1
Genetic reduction of @GENE$ also ameliorates autism-related symptoms including repetitive behaviour, defective social interaction and audiogenic @DISEASE$.	0
The @DISEASE$ forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C (γ sarcoglycan), LGMD2D (α sarcoglycan), LGMD2E (β sarcoglycan), LGMD2F (δ sarcoglycan), LGMD2G (cardiac muscle hypertrophy), LGMD2H (TRIM32), LGMD2I (protein O-linked mannosylation), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (protein complex oligomerization), LGMD2T (@GENE$), LGMD2U (protein O-linked mannosylation), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	1
The @DISEASE$ forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C (γ sarcoglycan), LGMD2D (α sarcoglycan), LGMD2E (β sarcoglycan), LGMD2F (δ sarcoglycan), LGMD2G (cardiac muscle hypertrophy), LGMD2H (TRIM32), LGMD2I (@GENE$), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (protein complex oligomerization), LGMD2T (GDP-mannose biosynthetic process), LGMD2U (protein O-linked mannosylation), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	1
The @DISEASE$ forms (LGMD2) are: LGMD2A (calpain 3), LGMD2B (dysferlin), LGMD2C (γ sarcoglycan), LGMD2D (α sarcoglycan), LGMD2E (β sarcoglycan), LGMD2F (δ sarcoglycan), LGMD2G (cardiac muscle hypertrophy), LGMD2H (TRIM32), LGMD2I (protein O-linked mannosylation), LGMD2J (titin), LGMD2K (POMT1), LGMD2L (anoctamin 5), LGMD2M (fukutin), LGMD2N (POMT2), LGMD2O (POMTnG1), LGMD2P (dystroglycan), LGMD2Q (plectin), LGMD2R (desmin), LGMD2S (protein complex oligomerization), LGMD2T (GDP-mannose biosynthetic process), LGMD2U (@GENE$), LGMD2V (Glucosidase, alpha ), LGMD2W (PINCH2)	1
@GENE$ expression is absent in normal urothelial cells, but it begins to be expressed in pre-neoplastic bladder @DISEASE$ and continues to be expressed in invasive mouse BCa.	1
Ablation of @GENE$-expressing cells within primary invasive intracellular signal transduction led to enhanced @DISEASE$ regression, supporting the essential role of SOX2-positive cells in regulating BCa maintenance and progression.	1
Ablation of osteoblast differentiation-expressing cells within primary invasive @GENE$ led to enhanced @DISEASE$ regression, supporting the essential role of SOX2-positive cells in regulating BCa maintenance and progression.	1
@GENE$ but not KRT6C mRNA expression was increased in chemotherapy resistant primary serous ovarian @DISEASE$ cells compared to chemotherapy sensitive cells.	1
KRT5 and @GENE$ (KRT6A, KRT6B &amp; KRT6C) gene expression was assessed in publically available serous ovarian @DISEASE$ data sets, ovarian cancer cell lines and primary serous ovarian cancer cells.	0
Our findings suggest that DEGs encoding subunits of NADH, G1/S transition of mitotic cell cycle, @GENE$, MAPK1, STAT3, activation of MAPKK activity, and JAK1 might be associated with the development of @DISEASE$.	0
Our findings suggest that DEGs encoding subunits of NADH, G1/S transition of mitotic cell cycle, G1/S transition of mitotic cell cycle, MAPK1, STAT3, @GENE$, and JAK1 might be associated with the development of @DISEASE$.	0
Oral @DISEASE$ studies have correlated @GENE$ expression with metastatic disease and poor prognosis.	0
The association between low @GENE$ expression and p16<sup>+</sup> HNSCCs suggests that alternative signaling pathways may be used for their @DISEASE$igenesis	1
A case with @GENE$ (C.700G&gt;A) had @DISEASE$ controlled for 6 mouths.	0
We studied a consanguineous Pakistani family with postnatal microcephaly, @DISEASE$, spastic quadriplegia and, on MRI, cortical atrophy with myelination delay, suggestive of a @GENE$-like presentation.	1
We studied a consanguineous Pakistani family with postnatal microcephaly, orofacial dyskinesia, @DISEASE$ and, on MRI, cortical atrophy with myelination delay, suggestive of a @GENE$-like presentation.	0
The regulation of the post-mitotic neural survival activity of TLE1 depends critically on an interaction with @GENE$, a gene shown to be involved in a postnatal @DISEASE$ syndrome.	1
Additionally, @GENE$ can be a potential @DISEASE$ suppressor	1
In conclusion, the hypermethylation of @GENE$ is an independent prognostic biomarker in breast @DISEASE$.	1
Interestingly, @GENE$ mutations have been linked to neurodegenerative disorders of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor @DISEASE$ type V (dHMN-V).	0
Altogether these data demonstrate that mutations in @GENE$ cause a congenital muscular dystrophy syndrome with short stature, @DISEASE$, and intellectual disability	1
Altogether these data demonstrate that mutations in @GENE$ cause a congenital @DISEASE$ syndrome with short stature, cataracts, and intellectual disability	1
This result represents another indication for the genetic @DISEASE$ of @GENE$ and extends the mutational spectrum of the disease by introducing nine novel mutations in five BBS genes.	0
Here, we applied domain-focused CRISPR screening to human @DISEASE$ cell lines to identify the transcription factor (TF) negative regulation by host of viral transcription (POU class 2 homeobox 3; also known as @GENE$-1a/regulation of cell migration-11) as a powerful dependency in a subset of SCLC lines.	1
Here, we applied domain-focused CRISPR screening to human @DISEASE$ cell lines to identify the transcription factor (TF) @GENE$ (POU class 2 homeobox 3; also known as smoothened signaling pathway-1a/regulation of cell migration-11) as a powerful dependency in a subset of SCLC lines.	1
Moreover, we show that most SCLC @DISEASE$s can be classified into one of three lineages based on the expression of POU2F3, @GENE$, or NEUROD1.	1
Prior studies that explored the hypothesis that @GENE$ gene variants contribute to epithelial @DISEASE$ (EOC) risk have been based on small sample sizes and none have sought replication in an independent population.	1
Perturbation of @GENE$ function has previously been suggested in Alzheimer's disease (AD) as shown in fibroblasts from AD patients and a @DISEASE$ cell line containing familial presenilin-2 AD mutation.	1
CGD is a genetically @DISEASE$ disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), @GENE$ (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	0
CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the superoxide metabolic process (OMIM #300481) gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the cytochrome complex assembly (OMIM #608508), @GENE$ (OMIM #608512), NCF2 (OMIM #608515) and NCF4 (OMIM #601488) genes encoding p22(phox), p47(phox), p67(phox) and p40(phox), respectively.	1
Taken together, these results suggest the implication of @GENE$ in a new @DISEASE$ MCA.	1
Here, integrated analysis of gene expression in non-small cell lung cancer revealed that @GENE$ expression is significantly correlated with increased @DISEASE$ size and regional lymph node spread, as well as shorter overall survival (OS) and disease-free survival (DFS).	1
Mutations in the Pejvakin (@GENE$) gene cause @DISEASE$ hearing loss DFNB59 with audiological features of auditory neuropathy spectrum disorder (ANSD) or cochlear dysfunction.	1
By contrast, loss of @GENE$ in adult OHCs causes a slowly progressive @DISEASE$ associated with OHC degeneration and delayed loss of inner hair cells (IHCs), indicating a primary role for pejvakin in regulating OHC function and survival.	1
Here, we demonstrate that mice with conditional ablation of the @GENE$ gene in all sensory hair cells or only in outer hair cells (OHCs) show similar auditory phenotypes with early-onset profound @DISEASE$.	1
Moreover, we confirmed that knockdown of @GENE$ could inhibit @DISEASE$ growth in vivo.	1
The SNPs rs2124437 (@GENE$), rs1335022 (GRIK2), rs4512367 (G protein-coupled receptor signaling pathway), rs4748011 (negative regulation of tumor necrosis factor-mediated signaling pathway), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral @DISEASE$s and 500 healthy controls with a minimum of 10 years of tobacco usage.	1
The SNPs rs2124437 (MAPK cascade), rs1335022 (GRIK2), rs4512367 (@GENE$), rs4748011 (negative regulation of tumor necrosis factor-mediated signaling pathway), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral @DISEASE$s and 500 healthy controls with a minimum of 10 years of tobacco usage.	1
The SNPs rs2124437 (MAPK cascade), rs1335022 (GRIK2), rs4512367 (G protein-coupled receptor signaling pathway), rs4748011 (@GENE$), and rs1435218 (LNX1) were analyzed in 500 histopathologically confirmed oral @DISEASE$s and 500 healthy controls with a minimum of 10 years of tobacco usage.	1
DLX3 mutations have been found to be responsible for Tricho-Dento-Osseous (@GENE$) syndrome, charcoenzyme A biosynthetic processerized by kinky hair, thin-pitted enamel and @DISEASE$.	0
In contrast, patients with the non-hereditary Carney triad, including paraganglioma, GIST, and @DISEASE$, usually lack germline @GENE$ mutations and instead show epigenetic SDH complex inactivation through SDHC promoter methylation.	0
<b>Conclusions:</b> The expression of @GENE$ in human @DISEASE$ is positively correlated with the malignant grade of glioma, which may be involved in the malignant progression of glioma by EMT	1
Real-time fluorescence quantitative PCR and Western blot were used to detect the expression level of @GENE$ mRNA and protein in 61 cases of fresh @DISEASE$ tissue (WHO grade Ⅱ 16 cases, Ⅲ 21 cases, Ⅳ 24 cases) and 12 cases of adjacent tissues, and the expression levels of E-cadherin, N-cadherin and vimentin were also investigated in fresh glioma tissue.	1
The percentages of @GENE$ expression were 75% (15/20), 95% (19/20), and 100% (20/20) in the WHO gradesⅡ, Ⅲ and Ⅳ @DISEASE$s, respectively.	0
Detection of key protein expression in cytokine production by Western blot displayed that the expression of E-cadherin was negatively associated with @GENE$ in @DISEASE$ (<i>r</i>=-0.972, <i>P</i>&lt;0.01).	1
Global-genome nucleotide excision repair (GG-@GENE$) prevents ultraviolet (UV) light-induced skin @DISEASE$ by removing mutagenic cyclobutane pyrimidine dimers (CPDs).	0
In this study @GENE$ exhibited sensitivity and specificity in diagnosis of @DISEASE$ melanoma which allows its application as an auxiliary diagnostic test in acral melanocytic tumours	0
This phenotypic variability should be taken into account when treating patients with @GENE$-associated @DISEASE$.	1
Here, we report two affected siblings with compound heterozygous truncating mutations in @GENE$ and intra-familial phenotypic @DISEASE$, with a less severe disease course in the female sibling.	0
Moreover, we demonstrated that pharmacological inhibition of 15-PGDH enhanced @GENE$ expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the ALDH1-positive subset in both human PDAC cells and @DISEASE$ cells of Kras<sup>LSL-G12D/+</sup>; Ptf1a<sup>Cre/+</sup> (KC) epidermis development.	1
Here, we found that 15-@GENE$ expression was inversely correlated with oxidation-reduction process, an important @DISEASE$ stem cell-associated marker indicative of poor prognosis in humans.	1
Here, we found that 15-L-serine biosynthetic process expression was inversely correlated with @GENE$, an important @DISEASE$ stem cell-associated marker indicative of poor prognosis in humans.	1
Blood and tissue samples from 48 @DISEASE$ patients were obtained, and the following polymorphisms were analyzed; @GENE$ 80G&gt;A, DHFR 829C&gt;T, MTHFR 677C&gt;T, MTHFR 1298A&gt;C, and ATIC 347C&gt;G.	0
Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, @GENE$, IRX1, BMP8A, GATA4, negative regulation of transcription by RNA polymerase II, regulation of transcription by RNA polymerase II, and regulation of erythrocyte differentiation were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of @DISEASE$.	0
Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, cartilage development, IRX1, BMP8A, GATA4, @GENE$, regulation of transcription by RNA polymerase II, and regulation of erythrocyte differentiation were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of @DISEASE$.	1
Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, cartilage development, IRX1, BMP8A, GATA4, negative regulation of transcription by RNA polymerase II, @GENE$, and regulation of erythrocyte differentiation were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of @DISEASE$.	0
Genes involved in tissue development, differentiation, and oncogenesis such as DNAJA4, cartilage development, IRX1, BMP8A, GATA4, negative regulation of transcription by RNA polymerase II, regulation of transcription by RNA polymerase II, and @GENE$ were hypermethylated in both RMS cell lines and primary samples, implicating aberrant DNA methylation in the pathogenesis of @DISEASE$.	1
@GENE$ mutations are one cause of @DISEASE$ RP making the CNGB1 mutant dog a valuable large animal model of the condition	1
This study demonstrates that @GENE$ and regulation of double-strand break repair via homologous recombination are indicators of poor prognosis for @DISEASE$s and that CSNK2A1-mediated phosphorylation of SIRT6 might be involved in the progression of breast carcinoma	1
This study demonstrates that peptidyl-serine phosphorylation and @GENE$ are indicators of poor prognosis for @DISEASE$s and that CSNK2A1-mediated phosphorylation of SIRT6 might be involved in the progression of breast carcinoma	1
Though using the term gray platelets for @GENE$ deficiency has been debated, a reduced number of α-granules has been described for @DISEASE$ due to <i>GATA1</i> mutations.	1
Biallelic mutations in @GENE$ have been identified as responsible for cases of @DISEASE$ Leigh syndrome associated with mitochondrial complex I deficiency.	1
Next, we show that @GENE$ functions as a @DISEASE$ suppressor in GBM.	1
The fetus inherited an additional likely pathogenic novel missense change to a second MKS gene, @GENE$; p.R2210C, suggesting @DISEASE$ in this disorder	1
<b>Objective:</b> To investigate the genotype-phenotype correlation in Chinese familial hypertrophic @DISEASE$ (HCM )focusing on the cardiac troponin C gene @GENE$ c.	1
However, only recently have genetic studies demonstrated sequence variation in @GENE$ and HCN2 genes associated with human @DISEASE$.	1
A plethora of human diseases are associated with mutations in the genes encoding human SLC26 transporters, including chondrodysplasias with varying severity in @GENE$ (~50 mutations, 27 point mutations), congenital chloride-losing diarrhea in SLC26A3 (~70 mutations, 31 point mutations) and Pendred Syndrome or @DISEASE$ autosomal recessive muscle organ development 4 in SLC26A4 (~500 mutations, 203 point mutations).	0
Of the genes detected out, @GENE$ gene mutation was with significant difference (χ<sup>2</sup> = 75.132, p = 0.000) between audio-no-pass group (417/1315, 31.711%) and random-selected cohort (159/1000, 15.900%); c.109G &gt; A was the most common allele, as well as the only one with significantly different allele frequency (χ<sup>2</sup> = 79.327, p = 0.000) between audio-no-pass group (392/1315, 16.84%) and random-selected cohort (140/1000, 7.55%), which suggested c.109G &gt; A mutation was critical for newborns' @DISEASE$.	1
In order to investigate essential molecular causes for @DISEASE$ and mutation frequency of deafness-related genes, 1315 newborns who did not pass the Newborn Hearing Screening (@GENE$) (audio-no-pass) and 1000 random-selected infants were subjected to detection for 101 hotspot mutations in 18 common deafness-related genes.	0
Treacher Collins syndrome (@GENE$, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric @DISEASE$ consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, cleft palate and deafness.	0
Treacher Collins syndrome (@GENE$, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, @DISEASE$, cleft palate and deafness.	0
Treacher Collins syndrome (@GENE$, OMIM 154500) is a well-defined mandibulofacial dysostosis characterized by symmetric facial anomalies consisting of malar hypoplasia, coloboma of the lower eyelid, dysplastic ears, micrognathia, @DISEASE$ and deafness.	0
Here we describe three unrelated patients showing clinical features overlapping with @GENE$, but who in addition have @DISEASE$, microcephaly and a distinct facial gestalt.	0
We have generated four thyroid @DISEASE$ cell lines with a greater than 30-fold increase in acquired resistance to the @GENE$ inhibitor dasatinib.	0
We specifically discuss the role of @GENE$ in the regulation of cell proliferation and survival within the context of the identified target genes, its interaction with viral oncogenes, and its association with the TP53 @DISEASE$ suppressor and MYC oncogene.	1
Hence, this previously unknown @GENE$/Brg1 signaling axis provides the molecular basis and the rationale to target Brg1 in FBW7-compromised human gastric @DISEASE$s	1
In keeping with a @DISEASE$ suppressive role of FBW7 in human gastric cancer, we find an inverse correlation between FBW7 and @GENE$ expression in human gastric cancer clinical samples.	1
A panel of hypermethylated genes including APC, CSPG2, @GENE$, visual perception, HOXA9, pyruvate metabolic process, cardiac cell fate determination, JAK3, regulation of transcription, DNA-templated, SOX1, and negative regulation of transcription, DNA-templated predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	1
A panel of hypermethylated genes including APC, CSPG2, neuron development, visual perception, HOXA9, @GENE$, cardiac cell fate determination, JAK3, regulation of transcription, DNA-templated, SOX1, and negative regulation of transcription, DNA-templated predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	1
A panel of hypermethylated genes including APC, CSPG2, neuron development, visual perception, HOXA9, pyruvate metabolic process, cardiac cell fate determination, JAK3, @GENE$, SOX1, and negative regulation of transcription, DNA-templated predicted @DISEASE$-specific survival and SOX1 (HR = 3.46), PITX2 (HR = 4.17), CSPG2 (HR = 5.35), and JAK3 hypermethylation (HR = 0.19) did so independently.	1
Further experiments demonstrated that the MYEOV ceRNA sequestered @GENE$-30c-2-3p from binding its targets TGFBR2 and USP15 mRNAs, which in turn leading to constitutive activation of TGF-β signaling and @DISEASE$ progression in NSCLC.	0
The glutamatergic hypothesis of @DISEASE$ lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, @GENE$, signal transduction, DTNBP1, DAAO, G72/30, GRM3).	0
Empty spiracles homeobox 2 (@GENE$) is a homeodomain-containing transcription factor that plays an essential role in @DISEASE$igenesis.	1
Global <i>@GENE$</i> gene deletion or conditional inactivation in Nestin-positive cells led to formation of supratentorial @DISEASE$ in the early postnatal period.	0
Expression of miR-17-92a miRNAs improved sensitivity of androgen dependent LNCaP 104-S prostate @DISEASE$ cells to anti-androgen drug Casodex, @GENE$ inhibitor MK-2206 2HCl, and docetaxel.	1
Our study identifies WDR4 as an oncoprotein that negatively regulates @GENE$ via ubiquitination to promote lung cancer progression by fostering an immunosuppressive and prometastatic @DISEASE$ microenvironment, suggesting the potential of immune-modulatory approaches for treating lung cancer with aberrant PML degradation	1
The WDR4/PML axis induces a set of cell-surface or secreted factors, including CD73, urokinase-type plasminogen activator receptor (uPAR), and serum amyloid A2 (@GENE$), which elicit paracrine effects to stimulate migration, invasion, and metastasis in multiple lung @DISEASE$ models.	1
@GENE$ overexpression promotes tumorigenesis and is associated with poor prognosis in several @DISEASE$s.	1
The high levels of @GENE$ expression in gastric GISTs was significantly associated with @DISEASE$ size (P &lt; .001), multivisceral resection (P = .006), metastasis at initial diagnosis (P = .006), mitotic count (P = .002) and NIH risk classification (P = .015).	1
In particular, the @GENE$, SPTA1 and VPS13B genes were commonly mutated in both early and late stage @DISEASE$, primary tumors and metastases, and tumors before and after chemotherapy, as in the case of the TP53 and RB1 genes.	1
Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, @GENE$, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	1
Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, @GENE$, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	0
Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, @GENE$, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	0
Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, G protein-coupled receptor signaling pathway, cell cycle arrest, FOXC1, ATXN2, @GENE$); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	0
Recent GWAS completed for three types of common adult-onset @DISEASE$ have identified novel loci for POAG (primary-open-angle glaucoma) (ABCA1, AFAP1, GMDS, PMM2, epithelial to mesenchymal transition, FNDC3B, @GENE$, cell cycle arrest, FOXC1, ATXN2, cell redox homeostasis); PACG (primary angle-closure glaucoma (EPDR1, phosphatidylcholine biosynthetic process, negative regulation of transcription by RNA polymerase II, FERMT2, DPM2-FAM102); and exfoliation syndrome (XFS) glaucoma (CACNA1A).	1
Recent studies have suggested possible therapeutic targets for some patients with early-onset @DISEASE$ based on the molecular and cellular events caused by MYOC, @GENE$ and TBK1 mutations.	1
Currently the only established high penetrance familial @DISEASE$ genes are @GENE$ and CDK4.	1
Notably, shRNA-mediated knockdown of @GENE$ suppressed the growth and invasion of @DISEASE$s in nude mouse xenograft models.	1
As for genes relating to the @DISEASE$ invasion of PLD2, we found that angiogenin (@GENE$) was positively regulated by PLD2.	0
The therapeutic strategy to recover immune function through the restoration of impaired Tregs function with the mounting evidences regarding @GENE$ in autoimmune mediated disorder (MS, SLE, RA, T1D) suggest as working hypothesis the direct targeting KRAS activation using @DISEASE$-derived small molecules may be clinically relevant	1
In order to investigate whether somatic @GENE$ gene mutations play a role in @DISEASE$ pediatric myeloproliferative diseases, we performed a mutation screening of a large representative cohort of pediatric acute myeloid leukemia, myeloid leukemia of Down syndrome, and juvenile myelomonocytic leukemia samples and show that gain-of-function THPO mutations are extremely rare in sporadic pediatric myeloproliferative diseases	1
We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (regulation of postsynapse organization), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic α-spectrin-1 (SPTAN1), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (positive regulation of receptor internalization), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1α subunit (SCN1A), protocadherin 19 (@GENE$), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	0
We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (@GENE$), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic α-spectrin-1 (SPTAN1), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (positive regulation of receptor internalization), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1α subunit (SCN1A), protocadherin 19 (homophilic cell adhesion via plasma membrane adhesion molecules), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	1
We summarize recent updates on the genes and related clinical syndromes involved in the pathogenesis of early-onset @DISEASE$: Aristaless-related homeobox (ARX), cyclin-dependent kinase-like 5 (regulation of postsynapse organization), syntaxin-binding protein 1 (STXBP1), solute carrier family 25 member 22 (SLC25A22), nonerythrocytic α-spectrin-1 (SPTAN1), phospholipase Cβ1 (PLCβ1), membrane-associated guanylate kinase inverted-2 (@GENE$), polynucleotide kinase 3'-phosphatase (PNKP), sodium channel neuronal type 1α subunit (SCN1A), protocadherin 19 (homophilic cell adhesion via plasma membrane adhesion molecules), and pyridoxamine 5-prime-phosphate oxidase (PNPO)	0
Overall, our results define an oncogenic role of <i>pancEts-1</i> in @DISEASE$ progression through @GENE$-mediated β-catenin stabilization, with potential implications for the clinical therapeutics of neuroblastoma.<b>Significance:</b> These findings reveal the oncogenic functions of a long noncoding RNA in neuroblastoma progression, offering a potential target for clinical therapeutics.	0
Meier-Gorlin syndrome (MGS) is a genetically @DISEASE$ primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, DNA replication initiation, @GENE$, CDT1, and CDC6.	1
Meier-Gorlin syndrome (MGS) is a genetically @DISEASE$ primordial dwarfism syndrome known to be caused by biallelic loss-of-function mutations in one of five genes encoding pre-replication complex proteins: ORC1, @GENE$, negative regulation of cell division, CDT1, and CDC6.	0
Multiple @DISEASE$ syndrome 1 (MMDS1) arises as a result of the missense mutation in @GENE$, an Fe/S cluster scaffold protein, which substitutes a glycine near the Fe/S cluster-binding pocket to a cysteine (p.Gly208Cys).	1
Retrospectively study revealed that @GENE$-34a expression was downregulated in human primary GC tissues compared with non-@DISEASE$ tissues and low miR-34a expression was associated with a significantly shorter overall survival and disease-free survival.	1
This case unravels a previously unrecognized phenotype of camptodactyly due to a significant skeletal deformity of PRS with a @DISEASE$ @GENE$ mutation of hexanucleotide duplication.	1
The @GENE$ pathway was significantly associated with overall and estrogen receptor-negative (ER-) breast @DISEASE$ risk (P = 0.003 and 0.03, respectively).	1
@GENE$ (Padj = 0.0018) and RPS6KA3 (Padj = 0.061) were the leading genes for the associations with overall breast @DISEASE$ risk and ER- breast cancer risk, respectively.	1
@GENE$ expression is lost in colonic malignancies, indicating that the CaSR is a biomarker for colonic @DISEASE$ progression.	1
More important, @GENE$ haploinsufficiency markedly increased the incidence and severity of abdominal @DISEASE$, and caused aortic arch ruptures and dissections, indicating that α2(V) chain deficits may play roles in these pathologies in humans	1
We aimed to investigate the effect of the AS to @GENE$ gene on non-small cell lung @DISEASE$ (NSCLC) development.	1
By GEPIA database analysis, we also found that the expression of lncRNA FEZF-AS1 and @GENE$ were significantly higher in @DISEASE$ tissues than those of the adjacent non-cancerous tissues in 969 NSCLC patients (P &lt; 0.05), and lncRNA FEZF-AS1 was positively correlated with FEZF1 (r = 0.90, P &lt; 0.001).	1
In the framework of this @DISEASE$, we report the clinical description of a neonate, first child of consanguineous parents, who had osteoclast-rich osteopetrosis and bone marrow failure in early life, but no other usual classical features of infantile malignant @GENE$, such as visual or hearing impairments.	0
A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a @DISEASE$ in haematological neoplasms including microtubule-based process, AML, MPN and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, IDH2, hemopoiesis, @GENE$ and DNMT3A.	1
A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a @DISEASE$ in haematological neoplasms including microtubule-based process, AML, MPN and MDS/MPN and often is associated with somatic mutations of @GENE$, negative regulation of transcription by RNA polymerase II, IDH2, hemopoiesis, Ras protein signal transduction and DNMT3A.	1
A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a @DISEASE$ in haematological neoplasms including microtubule-based process, AML, MPN and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, negative regulation of transcription by RNA polymerase II, IDH2, @GENE$, Ras protein signal transduction and DNMT3A.	0
A systematic study of serial samples from 30 patients show that ASXL1 c.1934dupG is a somatic mutation in haematological @DISEASE$ including microtubule-based process, AML, MPN and MDS/MPN and often is associated with somatic mutations of 5-methylcytosine catabolic process, @GENE$, IDH2, hemopoiesis, Ras protein signal transduction and DNMT3A.	0
When stratified by @DISEASE$ histology, three SNPs (ENO1 rs2274971A &gt; G, PFKM rs11168417C &gt; T, and @GENE$ rs3785921G &gt; A) were significantly associated with OS and/or DFS only in squamous cell carcinoma, whereas canonical glycolysis rs1132173C &gt; T exhibited a significant association with survival outcomes only in adenocarcinoma.	0
When stratified by tumor histology, three SNPs (ENO1 rs2274971A &gt; G, PFKM rs11168417C &gt; T, and @GENE$ rs3785921G &gt; A) were significantly associated with OS and/or DFS only in @DISEASE$, whereas canonical glycolysis rs1132173C &gt; T exhibited a significant association with survival outcomes only in adenocarcinoma.	1
Hypermethylated in @DISEASE$ 1 (@GENE$) is frequently deleted or epigenetically silenced in various human cancers.	1
The results provide evidence that lncRNA-numb is a newly proposed @DISEASE$ suppressor that is involved in @GENE$-induced phenotypes.	1
In this study, we present a male child demonstrating recurrent febrile episodes, @DISEASE$, and basal ganglia calcification suggestive of Aicardi-Goutières syndrome, who carries the same Arg822Gln mutation in @GENE$ previously associated with SMS.	1
De novo missense and frameshift mutations and deletions involving @GENE$ have been described in patients with intellectual disability and @DISEASE$, but without any of the dysmorphic findings or malformations associated with Pierpont syndrome, implying a mutation-specific mechanism for the pathogenicity of p.Tyr446Cys.	0
Here, we report mutations in @GENE$, which encodes an enzyme in the proline biosynthesis pathway, as the cause of a unique syndrome characterized by postnatal @DISEASE$, hypomyelination, and reduced cerebral white-matter volume.	1
In addition, through data mining analysis, we observed an extremely strong correlation between the expression levels of GATA3 and @GENE$ in para@DISEASE$, but the correlation turned insignificant in mammary tumors.	1
Using vectors encoding @GENE$ with mutations frequently occurring in mammary @DISEASE$, we found that several mutations on GATA3 led to a dysregulation of CtIP, and therefore HR repair.	1
Multivariate analysis data revealed that @GENE$ and protein phosphorylation protein expression were independent predictors of overall survival of ESCC patients after chemotherapy and/or radiotherapy (P &lt; .05).ERCC1 overexpression is an important phenotype that is associated with ESCC lymph node metastasis and advanced @DISEASE$ clinical stages.	1
Using homozygosity mapping followed by exome sequencing, we identified a Thr224Asn mutation in the @GENE$ gene in infants from consanguineous families who suffered from life-threatening neutropenia, which was refractory to granulocyte CSF, from @DISEASE$ and myelofibrosis.	1
Importantly, cell line and animal experiments both confirmed that E2F6 promotes ovarian @DISEASE$ stemness, whereas E2F6 or @GENE$ depletion derepressed miR-193a, which opposes cancer stemness, by alleviating DNA methylation and repressive chromatin.	1
To decipher a mechanism for this, we previously generated a mathematical model of how estrogen-mediated upregulation of the transcription factor, E2F6, upregulates the ovarian cancer stem/initiating cell marker, @GENE$, by epigenetic silencing the @DISEASE$ suppressor miR-193a, and a competing endogenous (ceRNA) mechanism.	1
@GENE$ showed the highest enrichment of gene signatures for interleukin-13/T-helper cell type 2 (Th2) and innate lymphoid cell type 2. TAC1 had the highest sputum @DISEASE$ and exhaled nitric oxide fraction, and was restricted to severe asthma with oral corticosteroid dependency, frequent exacerbations and severe airflow obstruction.	0
Our study shows that in @DISEASE$, @GENE$- or negative regulation of DNA replication-based PI provides valuable prognostic information and high PI indicates aggressive disease	0
By whole-exome sequencing, recessive protein-truncating mutations in @GENE$ were found in seven unrelated families that show a range of clinical phenotypes, including retinal degeneration, brachydactyly, craniofacial abnormalities, @DISEASE$, and neurological defects.	0
By whole-exome sequencing, recessive protein-truncating mutations in @GENE$ were found in seven unrelated families that show a range of clinical phenotypes, including @DISEASE$, brachydactyly, craniofacial abnormalities, short stature, and neurological defects.	1
Remarkably, variable expressivity of the human phenotype can be recapitulated in @GENE$ mutant mouse models, with significant embryonic lethality and severe phenotypes in the complete knockout mice while mice with a partial loss-of-function allele mimic the isolated @DISEASE$ phenotype.	1
The abnormal regulation of @GENE$-483 may play an important role in @DISEASE$igenesis, and G protein-coupled receptor signaling pathway is known to regulate cell polarity, cell migration, and cell division.	0
The abnormal regulation of protein polyubiquitination-483 may play an important role in @DISEASE$igenesis, and @GENE$ is known to regulate cell polarity, cell migration, and cell division.	1
Few studies have examined the roles of @GENE$ and GATA4 in @DISEASE$ or their association with pulmonary artery histopathology.	1
The melanogenic activity of 6-benzylaminopurine, the compound identified as the most potent, was further verified by measuring green fluorescent protein concentration in @GENE$ a: eGFP (tyrosinase-related protein 1) zebrafish and mitfa: eGFP (@DISEASE$ associated transcription factor) zebrafish and antioxidative activity.	0
Here, we applied next-generation sequencing in 89 patients with a clinical diagnosis of @DISEASE$, analyzing the prevalence of genetic defects in SLC4A1, ATP6V0A4, and @GENE$ genes and the clinical phenotype.	0
Cerebellar involvement is an important feature of @GENE$-CDG, the congenital @DISEASE$ due to dystroglycanopathy, and polyprenol catabolic process-CDG.	1
Cerebellar involvement is an important feature of protein glycosylation-CDG, the congenital @DISEASE$ due to dystroglycanopathy, and @GENE$-CDG.	1
Double-labeling immunohistochemistry for Pit-1/GH, Pit-1/NFP, Pit-1/MAP2, and @GENE$/GH was performed in 9/10 @DISEASE$.	1
Logistic regression analysis adjusted for age and gender reported a moderate association between rectal @DISEASE$ risk and two @GENE$ SNPs, rs1684575 T&gt;G (OR: 1.60, 95% CI: 1.13-2.27, recessive model) and rs3751710 (OR: 0.70, 95% CI: 0.51-0.96, dominant model).	1
Constitutive activation of interferon signaling pathways has been reported in colorectal @DISEASE$ (CRC), leading to a strong CD8+ T cell response through stimulation of @GENE$ expression.	1
Additionally, @GENE$ increases the metastatic ability of a @DISEASE$ by enhancing cell migration, matrix metalloproteinase-7 expression and EMT.	1
Transcriptome analysis of @GENE$-treated SW620 cells indicates that CXCL1 increases potential oncogene expression in colon @DISEASE$, including <i>PTHLH</i>, <i>TYRP1</i>, <i>FOXO1</i>, <i>TCF4</i> and <i>ZNF880</i>.	1
These include other keratin genes for monilethrix, the HR gene for atrichia congenita, the genes CDSN, negative regulation of Wnt signaling pathway and SNRPE for the autosomal dominant form of hypotrichosis simplex, and the genes DSG4, LIPH and @GENE$ for the @DISEASE$ forms of hypotrichosis as well as U2HR for hypotrichosis type Marie Unna.	1
Familial microscopic hematuria (FMH) is associated with a genetically @DISEASE$ group of conditions including the collagen-IV nephropathies, the heritable C3/@GENE$ nephropathy and the glomerulopathy with fibronectin deposits.	1
On the other hand, @DISEASE$ suppressor roles of YY1 appear to involve YY1 stimulation of tumor suppressor BRCA1, increased Bax transcription and apoptosis involving cytochrome c release and caspase-3/-7 cleavage, induction of heme oxygenase-1, inhibition of pRb phosphorylation and p21 binding to cyclin D1 and @GENE$, reduced expression of long noncoding RNA of SOX2 overlapping transcript, and MUC4/ErbB2/p38/MEF2C-dependent downregulation of MMP-10.	1
For example, YY1's roles in @DISEASE$ growth involve stabilization of hypoxia-inducible factor HIF-1α in a p53 independent manner, negative regulation of miR-9 transcription, control of biological_process transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and @GENE$ activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.	1
For example, YY1's roles in @DISEASE$ growth involve stabilization of hypoxia-inducible factor HIF-1α in a p53 independent manner, negative regulation of miR-9 transcription, control of @GENE$ transcription, a novel miR-193a-5p-YY1-APC axis, intracellular ROS and mitochondrial superoxide generation, p53 reduction and positive regulation of protein phosphorylation activation, control of genes associated with mitochondrial energy metabolism and miRNA regulatory networks involving miR-7, miR-9, miR-34a, miR-186, miR-381, miR-584-3p and miR-635.	1
YY1 expression is associated with that of @DISEASE$ stem cell markers SOX2, BMI1 and @GENE$ across many cancers suggesting multidynamic regulatory control and groups of cancers with distinct molecular signatures.	1
In the present case, a sporadic FGP with LGD did not develop into invasive @DISEASE$, but contained foci of @GENE$ 14 years after diagnosis.	0
Functional assays indicate that @GENE$ reactivation ameliorates the malignant phenotype, specifically reducing cell viability, migration and invasion in diverse @DISEASE$ cell lines.	1
Further, mice heterozygous for either @GENE$ or mRNA splicing, via spliceosome exhibit aberrant neurogenesis and @DISEASE$.	0
In MCDS epidermis development expressing the Col10a1.pN617K mutation, CBZ reduced the MCDS-associated expansion of the growth plate hypertrophic zone, attenuated enhanced expression of ER stress markers such as @GENE$ and response to endoplasmic reticulum stress, increased bone growth, and reduced @DISEASE$.	0
In MCDS epidermis development expressing the Col10a1.pN617K mutation, CBZ reduced the MCDS-associated expansion of the growth plate hypertrophic zone, attenuated enhanced expression of ER stress markers such as cellular response to glucose starvation and @GENE$, increased bone growth, and reduced @DISEASE$.	1
Overall, our findings show how the @DISEASE$ suppressor @GENE$ is regulated in hepatocellular carcinoma and establish the mechanism underlying positive regulation of protein ubiquitination-mediated tumorigenesis in this disease.<b>Significance:</b> These findings provide mechanistic insights into regulation of the tumor suppressive sirtuin SIRT6 and its implications for the development of hepatocellular carcinoma.	0
In mouse models of @DISEASE$, @GENE$ downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated tumorigenesis.	0
In mouse models of hepatocellular carcinoma, @GENE$ downregulation and consequent induction of ANXA2 were critical for UBE3A-mediated @DISEASE$igenesis.	1
Corresponding implicated genes, such as TNNI3K, @GENE$, MKL2, MTNR1B and PRKD1, may explain the associations between reproductive factors and @DISEASE$.	1
The insulin-secreting pancreatic neuroendocrine @DISEASE$, insulinomas, characterized by increased pancreatic islet β-cell proliferation, express the phosphorylated isoform of the β-cell differentiation factor regulation of transcription by RNA polymerase II that interacts with @GENE$/p54NRB, a survival factor.	1
The insulin-secreting pancreatic neuroendocrine tumors, @DISEASE$, characterized by increased pancreatic islet β-cell proliferation, express the phosphorylated isoform of the β-cell differentiation factor regulation of transcription by RNA polymerase II that interacts with @GENE$/p54NRB, a survival factor.	1
Also, two somatic heterozygous @GENE$ mutations were found in endocrine-related tumors, p.H146R (parathyroid) and p.R293H (small intestine neuroendocrine @DISEASE$).	1
Overall, our results highlight the importance of @GENE$ in conditions of β-cell excess (@DISEASE$) and in conditions of β-cell loss or dysfunction (diabetes).	1
Smith-Magenis syndrome (positive regulation of transcription, DNA-templated), a neurodevelopmental disorder characterized by dysmorphic features, @DISEASE$ (ID), and sleep disturbances, results from a 17p11.2 microdeletion or a mutation in the @GENE$ gene.	1
Smith-Magenis syndrome (positive regulation of transcription, DNA-templated), a neurodevelopmental disorder characterized by dysmorphic features, intellectual disability (ID), and @DISEASE$, results from a 17p11.2 microdeletion or a mutation in the @GENE$ gene.	1
The Gene Expression Profiling Interactive Analyses application (GEPIA) was used to analysis the expression of @GENE$ in breast @DISEASE$ tissues and normal samples.The polymorphism of rs1325774 was significantly associated with an increased risk of breast cancer (T/G vs T/T: OR = 2.073, 95% CI = 1.095-3.927, P = .025).	1
Among these genes, mutations in @GENE$ gene involve in inclusion body myopathy with Paget disease of bone and @DISEASE$ (IBMPFD), familial amyotrophic lateral sclerosis (ALS), autism spectrum disorders (ASD), and hereditary spastic paraplegia (HSP).	0
We chose to study UNCL-Sema3E rather than wild type sema3E because unlike full length sema3E, the major p61-Sema3E peptide that is produced by cleavage of sema3E with signal peptide processing like pro-protein convertases activates signal transduction mediated by the @GENE$ receptor and can promote @DISEASE$ metastasis in addition to its anti-angiogenic activity.	1
However, the relationship between @GENE$ and @DISEASE$ remains poorly understood.	1
While polyglutamine @DISEASE$, linked to CAG repeat expansions in genes such as ATXN1, negative regulation of receptor internalization, protein K63-linked deubiquitination, histone deubiquitination, @GENE$ and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	1
While polyglutamine @DISEASE$, linked to CAG repeat expansions in genes such as ATXN1, @GENE$, protein K63-linked deubiquitination, histone deubiquitination, positive regulation of cytosolic calcium ion concentration and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	1
While polyglutamine @DISEASE$, linked to CAG repeat expansions in genes such as ATXN1, negative regulation of receptor internalization, @GENE$, histone deubiquitination, positive regulation of cytosolic calcium ion concentration and TBP, have been extensively characterized in large cohorts, there is a need for comprehensive assessment of frequency and phenotype of more 'conventional' ataxias.	1
In conclusion, we identified relevant genetic variations in up to 15% of cases after exclusion of polyglutamine expansion spinocerebellar ataxias, and confirmed CACNA1A and @GENE$ as major @DISEASE$ genes.	1
We show that active cofilin, LIMK1, LIMK2, and @GENE$ are overexpressed in human CRC and are associated with @DISEASE$ progression parameters.	0
Our results suggest that F-actin regulators @GENE$K/cofilin pathway and SSH1 are associated with CRC progression and chemoresistance representing promising @DISEASE$ biomarkers and therapeutic targets in CRC	1
We recently reported a novel human phenotype resulting from a mutation in the critical coding region of the @GENE$ gene characterized by facial dysmorphism, severe growth restriction, @DISEASE$ hypotonia, global developmental delay and retinal pigmentary deposits.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, @GENE$, HTRA2, RIC3, EIF4G1, protein deubiquitination, CHCHD2, and GBA; or @DISEASE$ (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, antibacterial humoral response, FBXO7, DNAJC6, SYNJ1, chemical synaptic transmission, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, posttranscriptional gene silencing, HTRA2, RIC3, EIF4G1, @GENE$, CHCHD2, and GBA; or @DISEASE$ (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, antibacterial humoral response, FBXO7, DNAJC6, SYNJ1, chemical synaptic transmission, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, posttranscriptional gene silencing, HTRA2, RIC3, EIF4G1, protein deubiquitination, CHCHD2, and GBA; or @DISEASE$ (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, antibacterial humoral response, FBXO7, DNAJC6, SYNJ1, @GENE$, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	0
We summarize genetic, clinical and neuropathological findings related to the 27 genes reported in the literature since 1997, associated either with autosomal dominant (AD): LRRK2, SNCA, VPS35, GCH1, ATXN2, DNAJC13, TMEM230, posttranscriptional gene silencing, HTRA2, RIC3, EIF4G1, protein deubiquitination, CHCHD2, and GBA; or @DISEASE$ (AR) inheritance: PRKN, PINK1, DJ1, ATP13A2, @GENE$, FBXO7, DNAJC6, SYNJ1, chemical synaptic transmission, VPS13C, PODXL, and PTRHD1; or an X-linked transmission: RAB39B.	1
Murine double minute 2 (@GENE$) is the E3 ubiquitin ligase of the @DISEASE$ suppressor gene, p53, and inhibition of MDM2 can suppress tumor cell growth.	1
The @GENE$ G1 polymorphism, an identified risk factor for non-diabetic renal disease, was associated with @DISEASE$.	1
Growing evidence suggests that @GENE$ may represent an important genetic modifier locus for @DISEASE$ signal transduction.	0
Hemizygosity of the distal region, designated @GENE$1, can cause hypoparathyroidism and in addition sensorineuronal @DISEASE$ and renal dysplasia/insufficiency or a subset of this triad	1
Hemizygosity of the distal region, designated @GENE$1, can cause @DISEASE$ and in addition sensorineuronal deafness and renal dysplasia/insufficiency or a subset of this triad	1
Several therapeutic strategies expressing @GENE$ have been employed in clinical trials for treating metastatic colorectal @DISEASE$.	1
PAK3-related @DISEASE$ is caused by mutations in the gene encoding the @GENE$-activated kinase (PAK) protein.	1
We observed a higher rate of individuals with a history of high blood pressure among affected versus healthy individuals carrying @GENE$ variants, suggesting that ANGPTL6 could trigger cerebrovascular lesions when combined with other risk factors such as @DISEASE$.	1
High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal @DISEASE$ (CRC); germline mutations in NTHL1, RPS20, @GENE$, FAN1, TP53, regulation of sister chromatid cohesion, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.	1
High-throughput sequencing analysis has accelerated searches for genes associated with risk for colorectal @DISEASE$ (CRC); germline mutations in NTHL1, RPS20, resolution of meiotic recombination intermediates, FAN1, TP53, @GENE$, BUB3, LRP6, and PTPN12 have been recently proposed to increase CRC risk.	1
We found sufficient evidence for @GENE$ to be considered a CRC predisposition gene-members of 3 unrelated Dutch families were homozygous for inactivating p.Gln90Ter mutations; a Canadian woman with polyposis, CRC, and multiple @DISEASE$ was reported to be heterozygous for the inactivating NTHL1 p.Gln90Ter/c.709+1G&gt;A mutations; and a man with polyposis was reported to carry p.Gln90Ter/p.Gln287Ter; whereas no inactivating homozygous or compound heterozygous mutations were detected in controls.	1
Over 60 years after the initial description of cellular aldehyde metabolic process, we report the first animal model for this disease: an @GENE$-null zebrafish (<i>Danio rerio</i>) displaying deficient lysine metabolism and spontaneous and recurrent @DISEASE$ in the larval stage (10 days postfertilization).	1
Taken together, our data provide robust evidence implicating @GENE$-associated proteins and genes in @DISEASE$, and suggest that within the PSD, NMDA-interacting and endocytosis-related proteins contribute to disease pathophysiology	1
However, the clinical significance and precise role of @GENE$ in @DISEASE$ progression are largely unknown.	1
Zinc finger protein 687 (@GENE$), identified as a C2H2 zinc finger protein, has been found to be mutated and upregulated in giant cell tumor of bone and acute myeloid leukemia, suggesting an oncogenic role for ZNF687 in @DISEASE$.	1
Herein, we report that ZNF687 was markedly upregulated in @DISEASE$ (@GENE$) cell lines and HCC tissues, and was significantly correlated with relapse-free survival in HCC.	0
Moreover, @GENE$ predicted poor prognosis of pancreatic @DISEASE$, partially due to its role in E-cadherin expression regulation, and the results were further validated by analysis of the correlation between ALDOA and E-cadherin expression in pancreatic cancer tissue samples.	1
Mechanistically, the role of ALDOA in pancreatic @DISEASE$ might attribute to its regulation of negative regulation of transcription by RNA polymerase II, HIF1α and @GENE$ (Nuclear Factor, Erythroid 2-Like 2), which were key regulators of glycolysis and antioxidant response control.	1
Genetic or small-molecule inhibitor-based ablation of HIF-1α/TGF-β2-mediated @GENE$ signaling effectively reversed the chemoresistance caused by the @DISEASE$ microenvironment.	1
However, the ectopic expression of @GENE$ was recently discovered in intra-tumoral blood vessels endothelia and/or in tumoral cells of many extra-gonadal human @DISEASE$ (particularly in endocrine tumours).	1
The paper reviews the data concerning the appearance of ectopic @GENE$ in particular human @DISEASE$.	0
Patients exhibit a variety of symptoms predominantly linked to the function of @GENE$ protein in the nervous system like autistic behavior and mild-to-severe @DISEASE$.	1
The findings in this study expand our understanding of SRPS locus @DISEASE$ and demonstrate the importance of @GENE$ in dynein-2 complex stability, cilium function, Hedgehog regulation and skeletogenesis.	1
Megaconial congenital @DISEASE$ is a disease caused by pathogenic mutations in the gene encoding choline kinase beta (@GENE$).	1
Downregulation of miR-29a caused overexpression of LOXL2 and @GENE$ in lung @DISEASE$ and IPF, suggesting that these genes are involved in the pathogenesis of these two diseases	1
Overexpression of LOXL2 and @GENE$ was observed in clinical specimens of lung @DISEASE$ and fibrotic lesions.	1
Thus, increased expression of gene @GENE$ in blood cells appears to be associated with the isolated form of hypogonadotropic @DISEASE$ and, in prospect, may be used as one of the disease markers	1
@GENE$ is also known as a @DISEASE$ suppressor gene, and somatic mutations in that gene have been identified in Wilms tumors.	1
RESULTS There was an increased expression of @GENE$ in breast @DISEASE$ tissues compared to normal breast tissues (p&lt;0.05).	1
The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), @GENE$ (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive @DISEASE$, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	1
The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (@GENE$) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive @DISEASE$, myopathy, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), @GENE$ (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, @DISEASE$, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), @GENE$ (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, @DISEASE$, and hearing loss; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), @GENE$ (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and @DISEASE$; EDSKMH) and brain development (Kohlschütter-Tönz syndrome).	0
The created databases include ACAD8 (isobutyryl-CoA dehydrogenase deficiency (IBD)), branched-chain amino acid catabolic process (short-chain acyl-CoA dehydrogenase (fatty acid beta-oxidation using acyl-CoA dehydrogenase) deficiency), branched-chain amino acid catabolic process (3-methylglutaconic aciduria (3-MGCA)), DHCR7 (Smith-Lemli-Opitz syndrome), regulation of lipid metabolic process (3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency), protein homotetramerization (17-beta-hydroxysteroid dehydrogenase X deficiency), FKBP14 (Ehlers-Danlos syndrome with progressive @DISEASE$, myopathy, and hearing loss; EDSKMH) and @GENE$ (Kohlschütter-Tönz syndrome).	0
There has been virtually no tissue study on the expression of @GENE$ in prostate @DISEASE$ (PCa).	1
This study aimed to investigate the expression of PLZF by immunohistochemistry in different grade as well as metastatic @GENE$ and to correlate the alteration of PLZF expression with PCa @DISEASE$.	0
Our findings offer a foundation for understanding @GENE$-related neurodegeneration and how nucleic acid binding functions, localization, and pathogenic mutations drive @DISEASE$ and familial disease	1
Taken together, these data provide novel information for comprehending the @DISEASE$-suppressive role of miR-200a in HCC pathogenesis through inhibition of @GENE$ translation	0
@GENE$ and its ligand are members of the TNF/TNF receptor superfamily, which includes various molecules influencing cellular signaling and function of both @DISEASE$ and immune cells.	1
Thus, our results suggest that aberrantly expressed Aurora-C in somatic @DISEASE$ cells may impair @GENE$ by displacing the centromeric localization of CPCs.	0
CHIME syndrome is a rare @DISEASE$ neuroectodermal disorder associated with biallelic mutations in @GENE$.	1
Noonan syndrome (NS), the commonest RASopathy, is genetically @DISEASE$ and caused by functional dysregulation of signal transducers and regulatory proteins with roles in the RAS/extracellular signal-regulated kinase (@GENE$) signal transduction pathway.	0
The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), @GENE$-3 (GP3), Cystatin B (negative regulation of peptidase activity), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential @DISEASE$ markers for HCC in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.	1
The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (@GENE$), squamous cell carcinoma antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential @DISEASE$ markers for HCC in patients with alcoholic liver cirrhosis (biological_process) using imaging techniques (MSCT and MRI) as reference standards.	1
The aim of this study was to investigate the diagnostic sensitivity and specificity of protein induced by vitamin K absence or antagonist-II (PIVKAII), heparan sulfate proteoglycan catabolic process-3 (GP3), Cystatin B (negative regulation of peptidase activity), @DISEASE$ antigen 1 (SCCA1) and hepatocyte growth factor (HGF) as potential tumour markers for HCC in patients with alcoholic liver cirrhosis (@GENE$) using imaging techniques (MSCT and MRI) as reference standards.	0
Mice carrying kinase-dead @GENE$ also displayed @DISEASE$ and reduced cortical brain volume due to the enhanced cell death of neuronal progenitors that is associated with reduced numbers of cortical neurons.	1
Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, @GENE$, and regulation of transcription, DNA-templated) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated @DISEASE$ line (P &lt; 0.001).	0
Based on screening results, five unique genes (GNPAT, SUMO1, SPINT2, positive regulation of transcription, DNA-templated, and @GENE$) significantly potentiated the growth inhibitory effects of CDDO-Me and induced apoptosis in A375, a BRAF mutated @DISEASE$ line (P &lt; 0.001).	1
Our findings indicate that @GENE$, SUMO1, SPINT2, positive regulation of transcription, DNA-templated, and SSX1 play critical roles in synergy with inflammation pathways in modulating @DISEASE$ cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control	1
Our findings indicate that ether lipid biosynthetic process, SUMO1, SPINT2, @GENE$, and SSX1 play critical roles in synergy with inflammation pathways in modulating @DISEASE$ cell survival and could serve as sensitizing targets to enhance CDDO-Me efficacy in melanoma growth control	1
Furthermore, we performed in vitro assays in breast @DISEASE$ cell lines, and our results indicated that @GENE$, MRPS30, and ATG10 played a vital role in breast tumorigenesis via certain disruption of cell behaviors.	0
Here, we report 1 known (c.1489C&gt;T, p.Pro497Ser, P497S) and 3 novel (c.1481C&gt;T, p.Pro494Leu, P494L; c.1498C&gt;T, p.Pro500Ser, P500S; and c.1516C&gt;G, p.Pro506Ala, P506A) missense mutations in the PXX domain of @GENE$ in familial motor neuron diseases including ALS and @DISEASE$ (SP).	1
Mosaicism was identified for autosomal dominant (JAG1, @GENE$), @DISEASE$ (PYGM), and X-linked (carbohydrate metabolic process, acetyl-CoA biosynthetic process from pyruvate, urea cycle, and SLC6A8) disorders.	0
Mosaicism was identified for autosomal dominant (JAG1, cell-matrix adhesion), @DISEASE$ (PYGM), and X-linked (carbohydrate metabolic process, acetyl-CoA biosynthetic process from pyruvate, @GENE$, and SLC6A8) disorders.	0
Mosaicism was identified for autosomal dominant (JAG1, cell-matrix adhesion), @DISEASE$ (PYGM), and X-linked (carbohydrate metabolic process, @GENE$, urea cycle, and SLC6A8) disorders.	0
Some individuals with heterozygous @GENE$ mutations demonstrate a carrier ocular phenotype, which includes a mildly reduced corneal thickness, @DISEASE$ and blue sclera.	1
Hyperphosphatasia with mental retardation syndrome (HPMRS) is caused by mutations in @GENE$ and includes @DISEASE$ as a diagnostic hallmark.	1
Glutaric acidemia I (GAI) is an @DISEASE$ metabolic disease caused by a deficiency of glutaryl-CoA dehydrogenase enzyme (@GENE$).	0
Extensive @GENE$ gene deletions were identified in four patients; using DNA microarray analysis two patients showed the loss of the entire AFF2 gene, and @DISEASE$ developed in only one of them.	1
In vivo experiments were performed in nude mice bearing transfected @DISEASE$; results revealed that NET-@GENE$-coexpressing tumors had longer <sup>131</sup>I-MIBG retention time than NET-expressing tumors.	1
The reported hypertrophic @DISEASE$ relevant genes MYPN, @GENE$ and MYBP3 had also been found in case 1 and 2.	1
Given the lack of specific targeted genes and pathways known to be involved in @DISEASE$ cell dormancy, we proposed enriched candidate genes related to the negative regulation of cell proliferation, signalling pathways regulating pluripotency of stem cells and neuroactive ligand-receptor interaction, and 3 hub genes (FTH1, @GENE$ and DDIT3).	1
Carriers of CT or TT genotype of @GENE$ rs13900 had increased risk of @DISEASE$ at birth and at 6 months of age (aOR = 3.59; p = 0.028 and aOR = 4.10; p = 0.039, respectively).	1
Moreover, Reg-1α colocalizes with exostosin @DISEASE$-like 3 (@GENE$), its putative receptor, at the membrane of these cells.	1
In terms of prognostic features, a survival analysis revealed that the high @GENE$ and HK2 expression group exhibited poorer survival in @DISEASE$ patients.	0
The key clinical features of the patient with @GENE$ included short stature, joint contractures, pigeon breast, and myotonia that led to progressive stiffness of the interstrand cross-link repair and limbs; barely discernible @DISEASE$ was also noted.	1
Schwartz-Jampel syndrome @GENE$ 1 (SJS1) is a rare @DISEASE$ disease caused by mutations in the gene heparan sulfate proteoglycan 2 (HSPG2; also known as basement membrane‑specific heparin sulfate).	0
The family members harboring 1 heterozygous mutation in @GENE$ did not exhibit any @DISEASE$.	1
In ALDH<sup>+</sup>CD24<sup>-</sup>CD44<sup>+</sup> BCSCs, we identified P4HA2, PTGR1 and @GENE$ as potential prognostic markers, which were virtually related to the status of BCSCs and @DISEASE$ growth in TNBC cells	1
Missense mutations in SCN2A (p.Leu1342Pro) and @GENE$ (p.Ala306Thr) were found in two patients with no history of @DISEASE$ before the onset of ISs.	0
Other @GENE$ mutations and rRNA processing cases are intermediate - spliceosomal snRNP assembly muscle organ development 1-like presentation, @DISEASE$ (mostly in EXOSC8) and death between 3 months and 5 years.	1
The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/@GENE$ or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without @DISEASE$, nystagmus and optic atrophy.	1
The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/@GENE$ or mitochondrial membrane fission mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and @DISEASE$.	0
The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or @GENE$ mutations have a spliceosomal snRNP assembly type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without @DISEASE$, nystagmus and optic atrophy.	1
The PCH1sub-muscle organ developments with early death (between ages 1 day and 17 months), seen in patients with p.G31A/rRNA processing or mitochondrial membrane fission mutations have a @GENE$ type 1-like clinical presentation but with global developmental delay, visual and @DISEASE$, with or without microcephaly, nystagmus and optic atrophy.	0
Immunohistochemically, @DISEASE$ cells of all cases were positive for vimentin (100.0%, 60/60), positive regulation of transcription by RNA polymerase II (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, @GENE$, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-integrin-mediated signaling pathway, GFAP.	1
Immunohistochemically, @DISEASE$ cells of all cases were positive for vimentin (100.0%, 60/60), @GENE$ (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, protein polyubiquitination, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-integrin-mediated signaling pathway, GFAP.	1
Immunohistochemically, @DISEASE$ cells of all cases were positive for vimentin (100.0%, 60/60), positive regulation of transcription by RNA polymerase II (98.3%, 59/60), CD34 (61.7%, 37/60), and the tumor cells were typically positive for CD99, protein polyubiquitination, EMA and SSTR2 as well.Negative for S-100 protein, SOX10, E-@GENE$, GFAP.	0
To explore the underlying mechanism of @DISEASE$ suppression by @GENE$, its potential to promote apoptosis induced by TRAIL, an effector molecule elaborated by natural killer-T (NKT) cells was investigated.	1
These findings suggest that @GENE$ is not only driving EMT, but also contributes to the formation of osteolytic bone metastases in breast @DISEASE$.	1
In a few (non-Swedish) @DISEASE$ families, mutations in other genes have been found, including @GENE$, transcription, RNA-templated, POT1, ACD and TERF2IP.	1
In a few (non-Swedish) @DISEASE$ families, mutations in other genes have been found, including protein phosphorylation, @GENE$, POT1, ACD and TERF2IP.	1
In genes that regulate cellular pigmentation pathways, including MC1R, ASIP, IRF4, @GENE$, TYRP1 and OCA, there are different common variants that determine complexion traits, and those variants are also associated with different risks of @DISEASE$.	1
Individuals with known mutations in @DISEASE$ suppressor genes such as @GENE$ and BAP1 require, in addition, follow up for other cancers	1
Swedish @GENE$ mutation carriers have a young median age of onset of @DISEASE$, increased risks of multiple primary melanoma and of tobacco-associated cancers in respiratory and upper digestive tissues, and also worse survival compared to non-carriers.	1
Congenital myasthenic syndromes (@GENE$) are a @DISEASE$ group of genetic disorders.	0
Recently, @DISEASE$ loss-of-function mutations in @GENE$ (encoding exophilin-5, also known as Slac2-b, a protein involved in intracellular vesicle transport) were identified in a new mechanobullous disease resembling a form of epidermolysis bullosa simplex (EBS).	1
Here, we searched for mutations in @GENE$ in a 4-year-old white boy with EBS in whom initial Sanger sequencing of known genes implicated in intraepidermal @DISEASE$ failed to identify pathogenic mutations.	1
Cognitive impairment or autism-like performance were often identified in these patients, hematuria metabolic diseases screening was normal, no abnormal MRI imaging of the head, and de novo @GENE$ gene mutations were found in their @DISEASE$ gene protein polyubiquitination sequencing.	1
Nagashima-type @DISEASE$ (NPPK) is an autosomal recessive form of palmoplantar keratoderma (PPK), which is caused by mutations in the @GENE$ gene.	1
Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of @DISEASE$ patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, @GENE$ DMR in 21%, mesoderm development ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.	0
Tumor-specific methylation changes at IGF2 DMR2 were observed in 59% of @DISEASE$ patients, IGF2 DMR0 in 38%, DIRAS3 DMR in 36%, GRB10 ICR in 23%, negative regulation of transcription by RNA polymerase II DMR in 21%, @GENE$ ICR in 19%, H19 ICR in 18%, KvDMR in 8% and SNRPN/SNURF ICR in 4%.	1
At present, four loci associated with non‑syndromic auditory neuropathy have been mapped: Autosomal recessive @DISEASE$‑9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and autosomal recessive deafness‑59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous‑3 (@GENE$) gene]; and AUNX1, linked to chromosome X.	0
At present, four loci associated with non‑syndromic auditory neuropathy have been mapped: Autosomal recessive deafness‑9 [DFNB9; the otoferlin (@GENE$) gene] and @DISEASE$ deafness‑59 [DFNB59; the pejvakin (biological_process) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous‑3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosome X.	0
At present, four loci associated with non‑syndromic auditory neuropathy have been mapped: Autosomal recessive deafness‑9 [DFNB9; the otoferlin (synaptic vesicle exocytosis) gene] and @DISEASE$ deafness‑59 [DFNB59; the pejvakin (@GENE$) gene], associated with autosomal recessive inheritance; the autosomal dominant auditory neuropathy gene [AUNA1; the diaphanous‑3 (cytoskeleton organization) gene]; and AUNX1, linked to chromosome X.	1
Thus, the present study aimed to investigate molecular changes in the OTOF gene in patients with auditory @DISEASE$, and to develop a DNA @GENE$ for the molecular diagnosis of auditory neuropathy using cell adhesion mediated by integrin spectrometry for genotyping.	0
Several candidate genes for @DISEASE$ and T2D (e.g., IRS1 and @GENE$) were differentially expressed in discordant twins.	0
The mutations in the @GENE$ gene leads to X-linked Charcot-Marie-Tooth neuropathy type 5 (purine nucleobase metabolic process), PRS super activity, positive regulation of protein ubiquitination syndrome, X-linked @DISEASE$-1, breast cancer, and colorectal cancer.	1
A total of nine non-coding variants on 11q13.5 predispose men to prostate @DISEASE$ (PrCa). rs200331695 within the @GENE$ intron is associated with aggressive PrCa and two high linkage disequilibrium (LD) groups of single-nucleotide polymorphisms (SNPs) in the intergenic region are associated with PrCa death.	1
The high LD SNPs (rs143975731, rs12277366, rs2155225, and rs2155222) were associated with @GENE$ expression in both @DISEASE$ negative regulation of transcription, DNA-templateds (screening P = 0.035-0.043; validation P = 0.005-0.018).	1
Altogether, our study provides direct evidence that endogenous @GENE$ and Rspo3 chromosome rearrangements can initiate and maintain tumour development, and indicate a viable therapeutic window for LGK974 treatment of RSPO-fusion @DISEASE$s	1
We show that both Rspo2 and @GENE$ fusion events are sufficient to initiate hyperplasia and @DISEASE$ development in vivo, without additional cooperating genetic events.	1
Here, we describe the generation of transgenic, inducible CRISPR-based mouse systems to engineer and study recurrent colon @DISEASE$-associated EIF3E-RSPO2 and @GENE$-RSPO3 chromosome rearrangements in vivo.	1
Our results demonstrate that adenomyoepitheliomas are genetically @DISEASE$, and qualify mutations in @GENE$, a gene whose mutations are vanishingly rare in common-type breast cancers, as likely drivers of ER-negative adenomyoepitheliomas	0
Hennekam lymphangiectasia-lymphedema syndrome is an @DISEASE$ disorder, with 25% of patients having mutations in @GENE$.	1
While there were no significant correlations with both Se status markers, <i>SELENOF</i>, <i>SELENOK</i>, and <i>TXNRD1</i> @DISEASE$ tissue expression positively correlated with Se, while <i>TXNRD2</i> and <i>TXNRD3</i> negatively correlated with <i>@GENE$</i>.	0
Therefore, STX3 promotes the growth of breast @DISEASE$ cells by regulating the PTEN-PI3K-positive regulation of protein phosphorylation-@GENE$ signaling	1
We find that STX3 promotes the proliferation of breast @DISEASE$ cells by increasing the activation of the @GENE$-mTOR signaling, and Akt inhibitor Ipatasertib or MK-2206 represses STX3 effects on the growth of breast cancer cells.	0
The up-regulation of @GENE$ is correlated with high disease stage and predicts overall and disease-free survival in patients with breast @DISEASE$.	1
Our studies show that DKD susceptibility was linked to mitochondrial dysfunction, mediated largely by Edn1-@GENE$ in glomerular endothelial cells representing an early event in DKD progression, and suggest that cross talk between glomerular endothelial injury and podocytes leads to defects and depletion, @DISEASE$, and glomerulosclerosis	0
Selective @GENE$ blockade or mitochondrial-targeted reactive oxygen species scavenging prevented mitochondrial oxidative stress of endothelial cells and ameliorated diabetes-induced endothelial injury, podocyte loss, @DISEASE$, and glomerulosclerosis.	0
It is a genetic disorder caused by a mutation in the dysferlin gene (@GENE$) with an @DISEASE$ mode of inheritance.	1
In this article, we report a case of Limb-girdle @DISEASE$ @GENE$ 2B with a rare homozygous duplication c.164dupA, p.(Ile57Hisfs*8) (rs863225020) in DYSF in a Saudi patient.	0
Our results therefore confirm the KCNC3R423H allele as causative for @GENE$, through a dominant negative effect on KCNC3WT and links with positive regulation of protein phosphorylation that account for dominant @DISEASE$, congenital onset, and disease pathology	0
Our results therefore confirm the KCNC3R423H allele as causative for protein tetramerization, through a dominant negative effect on KCNC3WT and links with @GENE$ that account for dominant @DISEASE$, congenital onset, and disease pathology	0
In the present study, we first analyzed two expression quantitative trait loci (eQTL) datasets in healthy individuals and investigated the associations of eQTL of @GENE$ with @DISEASE$ in independent European samples.	1
Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast @DISEASE$ (TNBC) cells and increase the expression of epithelial-mesenchymal transition (cytokine production) related transcription factor negative regulation of transcription by RNA polymerase II, while had no effect on @GENE$, Slug or Twist.	0
Our present study confirmed radiation can promote the in vitro migration and invasion of triple negative breast @DISEASE$ (TNBC) cells and increase the expression of epithelial-mesenchymal transition (cytokine production) related transcription factor @GENE$, while had no effect on negative regulation of transcription by RNA polymerase II, Slug or Twist.	0
In vivo imaging, ex vivo imaging and @DISEASE$ tissue slides showed that PDT further contribute EGFP-@GENE$-nucleobase-containing compound metabolic process accumulation in tumor.	1
In vivo imaging, ex vivo imaging and @DISEASE$ tissue slides showed that PDT further contribute EGFP-mitochondrial translational elongation-@GENE$ accumulation in tumor.	1
In this study, a @GENE$-cascade-targeted strategy aiming to disrupt @DISEASE$ blood vessels was developed by combination of TF-targeted HMME-loaded drug delivery system and PDT.	0
Analysis of clinical samples of oral @DISEASE$ found a strong correlation of these genes with short survival, especially @GENE$ expression associated with metastasis.	1
Of these, Frem1, Foxo1, and @GENE$ have been implicated in the pathogenesis of @DISEASE$.	1
Previous studies have reported the association of prodynorphin (@GENE$) promoter polymorphism with temporal lobe @DISEASE$ (TLE) susceptibility, but the results remain inconclusive.	1
Examination of @DISEASE$-infiltrating immune cells from mice vaccinated with the @GENE$-expressing exosomes showed robust tumor-reactive CD8<sup>+</sup> T effector responses, Th1 cytokine responses, and higher CD8<sup>+</sup> T effector/CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> T regulatory cell ratio in the tumors.	1
The homeodomain transcription factor @GENE$ was recently reported to be a negative regulator of the Wnt pathway and has an emerging role in @DISEASE$.	1
To avoid this artifactual early priming of the host precluding the study of the interactions between the immune system and @DISEASE$s at the steady state, we generated a cell line expressing the @GENE$ Ag in an inducible manner.	1
In this study, we show that the presentation of a MHC class II-restricted model Ag (male, @GENE$) released by dying @DISEASE$ cells may last more than 4 wk.	0
In the case-control analysis, the rs9607195 A&gt;G on intergenic area 250 kb away from the @GENE$ gene and the rs12738007 A&gt;G on the intron of the MECR gene were the most strongly associated SNPs with the risk of @DISEASE$ (P = 6.2 × 10(-8) , OR = 0.50 and P = 3.7 × 10(-7) , OR = 2.39, respectively).	1
Clinical presentation of @GENE$ deficiency is @DISEASE$ ranging from mild to severe neuromuscular diseases.	0
Furthermore, we identified some potential lung @DISEASE$ driver genes, such as negative regulation of transcription by RNA polymerase II, @GENE$, SLC2A1, protein phosphorylation, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.	1
Furthermore, we identified some potential lung @DISEASE$ driver genes, such as negative regulation of transcription by RNA polymerase II, G1/S transition of mitotic cell cycle, SLC2A1, @GENE$, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.	1
Furthermore, we identified some potential lung @DISEASE$ driver genes, such as @GENE$, G1/S transition of mitotic cell cycle, SLC2A1, protein phosphorylation, and CDC20, whose expression is significantly upregulated in lung cancer, and the copy number of these genes is amplified in the genome of patients with lung cancer.	1
Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic @DISEASE$, including @GENE$ and inactivation of tumor suppressors, such as TP53, transforming growth factor beta receptor signaling pathway and CDKN2A.	1
Several important genetic alterations (i.e., mutations, deletions) have been identified to be involved in the initiation and progression of pancreatic cancer, including positive regulation of protein phosphorylation and inactivation of @DISEASE$ suppressors, such as TP53, @GENE$ and CDKN2A.	1
The most likely causal variant identified was a novel missense variant in the X-linked @GENE$ gene, which has been implicated in @DISEASE$.	1
In co-culture experiments using @GENE$-OVA melanoma cells and @DISEASE$-specific CD3+ T cells, EGCG reduced <i>PD-L1</i> mRNA expression about 30% in F10-OVA cells and restored <i>interleukin-2</i> mRNA expression in tumor-specific CD3+ T cells.	0
Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (cellular response to DNA damage stimulus, KRAS, Ras protein signal transduction and GNAS mutations), but there are newly identified @GENE$, MTOR, ACVR1B, negative regulation of protein kinase activity, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	0
Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (@GENE$, KRAS, Ras protein signal transduction and GNAS mutations), but there are newly identified transforming growth factor beta receptor signaling pathway, MTOR, ACVR1B, negative regulation of protein kinase activity, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	0
Our WES data is largely matched with the earlier 'adenoma-@DISEASE$ model' (cellular response to DNA damage stimulus, KRAS, @GENE$ and GNAS mutations), but there are newly identified transforming growth factor beta receptor signaling pathway, MTOR, ACVR1B, negative regulation of protein kinase activity, ATM, CNOT1, EP300, ARID2, RET and MAP2K4 mutations in this study.	1
We identified 22 genes including APC, @GENE$, TP53, GNAS, Ras protein signal transduction, SMAD4, nucleosome disassembly, and PIK3CA with non-silent mutations in the @DISEASE$ Census Genes.	1
We identified 22 genes including APC, positive regulation of protein phosphorylation, TP53, GNAS, Ras protein signal transduction, SMAD4, @GENE$, and PIK3CA with non-silent mutations in the @DISEASE$ Census Genes.	1
@GENE$, known as a human homologue of the Drosophila @DISEASE$ B (rdgB), lacks the N-terminal PIT domain needed for transport of phospholipids, renewal of photoreceptors membrane and providing the electroretinogram (positive regulation of transcription by RNA polymerase II) response to light.	1
Factor VII (FVII) activating protease (@GENE$) is a circulating serine protease that is likely to be involved in a number of disease conditions such as stroke, atherosclerosis, liver fibrosis, thrombosis and @DISEASE$.	0
Mining GWAS databases revealed association of cis-eSNPs for more than 50 genes with T2D (e.g. @GENE$, RBMS1, biological_process), gluco-metabolic phenotypes (e.g. INPP5E, SNX17, antigen processing and presentation of peptide antigen via MHC class I, FN3KRP), and @DISEASE$ (e.g. POMC, CPEB4).	0
Although @GENE$ has been shown to be a scaffold protein of the Ras-ERK pathway, its interaction with other signaling pathways and its involvement in @DISEASE$ malignancy has not been reported.	0
The @DISEASE$ cells expressed @GENE$, GLUT-1, and vimentin and were negative for S-100 protein, epithelial membrane antigen, smooth muscle actin, desmin, claudin-1, neurofilament and SOX10.	1
Mutations in the ubiquitously expressed pre-mRNA processing factors 3, 8, and 31 (PRPF3, @GENE$, and PRPF31) cause nonsyndromic dominant retinitis pigmentosa in humans, an inherited @DISEASE$.	1
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, @GENE$ proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and @GENE$ proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (@GENE$), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (@GENE$), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; @DISEASE$, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, @GENE$ proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (positive regulation of Ras protein signal transduction), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	0
Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and @DISEASE$ (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (peptidyl-tyrosine dephosphorylation), RAF, NF, regulation of neurotransmitter receptor localization to postsynaptic specialization membrane proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (protein phosphorylation), MEK1/2, positive regulation of protein phosphorylation proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (@GENE$), NRAS proto-oncogene, GTPase (NRAS), and activation of MAPKK activity proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade.	0
According to the Ottawa Heart Genomics Study genome-wide association study, a recent research identified that Q688 @DISEASE$ 7 (@GENE$) variant is associated with apoptotic DNA fragmentation as it bypasses the regulation of tyrosine phosphorylation of AFG3L2 and enhances the processing and maturation of SPG7 protein.	0
The @DISEASE$ genes GJB3, @GENE$, GRHL2, DFNA5, and ATP6B1 were expressed in marmoset cochleae in patterns different from those in mouse cochleae.	1
The other tested genes, including the @DISEASE$ gene @GENE$, in which mutation recapitulates deafness in epidermis development, were expressed in a similar manner in both species.	1
Ectopic expression of Cx31 in mouse skin results in @DISEASE$ resembling human @GENE$.	0
We first develop a doxycycline-inducible cell line expressing GFP-tagged cytoplasmic @GENE$ protein (iGFP-NLSm) as a cell-based system to screen and identify seeding activity of human brain-derived pathological TDP-43 isolated from @DISEASE$ FTLD-TDP and familial cases with Granulin (FTLD-TDP-GRN) or C9orf72 repeat expansion mutations (FTLD-TDP-C9+).	0
To provide new ideas based on the use of @GENE$ for risk prediction, prognostic assessment, and clinical treatment of @DISEASE$ and to promote the implementation of corin as a routine laboratory index, we summarize the latest studies of the association between corin and cardiovascular diseases in recent years and offer some prospective proposals for future research on corin in this review	0
Mutation analysis of the @GENE$ is warranted in isolated complex I deficiency presenting with infantile @DISEASE$ or encephalocardiomyopathy	1
Although @GENE$ plays a critical role in the regulation of RNA processing, mutation of the gene encoding this ubiquitously expressed RNA binding protein causes a specific form of @DISEASE$ termed oculopharyngeal muscular dystrophy (poly(A)+ mRNA export from nucleus).	1
A third of patients with paraganglial @DISEASE$, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, @GENE$, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial @DISEASE$, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, @GENE$, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial @DISEASE$, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, @GENE$, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial @DISEASE$, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, @GENE$, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial @DISEASE$, pheochromocytoma, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, @GENE$, and MAX.	1
A third of patients with paraganglial tumors, @DISEASE$, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, @GENE$, and MAX.	1
A third of patients with paraganglial tumors, @DISEASE$, and paraganglioma, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, @GENE$, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, pheochromocytoma, and @DISEASE$, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, @GENE$, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, pheochromocytoma, and @DISEASE$, carry germline mutations in one of the susceptibility genes, @GENE$, protein ubiquitination, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, pheochromocytoma, and @DISEASE$, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, @GENE$, NF1, mitochondrial electron transport, succinate to ubiquinone, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A third of patients with paraganglial tumors, pheochromocytoma, and @DISEASE$, carry germline mutations in one of the susceptibility genes, regulation of cell adhesion, protein ubiquitination, NF1, @GENE$, SDHA, SDHB, tricarboxylic acid cycle, tricarboxylic acid cycle, negative regulation of cell proliferation, and MAX.	1
A genetically determined generalized hyperexcitability had been predicted in primarily generalized @DISEASE$, but surprisingly the first epilepsy gene discovered, @GENE$, was in a focal (frontal lobe)-onset syndrome.	1
Mutations in the EFHC1 gene (unknown function) occur in other rare JME families, and yet in other families, associations are present between JME (or other generalized @DISEASE$) and single nucleotide polymorphisms in the @GENE$ gene (unknown function) and the malic enzyme 2 (ME2) gene.	0
The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with @DISEASE$-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (regulation of postsynapse organization, chloride transmembrane transport, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, cardiac muscle cell action potential involved in contraction, or @GENE$).	0
The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with @DISEASE$-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (regulation of postsynapse organization, chloride transmembrane transport, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, @GENE$, or sodium ion transport).	1
The purpose of this study was to evaluate the frequency of mosaicism detected by next-generation sequencing in genes associated with @DISEASE$-related neurodevelopmental disorders.MethodsWe conducted a retrospective analysis of 893 probands with epilepsy who had a multigene epilepsy panel or whole-exome sequencing performed in a clinical diagnostic laboratory and were positive for a pathogenic or likely pathogenic variant in one of nine genes (regulation of postsynapse organization, @GENE$, GABRG2, GRIN2B, KCNQ2, MECP2, PCDH19, cardiac muscle cell action potential involved in contraction, or sodium ion transport).	1
A large proportion of cases (approximately 44%) remain unexplained, indicating that @GENE$ in this breed is genetically @DISEASE$ and caused by at least three mutations.	0
@GENE$ is important for retinal function and has not previously been associated with spontaneously occurring @DISEASE$ in any other species, including humans	0
We report the association of many previously unreported variants with @DISEASE$, as well as new disease phenotypes associated with known genes, including the first association of the @GENE$ gene with retinitis pigmentosa.	1
This study aimed to elucidate the potential functional mechanism of @GENE$-135b-5p in migration, invasion and epithelial-to-mesenchymal transition (EMT) of pancreatic @DISEASE$ cells.	1
Haplotype @GENE$ for GRM6 markers rs2067011-rs2645339-rs762724 showed significance (P=0.0239), but such association did not remain significant after multiple testing corrections.ConclusionsOur data suggested that genetic variants in GRM6 are associated with high @DISEASE$.	1
The genetic model analysis found that @GENE$-rs11746675 and GRM6-rs2067011 were suggestively associated with high @DISEASE$ in the recessive model (OR=0.54, P=0.004; OR=0.52, P=0.003; respectively).	1
Fourteen single-nucleotide polymorphisms (SNPs) in three genes were genotyped by the TaqMan method using the real-time PCR system.ResultsThree SNPs @GENE$-rs11746675, GRM6-rs2067011, and GRM6-rs2645339 were associated with high @DISEASE$ (odds ratio (OR)=0.74, P=0.003; OR=0.78, P=0.018; and OR=0.78, P=0.023; respectively).	1
This review highlights recent advances in understanding how the @GENE$-positive regulation of gene expression axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including squamous cell carcinoma and @DISEASE$.	1
This review highlights recent advances in understanding how the negative regulation of transcription by RNA polymerase II-@GENE$ axis modulates cell differentiation and proliferation in human keratinocytes, hair follicles, and benign or malignant skin tumors including @DISEASE$ and malignant melanoma.	0
Seborrhoeic Dermatitis (@GENE$) is a common inflammatory skin disease that presents as itchy, @DISEASE$ in the seborrhoeic areas.	0
@GENE$ knockdown suppressed @DISEASE$ cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, negative regulation of transcription by RNA polymerase II and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.	1
protein catabolic process in the vacuole knockdown suppressed @DISEASE$ cell growth and proliferation in HCC cell lines; caused a significant increase in the proportion of cells in the G1/S phase of cell cycle; induced cell death; suppressed the metastatic potential of HCC cells by selectively regulating the epithelial-mesenchymal transition (EMT) regulatory proteins E-cadherin, N-cadherin, Fibronectin, @GENE$ and Slug; and significantly attenuated the metastatic potential of ras-transformed NIH-3T3 cells in vitro and in vivo.	0
Zebrafish with ryroxD1 knock-down recapitulate features of @GENE$ @DISEASE$ with sarcomeric disorganization, myofibrillar aggregates, and marked swimming defect.	0
We studied 46 cases of extramedullary @DISEASE$ by immunostaining with anti-phosphorylation antibody and fluorescence in situ hybridization (@GENE$) analysis using an ALK break-apart probe and found one case to be ALK protein-positive and demonstrated the disruption of the ALK gene in this case.	0
We studied 46 cases of extramedullary @DISEASE$ by immunostaining with anti-@GENE$ antibody and fluorescence in situ hybridization (superoxide metabolic process) analysis using an ALK break-apart probe and found one case to be ALK protein-positive and demonstrated the disruption of the ALK gene in this case.	1
This finding expands the lists of the @GENE$-positive @DISEASE$, and ALK-positive extramedullary plasmacytoma may benefit from the treatment of ALK inhibitor in the future	0
This finding expands the lists of the @GENE$-positive tumors, and ALK-positive extramedullary @DISEASE$ may benefit from the treatment of ALK inhibitor in the future	0
Biallelic loss-of-function mutations in TYROBP and @GENE$ cause a rare disease that resembles early-onset @DISEASE$ with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (myeloid leukocyte activation).	1
Biallelic loss-of-function mutations in TYROBP and @GENE$ cause a rare disease that resembles early-onset frontotemporal dementia with bone lesions called polycystic lipomembranous osteodysplasia with sclerosing @DISEASE$ (myeloid leukocyte activation).	0
Dual-specificity tyrosine phosphorylation-regulated kinase 1A (@GENE$) is a potential target in Alzheimer's disease (AD) because of the established correlation between its over-expression and generation of @DISEASE$ (NFT) as well as the accumulation of amyloid plaques.	1
This result has clinical and genetic counseling implications for genetically unsolved male case subjects with a classic @GENE$ phenotype that lack additional phenotypes such as @DISEASE$ or retinitis pignegative regulation of phosphatase activitytosa	0
A de novo heterozygous p.Pro209Leu (c.626C&gt;T) mutation in @GENE$ was identified in a female @DISEASE$.	1
We found @GENE$ mutation in one patient with @DISEASE$, myopathy and rigid spine syndrome, and performed electrophysiological study, whole body MRI and muscle biopsy on the patient.	1
She showed an axonal sensory-motor polyneuropathy like Charcot-Marie-Tooth disease (CMT), @DISEASE$, rigid spine and respiratory dysfunction; however, she did not show any cardiomyopathy, which is a common symptom in @GENE$ mutation.	0
Mutations in eight of them (PDSS1, @GENE$, COQ2, COQ4, COQ6, ADCK3, ADCK4, and ubiquinone biosynthetic process) cause primary CoQ(10) deficiency, a @DISEASE$ group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease.	1
Finally, we demonstrate that genetic incoenzyme A biosynthetic processivation of @GENE$ rescues axial elongation in a mouse model of @DISEASE$ caused by a null mutation in Egr1.	1
We have previously identified a role for the secreted serine protease @GENE$ in ocular size determination and PRSS56 variants have been implicated in the etiology of both hyperopia and @DISEASE$, highlighting its importance in refrcoenzyme A biosynthetic processive development.	1
Here, we investigated associations between genetic variants of @GENE$ GTPases-related genes and @DISEASE$-specific survival (CMSS) by re-analyzing a published melanoma genome-wide association study (GWAS) and validating the results in another melanoma GWAS.	1
As ubiquitination is a versatile post-translational modification that can affect target turnover, sub-cellular localisation or activity, it is likely that diverse substrates may be differentially affected by @GENE$-mediated ubiquitination, reflecting its multi-faceted roles in muscle physiology, @DISEASE$ and immunity.	1
In this review, we will focus on the ability of @GENE$ to mark specific substrates for proteasomal degradation discussing how the TRIM32-proteasome axis may (i) be important for muscle homeostasis and for the pathogenesis of muscular dystrophy; and (ii) define either an oncogenic or @DISEASE$ suppressive role for TRIM32 in the context of different types of cancer	1
Mice with a neuronal deletion of @GENE$ recapitulated the human phenotype, exhibiting @DISEASE$s and a severe survival defect in adulthood.	1
Is @GENE$ due to the bilateral occurrence of APCCs, to germline variants, or perhaps due to unknown serum factors? Lastly, the etiology of unsolved cases of apparently familial @DISEASE$ remains to be discovered.	0
In two large Turkish consanguineous families, a locus for @DISEASE$ nonsyndromic hearing loss (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci @GENE$ (COL11A2), DFNB66, and DFNB67.	1
In two large Turkish consanguineous families, a locus for autosomal recessive nonsyndromic @DISEASE$ (ARNSHL) was mapped to chromosome 6p21.3 by genome-wide linkage analysis in an interval overlapping with the loci @GENE$ (COL11A2), DFNB66, and DFNB67.	1
Fine mapping excluded DFNB53 and subsequently homozygous mutations were identified in the @DISEASE$ HMGIC fusion partner-like 5 (@GENE$) gene, also named tetraspan membrane protein of hair cell stereocilia (TMHS) gene, which was recently shown to be mutated in the &quot;hurry scurry&quot; mouse and in two DFNB67-linked families from Pakistan.	1
Thus, chronic colonization with <i>ETEC</i> producing ST could contribute to endemic @DISEASE$ resistance in developing countries, reinforcing a novel paradigm of colorectal cancer chemoprevention with oral @GENE$-targeted agents	1
Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (@GENE$) are rare @DISEASE$ with distinct sets of morphological features, both characterized by maintenance of gastrointestinal epithelium immunoreactivity.	0
Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (MAPK cascade) are rare @DISEASE$ with distinct sets of morphological features, both characterized by @GENE$ immunoreactivity.	1
Although disruption of the @GENE$ (INK4A/ARF) locus has been reported in end-stage disease, information is lacking on the status of this key @DISEASE$ suppressor gene in pleural lesions preceding mesothelioma.	1
CGD is a genetically @DISEASE$ disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an autosomal recessive (AR-CGD) form caused by mutations in the @GENE$, protein targeting to membrane, NCF2, or antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	0
CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the cytochrome complex assembly, @GENE$, NCF2, or antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	1
CGD is a genetically heterogeneous disease with an X-linked recessive (XR-CGD) form caused by mutations in the CYBB gene encoding the gp91(phox) protein, and an @DISEASE$ (AR-CGD) form caused by mutations in the cytochrome complex assembly, protein targeting to membrane, NCF2, or @GENE$ genes encoding p22(phox) , p47(phox) , p67(phox) , and p40(phox) , respectively.	1
Human kallikrein-related peptidases @GENE$-15 provide a rich source of serine protease-type biomarkers associated with @DISEASE$ growth and cancer progression for a variety of malignant diseases.	1
For this, @GENE$ protein expression was assessed by immunohistochemistry in primary @DISEASE$ tissue sections (tissue microarrays) of 188 TNBC patients, mainly treated with anthracycline- or CMF-based polychemotherapy.	1
In this study, recombinant @GENE$ protein was generated and affinity-purified KLK4-directed polyclonal antibody pAb587 established to allow localization of KLK4 protein expression in @DISEASE$ cell lines and archived formalin-fixed, paraffin-embedded TNBC tumor tissue specimens.	1
Using exome sequencing, we discovered missense mutations in @GENE$, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and @DISEASE$).	1
@GENE$ and PRND are significantly over-expressed in @DISEASE$.	1
PRNP and @GENE$ appear involved with some important genes related to @DISEASE$igenesis and apoptosis.	1
We identified the first de novo variant in @GENE$ (c.2984 A &gt; G (p.(N995S)))-encoding the BK channel-that causes epilepsy, but not @DISEASE$, in two independent families.	1
The 2016 revised World Health Organization (WHO) classification of lymphoid @DISEASE$ included the category of high-grade B cell lymphomas (HGBLs) with combined MYC and BCL2 and/or @GENE$ rearrangements (double-hit, DH).	1
Using exome sequencing in a multiplex family and three simplex case subjects with an atypical association of @GENE$ with early-onset @DISEASE$, we identified two heterozygous mutations affecting Arg391 in β-tubulin 4B isotype-encoding (G2/M transition of mitotic cell cycle).	1
Using exome sequencing in a multiplex family and three simplex case subjects with an atypical association of clathrin coat assembly with early-onset @DISEASE$, we identified two heterozygous mutations affecting Arg391 in β-tubulin 4B isotype-encoding (@GENE$).	0
Independent and pooled analyses verified that higher @GENE$ mRNA levels were significantly associated with poor survival of breast @DISEASE$ patients, regardless of estrogen receptor (ER) status.	1
For in vitro studies, inhibition of @GENE$ by small-hairpin RNA significantly reduced the growth and invasion capabilities of the cells, while enhancing the cytotoxicity of doxorubicin in breast @DISEASE$ cell lines MCF-7 (ER positive) and MDA-MB-231 (ER negative).	1
In response to surgical induction of @DISEASE$, @GENE$-/- female mice develop significant fibrosis in contrast to wild-type mice.	0
The present study aimed to molecularly define and determine the contribution of two rare, apparently novel @GENE$ LGRs, among Greek breast @DISEASE$ patients.	1
Patients with HCP show &lt;50% of normal activity and those with the rare @DISEASE$ harderoporphyria accumulate harderoporphyrinogen, an intermediate porphyrin of the @GENE$ reaction.	1
To identify the disease-causing defect in these families, we first analysed @GENE$ gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and embryo development ending in birth or egg hatching) previously implicated in different forms of @DISEASE$.	1
To identify the disease-causing defect in these families, we first analysed embryo development ending in birth or egg hatching gene, then some candidate genes (CHX10, OPA1, MITF, SOX2, CRYBB1-3 and CRYBA4) and loci (MCOP1, NNO1 and @GENE$) previously implicated in different forms of @DISEASE$.	0
The results showed that the concentration of inflammatory cytokines [interleukin 1β (IL1β) and @DISEASE$ necrosis factor α (T@GENE$-α)], myeloperoxidase (low-density lipoprotein particle remodeling) activity in the lung tissue and blood, protein abundance of toll-like receptor 4 (TLR4), nuclear factor κB (NF-κB, p65), phosphorylated p65 (p-p65), inhibitor κBα (IκBα), and phosphorylated IκBα (p-IκBα), and relative mRNA expression of genes associated with inflammation, such as TLR4, NF-κB, IL1β, interleukin 6 (IL6), and TNF-α, were significantly upregulated in the LPS group compared to the PBS group.	0
Another clinically relevant form of @GENE$-related hypophosphatemic disease is @DISEASE$-induced osteomalacia (TIO), a paraneoplastic syndrome associated with FGF23-producing tumors.	1
Another clinically relevant form of @GENE$-related hypophosphatemic disease is tumor-induced @DISEASE$ (TIO), a paraneoplastic syndrome associated with FGF23-producing tumors.	1
Malonyl coenzyme A (CoA) decarboxylase (EC 4.1.1.9, @GENE$) deficiency, or malonic aciduria, is a rare inborn error of metabolism characterised by a variable phenotype of @DISEASE$, seizures, cardiomyopathy and acidosis.	0
We identified 52 variants contributing to @DISEASE$ in 2% of cases including multiple novel variants in @GENE$, which were sometimes found with accelerated growth rather than short stature as described previously.	0
Besides the hallmark features, this patient also presents problems not previously associated with @GENE$ syndrome, including cervical vertebral fusion, mild @DISEASE$, and colonic fibrosis.	0
Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving @GENE$ in 16 individuals from 13 families with variable neurodevelopmental delay and @DISEASE$ (ID)-associated autistic features, cerebellar ataxia, and epilepsy.	1
Through a multi-centric collaboration, we identified three copy-number variant deletions (two de novo and one dominantly inherited in three generations), one de novo disrupting duplication, and nine de novo point mutations (three truncating, one canonical splice site, and five missense mutations) involving @GENE$ in 16 individuals from 13 families with variable neurodevelopmental delay and intellectual disability (ID)-associated autistic features, cerebellar ataxia, and @DISEASE$.	1
The spontaneous mutant mouse staggerer, with an @DISEASE$ caused by neurodegeneration of cerebellar Purkinje cells, was discovered two decades ago to result from homozygous intragenic @GENE$ deletions.	0
siRNA-mediated suppression of @GENE$ inhibited gastric @DISEASE$ cell proliferation and colony formation by promoting cell cycle arrest at G2/M phase and increasing apoptosis.	1
@GENE$ was highly expressed in gastric tumors and gastric @DISEASE$ cells.	1
Overexpression of @GENE$ in CK5-positive cell lineages, and differential protein isoform expression, was additionally found in other tissues and @DISEASE$ types, suggesting that overexpression of Phgdh is generally associated with CK5 cells, and that oncogenic function may be determined by isoform expression.	1
CONCLUSIONS @GENE$-1 is highly expressed in human esophageal carcinoma, and could be a marker for use in assessing @DISEASE$ stage and the deciding on treatment target	1
RESULTS @GENE$-1 was associated with patient age, gender, lymphatic metastasis, @DISEASE$ recurrence, and stage, with significantly (P&lt;0.05) positive correlations with age, lymphatic metastasis, tumor recurrence, and stage.	1
We investigated glioma-associated oncogene protein-1 (@GENE$-1) expression in human @DISEASE$ tissue and the inhibition of cyclopamine on EC9706 esophageal carcinoma cell growth.	1
Individuals had microcephaly, developmental delay, @DISEASE$, and recessive mutations in @GENE$.	0
In the present review, 22 loci of @DISEASE$ are presented, including the relevant genes (myocilin, interleukin 20 receptor subunit B, optineurin, ankyrin repeat‑ and SOCS box‑containing protein 10, WD repeat‑containing protein 36, EGF‑containing fibulin‑like extracellular matrix protein 1, neurotrophin 4, TANK‑binding kinase 1, cytochrome P450 subfamily I polypeptide 1, latent transforming growth factor β binding protein 2 and @GENE$ tyrosine kinase endothelial) and 74 other genes (including toll‑like receptor 4, sine oculis homeobox Drosophila homolog of 1, doublecortin‑like kinase 1, RE repeats‑encoding gene, retinitis pigmentosa GTPase regulator‑interacting protein, lysyl oxidase‑like protein 1, heat‑shock 70‑kDa protein 1A, baculoviral IAP repeat‑containing protein 6, 5,10‑methylenetetrahydrofolate reductase and nitric oxide synthase 3 and nanophthalmos 1) that are more closely associated with glaucoma.	0
Here we used an integrative strategy to examine the hypothesis that genetic variants at @GENE$/2 binding elements may be associated with sexual dimorphism of @DISEASE$ (HCC) risk.	0
Limb girdle @DISEASE$ muscle organ development 2I (@GENE$) is a progressive disorder caused by mutations in the FuKutin-Related Protein gene (FKRP).	0
Human genetic and pharmacological animal studies support this hypothesis, but no studies have explored @GENE$ dysfunction at the molecular level in the postmortem @DISEASE$ brain.	1
Conversely, @GENE$ regulatory proteins were expressed at lower levels in @DISEASE$ subjects compared to controls (Norbin -37%, p &lt; 0.001; Tamalin -30%, p = 0.084; Preso1 -29%, p = 0.001).	1
Next, using DLD-1 colon @DISEASE$ cells inducibly expressing @GENE$, SASS6 overexpression was shown to induce centrosome amplification, mitotic abnormalities such as chromosomal misalignment and lagging chromosome, and chromosomal numerical changes.	1
To date, the genetic alteration of @GENE$ has not been reported in human @DISEASE$s.	1
Here, we show that human spnegative regulation of peptidase activity @DISEASE$ also feature strong nuclear localisation of @GENE$ and overexpression of activated YAP (NLS-YAP-5SA) with Keratin-5 (K5-CreERt) is sufficient to induce rapid formation of both SCC and spSCC in mice.	1
The aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 (@GENE$) splice variant designated DX2 is induced by cigarette smoke carcinogens and is often detected in human lung @DISEASE$ specimens.	1
The aetiology of @GENE$ is @DISEASE$, and genetics play an important role in some cases.	1
Group 1 pulmonary hypertension or @DISEASE$ (@GENE$) is a rare disease characterized by proliferation and occlusion of small pulmonary arterioles, leading to progressive elevation of pulmonary artery pressure and pulmonary vascular resistance, and right ventricular failure.	0
The aim of our study was to determine the impact of genetic polymorphisms in the caspase (@GENE$) genes on prognosis of @DISEASE$ (HCC).	1
In addition, we demonstrated that @GENE$-enhanced @DISEASE$ growth is dependent on depletion of p62 in vivo.	1
Furthermore, @GENE$ enhanced @DISEASE$ cell proliferation, viability, and colony formation in vitro via suppression of p62.	1
In this study, we aimed to clarify the phenotypic spectrum of @GENE$/A2 mutations in the context of cortical malformations that include @DISEASE$, polymicrogyria and/or heterotopia	1
Functional studies support intraocular pressure-related influences of FMNL2 and @GENE$, with certain regulation of transcription, DNA-templated mutations causing high IOP and @DISEASE$ resembling POAG in mice.	1
Functional studies support intraocular pressure-related influences of FMNL2 and regulation of transcription, DNA-templated, with certain @GENE$ mutations causing high IOP and @DISEASE$ resembling POAG in mice.	1
Our results demonstrated pairwise epistatic interactions between @GENE$ and protein polyubiquitination SNPs that ERCC6 rs1917799-ERCC8 rs158572 combination was associated with decreased risk of chronic atrophic gastritis and increased risk of gastric @DISEASE$.	1
Our results demonstrated pairwise epistatic interactions between response to oxidative stress and @GENE$ SNPs that ERCC6 rs1917799-ERCC8 rs158572 combination was associated with decreased risk of chronic atrophic gastritis and increased risk of gastric @DISEASE$.	0
In conclusion, @GENE$ rs1917799, protein polyubiquitination rs158572 and rs158916 demonstrated pairwise epistatic interactions to associate with chronic atrophic gastritis and gastric @DISEASE$ risk.	1
In conclusion, response to oxidative stress rs1917799, @GENE$ rs158572 and rs158916 demonstrated pairwise epistatic interactions to associate with chronic atrophic gastritis and gastric @DISEASE$ risk.	1
In situ @GENE$ and protein polyubiquitination protein expression were detected by immunohistochemistry in 109 chronic superficial gastritis, 109 chronic atrophic gastritis and 109 gastric @DISEASE$ cases.	1
In situ response to oxidative stress and @GENE$ protein expression were detected by immunohistochemistry in 109 chronic superficial gastritis, 109 chronic atrophic gastritis and 109 gastric @DISEASE$ cases.	1
ERCC6 rs1917799 also showed a significant interaction with @GENE$ rs158916 to reduce gastric @DISEASE$ risk.	1
@GENE$ mutations have been linked to neurodegenerative PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and early-onset cataract), a rare, @DISEASE$, autosomal, recessive disease.	1
BBN @DISEASE$ showed overexpression of markers of basal cancer subtype, and had a high mutation burden with frequent Trp53 (80%), Kmt2d (70%), and @GENE$ (90%) mutations by exome sequencing, similar to human MIBC.	1
Here, we report that @GENE$ is highly overexpressed in multiple lung adenocarcinoma cell lines and @DISEASE$ tissues.	1
Our study indicates the novel @GENE$ p.W371G missense mutation causes infantile onset @DISEASE$ and cerebellar hypoplasia in recessive mode of inheritance.	1
Our study indicates the novel @GENE$ p.W371G missense mutation causes infantile onset intellectual disability and cerebellar hypoplasia in recessive @DISEASE$.	0
Our findings imply that @DISEASE$ is a variable phenomuscle organ development in @GENE$-related disease, suggest WDR73 to be a candidate gene of severe intellectual disability and cerebellar hypoplasia, and expand the molecular spectrum of WDR73-related disease	1
In Chinese siblings with late-onset @GENE$, the main clinic manifestation and abnormal radioimaging were cognitive decline and @DISEASE$ respectively.	0
Subsequent quantitative PCR experiments confirmed that PRDX4, @GENE$, MAGED2, and an EST (GenBank accession number BF696304) were expressed at significantly higher levels in @DISEASE$ with metastasis.	1
Here, we show that selective overexpression of the stress protein, heme oxygenase-1 (HO-1) in astrocytes of GFAP.HMOX1 transgenic mice between 8.5 and 19 months of age results in nigrostriatal hypodopaminergia associated with locomotor @DISEASE$ and stereotypy; downregulation of tyrosine hydroxylase, DAT, LMX1B, @GENE$, Pitx3 and DJ-1 mRNA and/or protein; overproduction of α-synuclein and ubiquitin; oxidative stress; basal ganglia siderosis; mitochondrial damage/mitophagy; and augmented GABAergic systems (increased GABA, GAD67 and reelin).	0
Of the 465,447 CpG sites analyzed, 12 showed differential methylation (false discovery rate &lt;0.15), including markers within genes associated with monogenic diabetes (@GENE$) or @DISEASE$ (positive regulation of transcription by RNA polymerase II).	0
Of the 465,447 CpG sites analyzed, 12 showed differential methylation (false discovery rate &lt;0.15), including markers within genes associated with monogenic diabetes (regulation of transcription by RNA polymerase II) or @DISEASE$ (@GENE$).	0
CD164 was co-expressed with @GENE$ on circulating CD4<sup>+</sup> T cells from high @DISEASE$ burden SS patients, further providing strong support for CD164 as a disease relevant surface biomarker	1
Oropharyngeal @DISEASE$ associations were limited to the human leukocyte antigen (HLA) region, and classical HLA allele imputation showed a protective association with the class II haplotype HLA-DRB1*1301-HLA-DQA1*0103-@GENE$*0603 (odds ratio (OR) = 0.59, P = 2.7 × 10<sup>-9</sup>).	1
The contiguous deletion of @GENE$ and its neighbouring genes, MAOA/B and cellular response to leukemia inhibitory factor, reportedly leads to syndromic clinical features such as microcephaly, @DISEASE$, and epilepsy.	1
Here, we identified three families with mutations in @GENE$, encoding for adducin-γ, with @DISEASE$, microcephaly, cataracts and skeletal defects.	0
Here, we identified three families with mutations in @GENE$, encoding for adducin-γ, with intellectual disability, @DISEASE$, cataracts and skeletal defects.	1
This review reflects the existing @GENE$/ephrin littranscription by RNA polymerase IIture while focusing on breast @DISEASE$ heterogeneity.	0
Depletion of the exon 3-containing long isoform of @GENE$ (MRPL33-L) led to impaired proliferation and increased apoptosis in @DISEASE$ cell lines and in a xenograft model.	1
More importantly, overexpression of @GENE$-L could increase @DISEASE$igenic potential of hnRNPK-depleted cancer cells, likely indicating that hnRNPK mediates tumorigenesis through splicing regulation of MRPL33 pre-mRNA.	0
Glutaric aciduria muscle organ development I (GA-I) is a rare organic aciduria caused by the @DISEASE$ inherited deficiency of glutaryl-CoA dehydrogenase (@GENE$).	0
The correlations between the expressions of CTHRC1 with clinicopathologic features,E-@GENE$ and Vimentin expression were analyzed.<b>Result:</b>CTHRC1 protein expression levels in @DISEASE$ tissue were significantly higher than those in adjacent normal thyroid tissue and benign disease(<i>P</i>&lt;0.01);CTHRC1 expression was significantly correlated with lymph node metastases(<i>P</i>&lt;0.05).	1
<b>Objective:</b>To investigate the expression and significance of @GENE$ in patients with papillary thyroid cancinoma.<b>Method:</b>We collected 63 specimens of @DISEASE$ tissue with 36 specimens of the adjacent normal thyroid tissue and 23 specimens of thyroid nodular goiter.	0
Finally, we show evidence that abnormal protein homeostasis is a prevalent mechanism responsible for @GENE$ deficiency and that modulators of UROS proteolysis such as proteasome inhibitors or chemical chaperones may represent an attractive therapeutic option to reduce porphyrin accumulation and prevent @DISEASE$ in CEP patients when the genotype includes a missense variant	0
Here, we show that breast-ovarian @DISEASE$ susceptibility 1 (@GENE$) interacts directly with actin cytoskeleton reorganization-interacting protein (ATRIP), an obligate partner of ATR.	1
Here, we show that breast-ovarian @DISEASE$ susceptibility 1 (double-strand break repair via homologous recombination) interacts directly with @GENE$-interacting protein (ATRIP), an obligate partner of ATR.	0
Single marker-based association tests for corneal @DISEASE$ identified four genome-wide significant loci (P &lt; 5 × 10<sup>-8</sup>) near the genes ZC3H11B (1q41), LINC00340 (6p22.3), @GENE$/OCA2 (15q13.1) and NPLOC4/TSPAN10 (17q25.3).	0
These loci have previously demonstrated association with axial length (ZC3H11B), @DISEASE$ (@GENE$), spherical equivalent refractive error (LINC00340) and eye colour (HERC2).	0
Aim of this study was to analyze the @GENE$ mRNA and protein expression in soft tissue @DISEASE$ and their association with patient outcome.	1
As the first report in Korea, this study identified three @GENE$ mutations as the underlying cause of axonal @DISEASE$ neuropathy with or without the HSP phenomuscle organ development.	0
Mutations in the @GENE$ showed a wide phenotypic spectrum from hereditary spastic paraplegia (HSP) to axonal Charcot-Marie-Tooth @DISEASE$ neuropathy muscle organ development 2 (microtubule-based movement).	1
The p.Arg204Trp mutation was identified from a @GENE$ patient with additional complex phenotypes of HSP, @DISEASE$, fatigability and pyramidal sign, but the p.Arg280His and p.Leu588Pro mutations were identified in each axonal CMT2 patient.	1
Here, we show that biallelic <i>@GENE$</i> deletion with <i>aP2-Cre</i> drives aggressive and metastatic @DISEASE$ independent of other genetically engineered oncogenes or tumor suppressor loss.	0
Here, we show that biallelic <i>@GENE$</i> deletion with <i>aP2-Cre</i> drives aggressive and metastatic angiosarcoma independent of other genetically engineered oncogenes or @DISEASE$ suppressor loss.	1
These studies illustrate that @GENE$ can function as a traditional loss-of-function @DISEASE$ suppressor gene, and they provide a fully penetrant animal model for the study of angiosarcoma development and metastasis.	1
Functional studies suggested that @GENE$ functions as a @DISEASE$ suppressor, as overexpression of CAB39L elicited suppression of multiple cancer phenotypes both in GC cells and an orthotopic mouse model; whilst its knockdown promoted tumorigenesis.	1
Functional studies suggested that @GENE$ functions as a tumor suppressor, as overexpression of CAB39L elicited suppression of multiple @DISEASE$ phenotypes both in GC cells and an orthotopic mouse model; whilst its knockdown promoted tumorigenesis.	1
Our data demonstrate that CAB39L is a novel @DISEASE$ suppressor which suppresses tumorigenesis by promoting LKB1-@GENE$-PGC1α axis, thereby preventing a metabolic shift that drives carcinogenesis.	1
Moreover, knockdown of LKB1 reversed growth inhibitory effect of @GENE$, indicating that @DISEASE$ suppression by CAB39L depended on LKB1-AMPK.	1
This disease is an @DISEASE$ disorder, and the gene @GENE$, which encodes cystatin B, a cysteine protease inhibitor, is the only gene known to be associated with ULD.	1
@GENE$ was identified from MS analysis, and its level was revealed to be correlated with the disease grade, clinical severity, and survival rate of patients with @DISEASE$.	1
Keratitis-ichthyosis-@DISEASE$ (KID) syndrome is a rare genodermatosis that typically results from mutations of the gap junction-mediated intercellular transport gene or, less commonly, the @GENE$ gene.	1
Keratitis-ichthyosis-@DISEASE$ (KID) syndrome is a rare genodermatosis that typically results from mutations of the @GENE$ gene or, less commonly, the apoptotic process gene.	1
@GENE$R2 overexpression is associated with increased risk of pelvic lymph node metastasis (PLNM, p = 0.001) and @DISEASE$ relapse (p = 0.009).	1
@GENE$ (Immunoglobulin Superfamily 1) gene defects cause @DISEASE$ hypothyroidism and macroorchidism.	1
@GENE$ (Immunoglobulin Superfamily 1) gene defects cause central @DISEASE$ and macroorchidism.	1
In conclusion, two relevant molecular mechanisms linked to central hypothyroidism and @DISEASE$ in @GENE$ deficiency are identified, revealing IGSF1 as an important regulator of TGFβ/Activin pathways in the pituitary	1
Our report of variant in @GENE$ Leading to Joubert syndrome phenotype (JS30), elucidates the genetic @DISEASE$ of Joubert syndrome, and expands the gene list for ciliopathies	0
The mitochondrial protein @GENE$ has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital ponto@DISEASE$.	0
The mitochondrial protein @GENE$ has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited @DISEASE$, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.	1
In summary, our results reveal that rare loss-of-function variants in @GENE$ increase the risk for a varying combination of epilepsy, @DISEASE$/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern	1
In these @DISEASE$, regulation of cell adhesion gene fusion product provides a constitutively active tyrosine kinase (@GENE$), leading to uncontrolled cellular proliferation, differentiation, and migration.	1
In these @DISEASE$, @GENE$ gene fusion product provides a constitutively active tyrosine kinase (glucose catabolic process), leading to uncontrolled cellular proliferation, differentiation, and migration.	1
RESULTS For those 384 cases, 7 (1.82%) cases had @DISEASE$ with identified @GENE$ rearrangement.	1
BACKGROUND @GENE$ rearrangements have been reported in 30% of papillary thyroid carcinomas and 1-2% of non-small cell lung @DISEASE$ (NSCLC).	0
@GENE$ mRNA is induced by peripheral nervous system development-kB, and overexpression of TNFAIP8 has been correlated with poor prognosis in many @DISEASE$s.	1
positive regulation of apoptotic process mRNA is induced by @GENE$-kB, and overexpression of TNFAIP8 has been correlated with poor prognosis in many @DISEASE$s.	0
Depending on the @DISEASE$ cell type, knockdown of positive regulation of apoptotic process was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, homophilic cell adhesion via plasma membrane adhesion molecules, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, @GENE$, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	1
Depending on the @DISEASE$ cell type, knockdown of positive regulation of apoptotic process was found to be associated with increased mRNA expression of several antiproliferative and apoptotic genes (e.g., IL-24, @GENE$, LPHN2, EPHA3) and fatty acid oxidation gene ACADL, and decreased mRNA levels of oncogenes (e.g., NFAT5, MALAT1, MET, response to estradiol, KRAS, S100P, OSTF1) and glutamate transporter gene SLC1A1.	1
Here we have investigated the effects of depletion of @GENE$ on the mRNA, microRNA and protein expression profiles in prostate and breast @DISEASE$s and melanoma.	1
We analyzed the nucleotide repeat lengths of 6 genes (ATXN8, @GENE$, PPP2R2B, NOP56, DMPK, and JPH3) that have previously been associated with neurologic or neuromuscular disorders, in several hundred @DISEASE$ patients with ALS and healthy control subjects.	1
Reduced representation bisulfite sequencing (RRBS) and gene expression microarrays were performed in the phosphatidylinositol phosphorylation @DISEASE$ and non-HCC liver tissues to investigate the molecular mechanisms of @GENE$-2-driven HCC.	1
In conclusion, this study demonstrated for the first time that enhanced COX-2 expression in hepatocytes is sufficient to induce HCC through inducing promoter hypermethylation by reducing @GENE$, silencing @DISEASE$-suppressive genes and activating key oncogenic pathways.	1
We characterize adult-onset, progressive clinical symptoms of two afflicted kindred and introduce the symptom of @DISEASE$ spasticity not previously associated with the @GENE$ phenotype.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, @GENE$, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, @GENE$, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, @GENE$, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	1
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, @GENE$, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	1
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, @GENE$, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause @DISEASE$ Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital macrothrombocytopenia, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, @GENE$P1, mitochondrial respiratory chain complex IV assembly, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, @GENE$, negative regulation of ERK1 and ERK2 cascade, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	0
Likely haploinsufficiency of one or several of the 19 genes in the common deleted interval (ACTN1, DCAF5, double-strand break repair via homologous recombination, GALNTL1, nucleobase-containing compound metabolic process, zinc ion transport, PLEKHD1, CCDC177, cellular response to DNA damage stimulus, LOC100289511, mRNA splicing, via spliceosome, SLC10A1, eye development, mitochondrial calcium ion transmembrane transport, single fertilizationP1, mitochondrial respiratory chain complex IV assembly, @GENE$, SYNJ2BP-COX16, ADAM21) was responsible for these manifestations, but apart from SMOC1, mutations in which cause autosomal recessive Waardenburg anophthalmia syndrome, and ACTN1, mutations in which are associated with congenital @DISEASE$, no disease associations have so far been reported for the other genes.	1
@GENE$ has been shown to be crucial to the progression of human @DISEASE$s.	1
Our data showed that @GENE$ expression gradually increased from normal to @DISEASE$ to metastatic tissues.	1
In a @DISEASE$ with inv(12), exon 3 of negative regulation of transcription by RNA polymerase II was fused to a sequence in intron 1 of the @GENE$ gene from 12q22.	1
In a @DISEASE$ with inv(12), exon 3 of @GENE$ was fused to a sequence in intron 1 of the positive regulation of apoptotic process gene from 12q22.	1
In the leiomyomas with 12q rearrangements, both @GENE$ and PLAG1 were expressed whereas in the @DISEASE$s with 8q aberrations, only PLAG1 was expressed.	1
We extend the @GENE$ associated phenotype by describing a syndrome characterized by primordial dwarfism, @DISEASE$, polysyndactyly, and dental anomalies, which is caused by a homozygous truncating KATNB1 mutation	1
Interestingly, de novo loss-of-function and missense variants in @GENE$ were identified in patients with @DISEASE$ (ID) and autism spectrum disorder (ASD) but also in unaffected individuals.	1
Proteomic analysis of 12 tumours from an @GENE$-driven @DISEASE$ mouse model revealed that NME1 and nucleoside diphosphate phosphorylation, the only known mammalian histidine kinases, were upregulated.	1
Proteomic analysis of 12 tumours from an regulation of cell growth-driven @DISEASE$ mouse model revealed that NME1 and @GENE$, the only known mammalian histidine kinases, were upregulated.	1
To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in @DISEASE$ development (MAPK8, @GENE$, MAP3K12, MAPK3, protein phosphorylation, MAPK7 and negative regulation of transcription by RNA polymerase II), were calculated.	1
To gain an insight into the likely molecular basis of their observed cytotoxic effects, Autodock Vina binding free energies of each of the isolated compounds with seven molecular targets implicated in @DISEASE$ development (MAPK8, protein phosphorylation, MAP3K12, MAPK3, @GENE$, MAPK7 and negative regulation of transcription by RNA polymerase II), were calculated.	1
A large, complex, and robust gene network containing well-known lung cancer-related genes, including @GENE$ and transcription, RNA-templated, was identified from combined gene lists for @DISEASE$.	0
Further @GENE$ proportional hazard models analysis revealed that the reduced expression of PLIN1 is an independent predictor of overall survival in estrogen receptor positive (p &lt; 0.0001, HR = 0.87, 95% CI = 0.81-0.92, N = 3,600) and luminal A-subtype (p = 0.02, HR = 0.88, 95% CI = 0.78-0.98, N = 1,469) breast @DISEASE$ patients.	1
Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&gt;C, p.V378L) @GENE$ mutation in a patient with global developmental delay, intellectual disability, severe @DISEASE$, but no episode of epilepsy until the lastly examined age of 6 years old.	1
Using whole-exome sequencing, we identified a novel de novo missense (c.1132G&gt;C, p.V378L) @GENE$ mutation in a patient with global developmental delay, intellectual disability, severe speech impairment, but no episode of @DISEASE$ until the lastly examined age of 6 years old.	1
We present a case of a patient with long-standing hyperpigmented macules and @DISEASE$ over his chest, abdomen, back and @GENE$, suggestive of Dowling-Degos disease (DDD).	0
Familial adenomatous polyposis (@GENE$) is an autosomal dominant‑inherited colorectal @DISEASE$.	0
We present a case of @DISEASE$-dystonia syndrome illustrated by three videos in which we found a novel @GENE$ mutation.	1
PRUNE is a member of the @GENE$ (Asp-His-His) phosphoesterase protein superfamily of molecules important for cell motility, and implicated in @DISEASE$ progression.	1
In this study, we have found that @GENE$ expression was greatly decreased in clinical HCC samples, positively correlated with overall survival, and negatively associated with histological differentiation, @DISEASE$ size and organ metastasis.	1
Five variants were previously reported to confer risk of various malignant or benign tumors (rs78378222 in TP53, rs10069690 in @GENE$, rs1800057 and rs1801516 in ATM, and rs7907606 at OBFC1) and four signals are located at established risk loci for hormone-related negative regulation of transcription by RNA polymerase II (endometriosis and breast @DISEASE$) at 1q36.12 (CDC42/WNT4), 2p25.1 (GREB1), 20p12.3 (MCM8), and 6q26.2 (SYNE1/ESR1).	1
We noted that Sirtuin 1 (@GENE$) is overexpressed in HPV-infected cervical @DISEASE$ cells and hypothesized that SIRT1 counteracts antiviral immunity.	1
In conclusion, SIRT1 enabled HPV-infected cervical @DISEASE$ cells to continue growing by nullifying @GENE$ inflammasome-mediated immunity.	1
Without SIRT1, cervical @DISEASE$ cells could no longer survive because of the derepression of the @GENE$ inflammasome.	1
Furthermore, the growth of cervical @DISEASE$ xenografts was significantly inhibited by either @GENE$-targeting siRNAs or SIRT1-knockdown-derived extracellular vesicles.	1
However, the functions of @GENE$ in the thyroid gland and the mechanism by which GLIS3 dysfunction causes @DISEASE$ are unknown.	0
Four established @DISEASE$ susceptibility genes achieved nominal statistical significance, MC1R (p = .0014), MITF (p = .0165) BRCA2 (p = .0206), and @GENE$ (p = .0393).	0
The data indicate a significant role of @GENE$ for mitotic cell cycle progression and survival of MYCN-amplified @DISEASE$ cells, and suggests that HDAC11 could be a valuable drug target	1
Although ABCD1 is responsible for X-linked @GENE$ (X-ALD), its phenotype differs from that of CADDS, which manifests with many features of Zellweger syndrome (ZS), including severe growth and developmental retardation, @DISEASE$, cholestasis and early infantile death.	0
The @GENE$-expressing @DISEASE$ cells coexpressed vimentin but repressed E-cadherin and exhibited invasive behavior.	1
Markers such as SERPINI1, biological_process, and @GENE$ were modulated by ABBV-075 and other central nervous system development inhibitors across cancer cell lines and xenograft @DISEASE$ but not in blood and skin.	1
Markers such as SERPINI1, biological_process, and negative regulation of cell migration were modulated by ABBV-075 and other @GENE$ inhibitors across cancer cell lines and xenograft @DISEASE$ but not in blood and skin.	0
Until recently, four loci (DFN2, @GENE$, DFN4, and DFN6) had been implicated in nonsyndromic X-linked @DISEASE$; however, a new classification (purine nucleobase metabolic process-5) has been proposed to reduce confusion in the terminology.	1
Until recently, four loci (DFN2, cochlea morphogenesis, DFN4, and DFN6) had been implicated in nonsyndromic X-linked @DISEASE$; however, a new classification (@GENE$-5) has been proposed to reduce confusion in the terminology.	1
To better understand @GENE$ and its role in modifying @DISEASE$, we created transgenic epidermis development overexpressing the protective murine allele of LTBP4 specifically in mature myofibers using the human skeletal actin promoter.	1
Several myotubularins have been genetically linked to human diseases: @GENE$ is mutated in the congenital @DISEASE$ X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while phosphatidylinositol dephosphorylation and myelination are mutated in Charcot-Marie-Tooth (CMT) neuropathies.	1
Several myotubularins have been genetically linked to human diseases: protein dephosphorylation is mutated in the congenital @DISEASE$ X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while @GENE$ and myelination are mutated in Charcot-Marie-Tooth (CMT) neuropathies.	1
Several myotubularins have been genetically linked to human diseases: protein dephosphorylation is mutated in the congenital @DISEASE$ X-linked centronuclear or myotubular myopathy (XLCNM) and MTMR14 (JUMPY) has been linked to an autosomal form of such disease, while phosphatidylinositol dephosphorylation and @GENE$ are mutated in Charcot-Marie-Tooth (CMT) neuropathies.	1
Whole exome sequencing in triple negative breast @DISEASE$ cases (n = 8) and targeted sequencing in healthy controls (n = 48) revealed BRIP1 rs552752779 (@GENE$: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), signal transduction rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), DNA repair rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	0
Whole exome sequencing in triple negative breast @DISEASE$ cases (n = 8) and targeted sequencing in healthy controls (n = 48) revealed BRIP1 rs552752779 (transcription by RNA polymerase II: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), @GENE$ rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), DNA repair rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	1
Whole exome sequencing in triple negative breast @DISEASE$ cases (n = 8) and targeted sequencing in healthy controls (n = 48) revealed BRIP1 rs552752779 (transcription by RNA polymerase II: 75% vs. 6.25%, OR 45.00, 95% CI 9.43-243.32), signal transduction rs527779103 (MAF: 62.5% vs. 7.29%, OR 21.19, 95% CI 5.11-94.32), ERCC2 rs121913016 (MAF: 56.25% vs. 7.29%, OR 16.34, 95% CI 4.02-70.41), @GENE$ rs2020912 (MAF: 56.25% vs. 1.04%, OR 122.13, 95% CI 12.29-2985.48) as risk factors for triple negative breast cancer.	1
We found that rs1042752-located in the 3'-UTR of @GENE$, which plays a vital role in @DISEASE$genesis-was significantly associated with lymphoma risk in a case-control study with 793 patients and 939 controls.	0
Cystinuria is a @DISEASE$, rare but important cause of inherited kidney stone disease due to mutations in 2 genes: @GENE$ and SLC7A9.	1
These studies suggest that compound 4d behaves well in lowering body weight and maintaining energy expenditure without a chance of hyperglycaemia, 4d has strong clinical potential as an efficient GLP-1/@GENE$ agonist in the prevention and treatment of @DISEASE$ and dyslipidemia	0
Familial hypercholesterolemia (FH) is mostly caused by low-density lipoprotein receptor (@GENE$) mutations and results in an increased risk of early-onset @DISEASE$ due to marked elevation of LDL cholesterol (LDL-C) in blood.	1
Basic immunological assessments have confirmed that this strain of human CD3 EDG-replaced epidermis development are entirely immune competent, and we have also demonstrated that a bispecific antibody that simultaneously binds to human CD3 and a @DISEASE$-associated antigen (e.g. @GENE$ or GPC3) can be evaluated in human CD3 EDG-replaced mice engrafted with tumors.	1
In severe bilateral cases (anophthalmia or severe @DISEASE$) the genetic cause is now identifiable in approximately 80 percent of cases, with de novo heterozygous loss-of-function mutations in @GENE$ or OTX2 being the most common.	1
Concurrently, global transcriptional profiling analysis reveals that multiple @DISEASE$-associated genes such as CCND3, E2F1/2, sensory perception of sound, Bcl2 modifying factor (BMF), @GENE$, and Myc; and signaling pathways of cellular dedifferentiation, proliferation, adhesion, survival including p53, cadherin, Myc, and anti-apoptotic pathways are differentially expressed or significantly altered in these lung epithelial cells upon downregulation of H2Bub1.	0
Consistent with our description of this pathway and the phenotype of patients with @GENE$ mutations, mice with a targeted deletion of Mlk3 displayed multiple skeletal defects, including @DISEASE$, deficient calvarial mineralization, and reduced bone mass.	1
We describe two families in which two different homozygous @GENE$ mutations (missense and frameshift deletion) segregate with a phenotype comprising intellectual disability and progressive @DISEASE$.	1
An array of @DISEASE$ syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, @GENE$, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (@GENE$, tricarboxylic acid cycle, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of @DISEASE$, and a specific subtype of gastrointestinal stromal tumors (GIST).	0
An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, @GENE$, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-pheochromocytomas, a diverse group of @DISEASE$, and a specific subtype of gastrointestinal stromal tumors (GIST).	0
An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, @GENE$, tricarboxylic acid cycle, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary paraganglioma-@DISEASE$, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
An array of tumor syndromes caused by complex II-associated gene mutations, in both succinate dehydrogenase and associated accessory factor genes (succinate metabolic process, tricarboxylic acid cycle, @GENE$, SDHD, SDHAF1, SDHAF2), have been identified over the last 12 years and include hereditary @DISEASE$-pheochromocytomas, a diverse group of renal cell carcinomas, and a specific subtype of gastrointestinal stromal tumors (GIST).	1
The expression pattern of @GENE$ in gastric @DISEASE$ tissue and adjacent non-cancerous tissue was detected by immunohistochemistry.	1
These @GENE$NAs may play a role in pathways previously implicated in @DISEASE$ and coenzyme A biosynthetic process as biomarkers for disease pathogenesis	0
While none of these miRNAs have been previously linked to @DISEASE$, miR-122-5p may target three glaucoma-associated genes: @GENE$, ER overload response and TGF-ß1.	1
